signpath10q20120930.htm

0001096906-12-002851.txt : 20121114 0001096906-12-002851.hdr.sgml : 20121114 20121114173611 ACCESSION NUMBER: 0001096906-12-002851 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20120930 FILED AS OF DATE: 20121114 DATE AS OF CHANGE: 20121114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SignPath Pharma, Inc. CENTRAL INDEX KEY: 0001455694 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205079533 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-158474 FILM NUMBER: 121205848 BUSINESS ADDRESS: STREET 1: 1375 CALIFORNIA ROAD CITY: QUAKERTOWN STATE: PA ZIP: 18951 BUSINESS PHONE: 267-772-0107 MAIL ADDRESS: STREET 1: 1375 CALIFORNIA ROAD CITY: QUAKERTOWN STATE: PA ZIP: 18951 10-Q 1 signpath10q20120930.htm SIGNPATH PHARMA INC.FORM 10-Q SEPTEMBER 30, 2012 signpath10q20120930.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

ý	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: SEPTEMBER 30, 2012

¨	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to __________

Commission file number: 333-158474

SIGNPATH PHARMA INC.

(Exact name of Registrant as specified in its charter)

Delaware	20-5079533
(State or other jurisdiction of	(IRS Employer
incorporation or organization)	Identification No.)

1375 California Road

Quakertown, PA 18951

(Address of principal executive offices)

(215) 538-9996

(Registrant’s telephone number, including Area Code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ý Yes ¨ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ý Yes ¨ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated file” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer ¨

Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting company ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes ý No

APPLICABLE ONLY TO CORPORATE ISSUERS

As of November 15, 2012, the Company had authorized 45,000,000 shares, $.001 par value, common stock, of which 12,837,500 shares of common stock were issued and outstanding.

SignPath Pharma Inc.

Quarterly Report on Form 10-Q

Period Ended September 30, 2012

Table of Contents

	Page
PART I . FINANCIAL INFORMATION

Item 1. Financial Statements:

Condensed Balance Sheets as of September 30, 2012 (unaudited) and December 31, 2011 (audited)	4

Condensed Statements of Operations for the three and nine months ended September 30, 2012 and 2011 and for the period from Inception
on May 15, 2006 through September 30, 2012 (unaudited).	5

Condensed Statements of Cash Flows for the nine months ended September 30, 2012 and 2011 and for the period from
Inception on May 15, 2006 through September 30, 2012 (unaudited)	6

Notes to Condensed Financial Statements (unaudited)	7-17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation	18-23

Item 3. Quantitative and Qualitative Disclosures About Market Risk	23

Item 4. Evaluation of Disclosure Controls and Procedures	23

PART II . OTHER INFORMATION

Item 1. Legal Proceedings	24

Item 1A. Risk Factors – Not Applicable	24

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	24

Item 3. Defaults Upon Senior Securities	25

Item 4. Mine Safety Disclosures	25

Item 5. Other Information	25

Item 6. Exhibits	25

SIGNATURES	27

SIGNPATH PHARMA, INC.
(A Development Stage Company)
Balance Sheets
(Unaudited)

ASSETS

	September 30,			December 31,
	2012			2011
CURRENT ASSETS

Cash	$	74,934		$	20,424

Total Current Assets		74,934			20,424

EQUIPMENT, net		460			1,409

TOTAL ASSETS	$	75,394		$	21,833


LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES

Accounts payable and accrued expenses	$	534,710		$	499,435
Related party note payable		20,075			-
Derivative liability		5,660,208			5,377,308

Total Current Liabilities		6,214,993			5,876,743


STOCKHOLDERS' DEFICIT

Preferred stock; $0.10 par value, 5,000,000 shares
authorized 5,217 and 4,286 shares issued and
outstanding, respectively		522			429
Common stock; $0.001 par value, 45,000,000 shares
authorized; 12,837,500 and 12,830,000 shares issued
and outstanding, respectively		12,839			12,831
Additional paid-in capital		2,047,844			1,532,432
Deficit accumulated during the development stage		(8,200,804	)		(7,400,602	)

Total Stockholders' Deficit		(6,139,599	)		(5,854,910	)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	75,394		$	21,833

The accompanying notes are an integral part of these financial statements.

SIGNPATH PHARMA, INC.

(A Development Stage Company)

Statements of Operations

(Unaudited)


													From Inception
													on May 15, 2006
	For the Three Months Ended						For the Nine Months Ended						Through
	September 30						September 30						September 30
	2012			2011			2012			2011			2012

REVENUES	$	-		$	-		$	-		$	-		$	-

OPERATING EXPENSES

General and administrative		15,177			40,723			29,889			113,916			1,233,932
Professional fees		20,825			35,685			66,363			116,917			920,130
Financing expense		-			-			-			-			1,063,401
Research and development		173,108			161,765			517,590			934,972			3,034,224
Salaries and wages		52,486			-			153,437			-			947,432

Total Operating Expenses		261,596			238,173			767,279			1,165,805			7,199,119

OPERATING LOSS		(261,596	)		(238,173	)		(767,279	)		(1,165,805	)		(7,199,119	)

OTHER INCOME (EXPENSE)

Gain (loss) on derivative liability		(18,385	)		(177,011	)		(32,923	)		(172,327	)		(1,019,246	)
Grant income		-			-			-			-			81,556
Interest expense		-			-			-			-			(63,995	)

Total Other Income (Expense)		(18,385	)		(177,011	)		(32,923	)		(172,327	)		(1,001,685	)

NET LOSS BEFORE INCOME TAXES		(279,981	)		(415,184	)		(800,202	)		(1,338,132	)		(8,200,804	)
Provision for income taxes		-			-			-			-			-

NET LOSS	$	(279,981	)	$	(415,184	)	$	(800,202	)	$	(1,338,132	)	$	(8,200,804	)

BASIC AND DILUTED LOSS PER SHARE	$	(0.02	)	$	(0.03	)	$	(0.06	)	$	(0.11	)

WEIGHTED AVERAGE NUMBER
OF SHARES OUTSTANDING		12,835,462			12,190,000			12,831,834			12,190,000

The accompanying notes are an integral part of these financial statements.

SIGNPATH PHARMA, INC.

(A Development Stage Company)

Statements of Cash Flows

(Unaudited)

							From Inception
							on May 15, 2006
	For the Nine Months Ended						Through
	September 30,						September 30,
	2012			2011			2012

OPERATING ACTIVITIES

Net loss	$	(800,202	)	$	(1,338,132	)	$	(8,200,804	)
Adjustments to reconcile net loss to
net cash used in operating activities:
Common stock issued for services		6,375			-			1,272,875
Warrants and options issued for services		14,443			17,526			77,021
Common stock issued with bridge financing		-			-			1,139,001
Depreciation expense		949			948			4,930
Change in derivative liability, net of bifurcation		32,923			172,327			1,019,246
Notes payable issued for services		-			5,000			-
Changes in operating assets and liabilities
Accounts payable and accrued expenses		35,272			573,072			534,707

Net Cash Used in Operating Activities		(710,240	)		(569,259	)		(4,153,024	)

INVESTING ACTIVITIES

Purchase of equipment		-			-			(5,390	)

Net Cash Used in Investing Activities		-			-			(5,390	)

FINANCING ACTIVITIES

Preferred stock issued for cash		931,000			1,018,499			4,326,500
Stock offering costs paid		(186,325	)		(173,966	)		(1,013,102	)
Common stock issued for cash		-			-			10,000
Proceeds from notes payable		55,075			-			944,950
Repayments of notes payable		(35,000	)		-			(35,000	)

Net Cash Provided by Financing Activities		764,750			844,533			4,233,348

NET INCREASE (DECREASE) IN CASH		54,510			275,274			74,934
CASH AT BEGINNING OF PERIOD		20,424			48,993			-

CASH AT END OF PERIOD	$	74,934		$	324,267		$	74,934

SUPPLEMENTAL DISCLOSURES OF
CASH FLOW INFORMATION:

CASH PAID FOR:
Interest	$	-		$	-		$	-
Income taxes	$	-		$	-		$	-

NON CASH FINANCING ACTIVITIES:
Preferred stock issued for bridge financing	$	-		$	-		$	889,875
Derivative liability	$	249,979		$	1,531,796		$	4,640,965

The accompanying notes are an integral part of these financial statements.

SIGNPATH PHARMA, INC.

Note to the Financial Statement

September 30, 2012 and Decemeber 31, 2011

(unaudited)

NOTE 1 - CONDENSED FINANCIAL STATEMENTS

The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at September 30, 2012, and for all periods presented herein, have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2011 audited financial statements. The results of operations for the period ended September 30, 2012 are not necessarily indicative of the operating results for the full year.

NOTE 2 - GOING CONCERN

The Company's financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. During the nine months ended September 30, 2012, the Company recognized sales revenue of $-0- and incurred a net loss of $800,202. As of September 30, 2012, the Company had an accumulated deficit of $8,200,804. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's planned business. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Reclassification of Financial Statement Accounts

Certain amounts in the September 30, 2011 financial statements have been reclassified to conform to the presentation in the September 30, 2012 financial statements.

Derivative Financial Instruments

The Company generally does not use derivative financial instruments to hedge exposures to cash-flow risks or market-risks that may affect the fair values of its financial instruments. The Company utilizes various types of financing to fund our business needs, including preferred stock with warrants attached and other instruments not indexed to our stock. The Company is required to record its derivative instruments at their fair value. Changes in the fair value of derivatives are recognized in earnings in accordance with ASC 815.

Fair Value of Financial Instruments

In accordance with ASC 820, the carrying value of cash and cash equivalents, accounts receivable and accounts payable approximates fair value due to the short-term maturity of these instruments. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The carrying amounts reported in the balance sheets for cash, accounts payable and accrued expenses, approximate their fair market value based on the short-term maturity of these instruments. The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2012, on a recurring basis:

Description	Level 1		Level 2		Level 3			Gains (Losses)
Derivative Liability	$	-	$	-	$	(5,660,208	)	$	(32,923	)
Total	$	-	$	-	$	(5,660,208	)	$	(32,923	)

The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2011, on a recurring basis:

Description	Level 1		Level 2		Level 3			Gains (Losses)
Derivative Liability	$	-	$	-	$	(5,377,308	)	$	(245,087	)
Total	$	-	$	-	$	(5,377,308	)	$	(245,087	)

A financial instrument's categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The following is a description of the valuation methodology used to measure fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy.

Derivative Liability: Market prices are not available for the Company's warrants nor are market prices of similar warrants available. The Company assessed that the fair value of this liability approximates its carrying value since carrying value has been adjusted to fair value.

The method described above may produce a current fair value calculation that may not be indicative of net realizable value or reflective of future fair values. If a readily determined market value became available or if actual performance were to vary appreciably from assumptions used, assumptions may need to be adjusted, which could result in material differences from the recorded carrying amounts. The Company believes its method of determining fair value is appropriate and consistent with other market participants. However, the use of different methodologies or different assumptions to value certain financial instruments could result in a different estimate of fair value.

The following tables present the fair value of financial instruments as of September 30, 2012, by caption on the condensed balance sheet and by ASC 820 valuation hierarchy described above.

	Stock Warrant
Level 3 Reconciliation:	Derivative
Level 3 assets and liabilities at December 31, 2011		$	(5,377,308	)
Purchases, sales, issuances and settlements (net)			(282,900	)
Total level 3 assets and liabilities at September 30, 2012		$	(5,660,208	)

Recent Accounting Pronouncements

The Company has evaluated recent accounting pronouncements and their adoption has not had nor is it expected to have a material impact on the Company’s financial position, or statements.

NOTE 4 – EQUIPMENT

Property and equipment consists of the following as of September 30, 2012 and December 31, 2011, respectively. Depreciation expense was $949 for the nine months ended September 30, 2012 and December 31, 2011, respectively.

	September 30,				December 31,
	2012				2011
Computer equipment		$	5,390			$	5,390
Accumulated Depreciation			(4,930	)			(3,981	)
Net Book Value		$	460			$	1,409

NOTE 5 – ACCRUED LIABILITIES

Pursuant to the applicable Codification literature, the Company has concluded it is probable that it will pay $85,738 in liquidated damages pursuant to the registration rights clause in certain of the securities sold in fiscal years 2008 and 2009, the Company was required to file a registration statement by January 27, 2009. The Company failed to do so until April 7, 2009, resulting in liquidated damages of 2% per month of the gross proceeds, which approximated $1.8 million as of that date. During the year ended December 31, 2009, the Company’s registration statement covering the securities was declared effective by the SEC. Each holder is entitled to $47.32 per share owned. The Company has resolved to pay the liquidated damages in shares of Common Stock valued at $1.00 per share, pursuant to the terms and provisions of the Certificate of Designation, Preferences and Rights of Series A Convertible Preferred Stock.

NOTE 6 – NOTE PAYABLE

In January 2012, the Company received cash pursuant to a short-term promissory note with a related party. The cash was repaid in full in February 2012. The note did not bear interest.

On September 27, 2012, the Company received $45,075 in cash pursuant to a short-term promissory note with a related party. The note does not bear interest and is due on demand. During the nine months ended September 30, 2012, the Company repaid a total of $20,000 of principal due on this note leaving a balance of $20,075.

NOTE 7 – DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS

The Company’s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with its Series A Preferred Stock and associated warrants to purchase common stock. On January 1, 2009, the Company adopted ASC Topic No. 815-40 which defines determining whether an instrument (or embedded feature) is solely indexed to an entity’s own stock. As of January 1, 2009, the Company had issued 3,572,714 warrants which have exercise prices that are subject to “reset” provisions in the event the Company subsequently issues common stock, stock warrants, stock options or convertible debt with a stock price, exercise price or conversion price lower than $0.85 and $1.27, respectively. If these provisions are triggered, the exercise price of all of those warrants will be reduced. As a result, the warrants are not considered to be solely indexed to the Company’s own stock and are not afforded equity treatment.

As a result, on January 1, 2009, 3,572,714 of the Company’s outstanding warrants containing exercise price reset provisions, originally classified as permanent equity, were reclassified to derivative liability. These warrants had exercise prices ranging from $0.85 - $1.27 and expire starting in December 2013. As of January 1, 2009, the fair value of these warrants of $1,676,633 was recognized and resulted in a cumulative effect adjustment to retained earnings of $43,808. The change in fair value during the years ended December 31, 2011 and 2010 of ($272,970) and ($538,010), respectively, is recorded as a derivative loss in the accompanying Statements of Operations.

During the nine months ended September 30, 2012, the Company issued 626,576 warrants as stock offering costs to the Company’s placement agent. The combined fair market value of the derivative liability associated with these issuances at the date of issuance was $249,979.

During the year ended December 31, 2011, the Company issued 1,704,884 warrants which were attached to 1,449 shares of convertible preferred stock. The Company issued an additional 1,022,931 warrants as stock offering costs to the Company’s placement agent. The combined fair market value of the derivative liability associated with these issuances at the date of issuance was $2,184,753.

During the year ended December 31, 2010, the Company issued 676,775 warrants which were attached to 575 shares of convertible preferred stock. The Company issued an additional 391,353 warrants as stock offering costs to the Company’s placement agent. The Combined fair market value of the derivative liability associated with these issuances for the year ended December 31, 2010 was $852,346.

During the year ended December 31, 2009, the Company issued 953,370 warrants which were attached to 810 shares of convertible preferred stock. The Company issued an additional 286,011 warrants as stock offering costs to the Company’s placement agent. The Combined fair market value of the derivative liability associated with these issuances for the year ended December 31, 2009 was $988,552.

The Company classifies the fair value of these warrants under level three of the fair value hierarchy of financial instruments. The fair value of the derivative liability was calculated using a lattice model that values the compound embedded derivatives based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The embedded derivatives that were analyzed and incorporated into the model included the conversion feature with the full ratchet reset, and the redemption options.

The Series A Preferred Derivatives were valued using the following assumptions:

	●	The Company was 3 months from being publicly traded and the Company/Holder would convert the Preferred Stock based on 200% of the adjusted conversion price;
	●	The Preferred maturity date used was 7 years following the Company being publically traded (rolling 6 years from the Valuation Date);
	●	The stock price of $0.85 was used as the fair value of the common stock based on the previous common stock transaction;
	●	The projected volatility curve was based on the average of 15 comparable biotech companies historical volatility:
	●	The Holder would automatically convert at a stock price of $1.70 if the Company was not in default;
	●	The Holder would convert on a quarterly basis in equal amounts to maturity if in the money; and
	●	Capital raising events would occur annually, generating reset events based on pricing not greater than 100% of market.

The warrants were valued at issuance and marked to market quarterly for the period 2009 through December 2011. The five-year warrants are options to purchase shares of common stock at an exercise price of $0.85 per share and $1.27, subject to adjustments. The following assumptions were used for the valuation of the derivative:

	●	The stock price of $0.85 was used as the fair value of the common stock based on the previous common stock transaction;
	●	The projected volatility curve was based on the average of comparable companies as provided in the Preferred assumptions above;
	●	The Holder would exercise the warrant at maturity if the stock price was above the exercise price;
	●	The Holder would exercise the warrant at target prices starting at $1.58 for the Investor Warrants and $1.40 for the Placement Agent Warrants, and lowering such target as the warrants approached maturity.
	●	The Holder would automatically convert all of the shares at a stock price of $1.58 for the Investor Warrants and $1.40 for the Placement Agent Warrants;
	●	The Holder would convert on a quarterly basis in amounts not to exceed the average quarters trading volume based on historical performance, assuming the volume would increase by 5% each quarter; and
	●	Capital raising events would occur annually, generating reset events based on pricing not greater than 100% of market for the Placement Agent Warrants and for the Investor Warrants the reset would be 150% of the Preferred.

The Company determined the fair value of the preferred stock to be $3,352,205 and $3,146,367 and the fair value of the warrants to be $2,296,444 and $2,230,941 at September 30, 2012 and December 31, 2011, respectively.

The following shows the changes in the level three liability measured on a recurring basis from December 31, 2011 through September 30, 2012:

Balance, December 31, 2011	$	5,377,308
Derivative liability for warrants issued during the period		249,977
Derivative loss		32,923
Balance, September 30, 2012	$	5,660,208

NOTE 8 – PREFERRED STOCK

Series A Convertible Preferred Stock

The Series A Convertible Preferred Stock (“Preferred Stock”) has been authorized by resolutions adopted by the Company’s Board of Directors and set forth in a Certificate of Designation, Preferences and Rights (“Certificate of Designation”), filed with the Secretary of State of Delaware on November 26, 2008, which contains the designations, rights, powers, preferences, qualifications and limitations of the Series A Preferred Stock. The shares of Preferred Stock are fully paid and non-assessable. As of September 30, 2012, the Company has issued 3,256 shares of Series A Preferred Stock.

Rank

The Preferred Stock ranks(i) senior to the common stock and any other class or series of the Company’s capital stock either specifically ranking by its terms junior to the Preferred Stock or not specifically ranking by its terms senior to or on parity with the Preferred Stock, (ii) on parity with any class or series of the Company’s capital stock specifically ranking by its terms on parity with the Preferred Stock, and (iii) junior to any class or series of capital stock specifically ranking by its terms senior to the Preferred Stock, in each case, as to payment of dividends or as to distributions of assets upon liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary. The approval of the holders of a majority of the Preferred Stock is required in order for the Company to issue any capital stock with rights on parity with or senior to the Preferred Stock.

Dividends

The holders of the Preferred Stock are entitled to receive annual cumulative per share dividends of 6.5% of the liquidation preference of the Preferred Stock, out of funds legally available, prior to any payment of dividends on the Company’s common stock or any other class of stock ranking junior to the Preferred Stock. Such dividends are payable in cash or shares of common stock, at the option of the Company, semiannually on the last business day of February and August of each year (each a “Dividend Payment Date”), commencing in February 2009 with respect to the period from issuance through such date. The holders of the Preferred Stock are entitled to share ratably with the holders of the common stock in any dividend declared on the common stock.

Dividends on the Preferred Stock will accrue whether or not the Company has earnings, whether or not there are funds legally available for the payment of such dividends and whether or not such dividends are declared. Dividends accumulate to the extent they are not paid on the Dividend Payment Date to which they relate. Dividends that are due in cash and which are not paid within (5) business days of the Dividend Payment date shall bear interest until paid at the default rate. According to Delaware law, the Company may declare and pay dividends or make other distributions on its capital stock only out of legally-available funds. In addition, no dividends or distributions may be declared, paid or made if the Company is or would be rendered insolvent by virtue of such dividend or distribution. The Company may not (i) pay any dividends in respect of any shares of capital stock ranking junior to the Preferred Stock (including the common stock), other than dividends payable in the form of additional shares of the same junior stock as that on which such dividend is declared, or (ii) redeem any shares of capital stock ranking junior to the Preferred Stock (including the common stock), unless and until all accumulated and unpaid dividends on the Preferred Stock have been, or contemporaneously are, declared and paid in full.

Conversion

At the election of the holder thereof, each share of Preferred Stock will be convertible into common stock, at any time after issuance, at the Conversion Rate, as it may be adjusted from time to time in accordance with the Certificate of Designation. The Preferred Stock will not convert automatically into Common Stock upon completion of this offering and only the underlying Common Stock issuable upon conversion is registered for the resale under this prospectus. The Conversion Rate initially will be 1,177 shares of common stock ($.85 per share) for each Share of Preferred Stock. If the Company issues or sells any shares of its common stock (or options, warrants or convertible securities, convertible or exchangeable into shares of common stock) hereinafter, a “Subsequent common stock Issuance”), then the Conversion Rate will be adjusted so that the number of shares of common stock issuable upon conversion of each share of preferred stock shall be equal to the quotient obtained by dividing $1,000 by the price per share of common stock (or the conversion price per share in the case of a sale of options, warrants or convertible securities) sold in such Subsequent common stock Issuance.

The Conversion Price is also subject to adjustment from time to time in the event of (i) the issuance of common stock as a dividend or distribution on any class of the Company’s capital stock; or (ii) the combination, subdivision or reclassification of the common stock. No fractional shares will be issued upon conversion. Payment of accumulated and unpaid dividends will be made upon conversion to the extent of legally-available funds. The shares of Preferred Stock may also be converted into common stock at the Conversion Rate at the Company’s option following the effectiveness of a Registration Statement, if the Company’s common stock trades above 200% of the Conversion Rate per share for a period of 20 consecutive trading days.

Voting Rights

The affirmative vote of the holders of at least two-thirds of the outstanding shares of Preferred Stock, voting as a class, shall be required to authorize, effect or validate (i) any change in the rights, privileges or preferences of the Preferred Stock that would adversely affect the Preferred Stock, or (ii) the authorization, creation, issuance or increase in the authorized or issued amount of any class or series of stock ranking on parity with or superior to the Preferred Stock with respect to the declaration and payment of dividends or distribution of assets upon liquidation, dissolution or winding-up of our Company. In addition, the holders of Preferred Stock shall have the right to vote, together with holders of common stock as single class, on all matters upon which the holders of common stock are entitled to vote pursuant to applicable Delaware law or the Company’s Certificate of Incorporation. The Preferred Stock shall vote on an “as converted basis” with each holder of Preferred Stock having one vote for each Conversion Share underlying such holder’s shares of Preferred Stock.

Liquidation

In the event of any voluntary or involuntary liquidation, dissolution or winding-up of the Company, before any payment or distribution of the assets of the Company (whether capital or surplus), or the proceeds thereof, may be made or set apart for the holders common stock or any stock ranking junior to Preferred Stock, the holders of Preferred Stock will be entitled to receive, out of the assets of the Company available for distribution to stockholders, a liquidating distribution of $1,000 per share, plus any accrued and unpaid dividends, subject to adjustment upon the occurrence of certain events. If, upon any voluntary or involuntary liquidation, dissolution or winding up of the Company, the assets of the Company are insufficient to make the full payment of $1,000 per share, plus all accrued and unpaid dividends on the Preferred Stock and similar payments on any other class of stock ranking on a parity with the Preferred Stock upon liquidation, then the holders of Preferred Stock and such other shares will share ratably in any such distribution of the Company’s assets in proportion to the full respective distributable amounts to which they are entitled. Certain events, including a consolidation or merger of the Company with or into another corporation or sale or conveyance of all or substantially all the property and assets of the Company will be deemed to be a liquidation, dissolution or winding-up of the Company for purposes of the foregoing.

Series B Convertible Preferred Stock

The Series B Convertible Preferred Stock (“Series B Preferred Stock”) has been authorized by resolutions adopted by the Company’s Board of Directors and set forth in a Certificate of Designation, Preferences and Rights (“Certificate of Designation”), filed with the Secretary of State of Delaware on September 2, 2011, which contains the designations, rights, powers, preferences, qualifications and limitations of the Series B Preferred Stock. The shares of Series B Preferred Stock are fully paid and non-assessable. As of September 30, 2012, the Company had issued 1,961 shares of Series B Preferred Stock.

Rank

The Series B Preferred Stock ranks(i) senior to the common stock and any other class or series of the Company’s capital stock either specifically ranking by its terms junior to the Series B Preferred Stock or not specifically ranking by its terms senior to or on parity with the Series B Preferred Stock, (ii) on parity with any class or series of the Company’s capital stock specifically ranking by its terms on parity with the Series B Preferred Stock, and (iii) junior to Series A Preferred Stock, in each case, as to distributions of assets upon liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary.

Dividends

The holders of the Series B Preferred Stock are entitled to receive annual cumulative per share dividends of 6.5% of the liquidation preference of the Series B Preferred Stock, out of funds legally available, prior to any payment of dividends on the Company’s common stock or any other class of stock ranking junior to the Series B Preferred Stock. Such dividends are payable in cash or shares of common stock, at the option of the Company. The holders of the Series B Preferred Stock are entitled to share ratably with the holders of the common stock in any dividend declared on the common stock.

Dividends on the Series B Preferred Stock will accrue whether or not the Company has earnings, whether or not there are funds legally available for the payment of such dividends and whether or not such dividends are declared. Dividends accumulate to the extent they are not paid on the Dividend Payment Date to which they relate. According to Delaware law, the Company may declare and pay dividends or make other distributions on its capital stock only out of legally-available funds. In addition, no dividends or distributions may be declared, paid or made if the Company is or would be rendered insolvent by virtue of such dividend or distribution. The Company may not (i) pay any dividends in respect of any shares of capital stock ranking junior to the Series B Preferred Stock (including the common stock), other than dividends payable in the form of additional shares of the same junior stock as that on which such dividend is declared, or (ii) redeem any shares of capital stock ranking junior to the Series B Preferred Stock (including the common stock), unless and until all accumulated and unpaid dividends on the Series B Preferred Stock have been, or contemporaneously are, declared and paid in full.

Conversion

At the election of the holder thereof, each share of Series B Preferred Stock will be convertible into common stock, at any time after issuance, at the Conversion Rate, as it may be adjusted from time to time in accordance with the Certificate of Designation. The Conversion Rate initially will be 1,177 shares of common stock ($.85 per share) for each Share of Series B Preferred Stock.

The Conversion Price is subject to adjustment from time to time in the event of (i) the issuance of common stock as a dividend or distribution on any class of the Company’s capital stock; or (ii) the combination, subdivision or reclassification of the common stock but does not contain the same price protection ratchets as the Series A Preferred Stock. No fractional shares will be issued upon conversion. Payment of accumulated and unpaid dividends will be made upon conversion to the extent of legally-available funds. The shares of Preferred Stock may also be converted into common stock at the Conversion Rate at the Company’s option following the effectiveness of a Registration Statement, if the Company’s common stock trades above 200% of the Conversion Rate per share for a period of 20 consecutive trading days.

Voting Rights

The affirmative vote of the holders of at least a majority of the outstanding shares of Preferred Stock, voting as a class, shall be required to authorize, effect or validate (i) any change in the rights, privileges or preferences of the Series B Preferred Stock that would adversely affect the Series B Preferred Stock, or (ii) the authorization, creation, issuance or increase in the authorized or issued amount of any class or series of stock ranking on parity with or superior to the Series B Preferred Stock with respect to the declaration and payment of dividends or distribution of assets upon liquidation, dissolution or winding-up of our Company. In addition, the holders of Preferred Stock shall have the right to vote, together with holders of common stock as single class, on all matters upon which the holders of common stock are entitled to vote pursuant to applicable Delaware law or the Company’s Certificate of Incorporation. The Series B Preferred Stock shall vote on an “as converted basis” with each holder of Preferred Stock having one vote for each Conversion Share underlying such holder’s shares of Preferred Stock.

Liquidation

In the event of any voluntary or involuntary liquidation, dissolution or winding-up of the Company, before any payment or distribution of the assets of the Company (whether capital or surplus), or the proceeds thereof, may be made or set apart for the holders common stock or any stock ranking junior to Preferred Stock, after payment to the holders of Series A Preferred Stock the holders of Preferred Stock will be entitled to receive, out of the assets of the Company available for distribution to stockholders, a liquidating distribution of $1,000 per share, plus any accrued and unpaid dividends, subject to adjustment upon the occurrence of certain events. If, upon any voluntary or involuntary liquidation, dissolution or winding up of the Company, the assets of the Company are insufficient to make the full payment of $1,000 per share, plus all accrued and unpaid dividends on the Preferred Stock and similar payments on any other class of stock ranking on a parity with the Preferred Stock upon liquidation, then the holders of Preferred Stock and such other shares will share ratably in any such distribution of the Company’s assets in proportion to the full respective distributable amounts to which they are entitled. Certain events, including a consolidation or merger of the Company with or into another corporation or sale or conveyance of all or substantially all the property and assets of the Company will be deemed to be a liquidation, dissolution or winding-up of the Company for purposes of the foregoing.

During the nine months ended September 30, 2012, the Company issued 931 shares of its par value $0.10 Series B Convertible Preferred Stock for cash at $1,000 per share.

During the year ended December 31, 2011, the Company issued 419 shares of its par value $0.10 Series A Convertible Preferred Stock and 1,030 shares of its par value $0.10 Series B Convertible Preferred Stock, for a total of 1,449 shares of Preferred Stock, for cash at $1,000 per share.

During the year ended December 31, 2010, the Company issued 575 shares of its par value $0.10 Series A Convertible Preferred Stock for cash at $1,000 per share.

During the year ended December 31, 2009, the Company issued 810 shares of its par value $0.10 Series A Convertible Preferred Stock at $1,000 per share.

On November 25, 2008, the Company issued 562 shares of its par value $0.10 Series A Convertible Preferred Stock for cash at $1,000 per share.

On November 25, 2008, the Company issued 890 shares of its par value $0.10 Series A Convertible Preferred Stock to extinguish bridge debt financing totaling $889,875.

Between January 24 and April 15, 2008, the Company issued 1,082,500 common shares of the Company at $0.85 per common share in accordance with the Bridge Note agreements.

NOTE 9 – COMMON STOCK

During the nine months ended September 30, 2012, the Company issued 7,500 shares of common stock to its attorneys for services rendered. The shares were valued based on the price of $0.85 per share and the Company recognized $6,375 in consulting expenses.

During the year ended December 31, 2011, the Company issued 640,000 shares of common stock to officers and consultants in exchange for services provided. The shares were valued based on the price of $0.85 per share and the Company recognized $151,000 in salaries and wages, $289,000 in consulting expense, and extinguished $104,000 in accrued officer salary.

On September 16, 2010 the Company issued 400,000 shares of common stock to officers and consultants of the Company in exchange for services provided. The shares were valued based on the price of $0.85 per share and the Company recognized $340,000 in consulting expense.

On December 28, 2010 the Company issued 450,000 shares of common stock to officers and consultants of the Company in exchange for services provided. The shares were valued based on the price of $0.85 per share and the Company recognized $382,500 in consulting expense.

NOTE 10 – WARRANTS

A summary of the status of the Company's warrants as of September 30, 2012 and changes from inception through September 30, 2012are presented below:

Date of	Warrant	Exercise	Value if		Expiration
Issuance	Shares	Price	Exercised		Date
11/25/08	1,259,639	1.27	$	1,599,742	08/10/14
11/25/08	530,314	0.85		450,767	08/10/14
11/26/08	449,220	1.27		570,509	08/10/14
Outstanding at 12/31/2008	2,239,173	1.17		2,621,018
03/05/09	347,215	1.27		440,963	08/10/14
03/05/09	104,165	0.85		88,540	08/10/14
04/01/09	17,655	1.27		22,422	08/10/14
04/01/09	5,296	0.85		4,502	08/10/14
06/17/09	235,400	1.27		298,958	08/10/14
06/17/09	70,620	0.85		60,027	08/10/14
07/23/09	58,850	1.27		74,740	08/10/14
07/23/09	35,310	0.85		30,014	08/10/14
08/20/09	58,850	1.27		74,740	10/14/15
09/09/09	235,400	1.27		298,958	10/14/15
09/09/09	70,620	0.85		60,027	10/14/15
Outstanding at 12/31/2009	3,478,554	1.17		4,074,909
02/11/10	29,425	1.27		37,370	10/14/15
02/11/10	17,655	0.85		15,007	10/14/15
05/21/10	29,425	1.27		37,370	10/14/15
05/21/10	17,655	0.85		15,007	10/14/15
08/10/10	88,275	1.27		112,109	10/14/15
08/10/10	52,965	0.85		45,020	10/14/15
09/15/10	264,825	1.27		336,328	10/14/15
09/15/10	52,965	0.85		45,020	10/14/15
09/24/10	105,930	0.85		90,041	10/14/15
10/27/10	147,125	1.27		186,849	*
10/27/10	73,563	0.85		62,529	*
11/19/10	117,700	1.27		149,479	*
11/24/10	70,620	0.85		60,027	*
Outstanding at 12/31/2010	4,546,682	1.16	$	5,267,063
01/26/11	117,700	1.27		149,479	*
01/26/11	60,027	1.27		76,234	*

01/26/11	106,636	0.85		90,641	*
03/15/11	58,850	1.27		74,740	*
03/15/11	35,310	0.85		30,014	*
04/06/11	70,620	0.85		60,027	*
04/06/11	117,700	1.27		149,479	*
06/08/11	51,200	0.85		43,520	*
06/08/11	85,333	1.27		108,373	*
06/20/11	17,655	0.85		15,007	*
06/20/11	29,425	1.27		37,370	*
07/26/11	23,540	1.27		29,896	*
07/26/11	14,124	0.85		12,005
08/22/11	29,424	1.27		37,368	*
08/22/11	17,655	0.85		15,007	*
08/30/11	105,930	0.85		90,041	*
09/02/11	176,550	1.27		224,219	*
09/09/11	58,850	1.27		74,740	*
09/09/11	35,310	0.85		30,014	*
09/22/11	441,375	1.27		560,546	*
09/22/11	264,825	0.85		225,101	*
11/02/11	141,240	0.85		120,054	*
11/02/11	235,400	1.27		298,958	*
11/23/11	35,310	0.85		30,014	*
11/23/11	58,850	1.27		74,740	*
12/27/11	127,116	0.85		108,049	*
12/27/11	211,860	1.27		269,062	*
Outstanding at 12/31/11	7,274,497	1.14	$	8,301,757
01/31/12	117,700	1.27		149,479	*
01/31/12	70,620	0.85		60,027	*
02/02/12	76,505	1.27		97,161	*
02/02/12	45,903	0.85		39,018	*
02/10/12	58,850	1.27		74,740	*
02/10/12	35,310	0.85		30,014	*
04/10/12	41,666	0.85		35,416	*
04/10/12	69,443	1.27		88,193	*
05/11/12	35,310	0.85		30,014	*
05/11/12	58,850	1.27		74,740	*
06/04/12	35,310	0.85		30,014	*
06/19/12	35,310	0.85		30,014	*
06/19/12	58,850	1.27		74,740	*
07/24/12	44,138	1.27		56,055	*
07/24/12	30,896	0.85		26,262	*
07/30/12	235,400	1.27		298,958	*
07/30/12	141,240	0.85		120,054	*
08/28/12	258,352	1.27		328,107	*
08/28/12	155,011	0.85		131,759	*
Outstanding at 9/30/12	8,879,161	1.13		10,076,519

The warrants were issued in connection with the Preferred Stock Offering and were valued using the Lattice model and accounted for as described in Note 7.

NOTE 11 – STOCK OPTIONS

The Company’s 2009 Employee Stock Incentive Plan (the “2009 Option Plan”) was adapted by the Company’s Board of Directors on February 9, 2009 in order to motivate participants by means of stock options and restricted stock to achieve the Company’s long-term performance goals and enable our employees, officers, directors and consultants to participate in our long term growth and financial success. The 2009 Plan, which is administered by our Board of Directors, authorizes the issuance of a maximum of 500,000 shares of our common stock, which may be authorized and unissued shares or treasury shares. Employee options shall be deemed Incentive Stock Options (as defined in the 2009 Option Plan) to the maximum extent permitted by Section 422 of the Internal Revenue Code including a five-year limit on exercise for 10% or greater stockholders with any excess grant to the above individuals over the limits set by Section 422 being Non-Qualified Stock Options as defined in the 2009 Option Plan. Both the Incentive Stock Options or any Non-Qualified Stock Options must be granted at an exercise price of not less than the fair market value of shares of common stock at the time the option is granted and Incentive Stock Options granted to 10% or greater stockholders must be granted at an exercise price of not less than 110% of the fair market value of the shares on the date of grant.

If any award under the 2009 Plan terminates, expires unexercised, or is cancelled, the shares of common stock that would otherwise have been issuable pursuant thereto will be available for issuance pursuant to the grant of new awards. The 2009 Plan will terminate on February 9, 2019. As of September 30, 2012 the following options had been granted under the plan:

On July 12, 2010 the Company issued 100,000 options to a member of its board of directors under the 2009 plan. The options have an exercise price of $0.85 per share and have a life of ten years. The options vest as follows: one third on the date of grant, one third on each of the second and third anniversary dates from the date of grant. The Company valued these options using the Black-Scholes option pricing model under the following assumptions: $0.85 stock price, $0.85 stock price, 10 years to maturity, 400% volatility, 2.02% risk free rate. The Company has recorded amortization expense of $14,443 and $17,526 related to these options for the nine months ended September 30, 2012 and 2011, respectively.

NOTE 12– SUBSEQUENT EVENTS

In accordance with ASC 855-10 Company management reviewed all material events through the date of this report and there are no material subsequent events to report.

PART I Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

Statements contained in this Item 2. “Management’s Discussion and Analysis of Financial Conditions and Results of Operations” and elsewhere in this report that are not historical or current facts may constitute “forward-looking statements” within the meaning of such term in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements relate to future events or future predictions, including events or predictions relating to our future financial performance, and are generally identifiable by use of the words "may," "will," “forecast,” "should," "expect," "plan," "anticipate," "believe," "feel," "confident," "estimate," "intend," "predict," "potential" or "continue" or the negative of such terms or other variations on these words or comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause the Company's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors to consider and evaluate that could cause actual results to differ materially from those predicted in any such forward-looking statements include: (i) the general economy and changes in the external competitive market factors which might impact the Company's results of operations; (ii) unanticipated working capital or other cash requirements including those created by the failure of the Company to adequately anticipate the costs associated with clinical trials, manufacturing and other critical activities; (iii) changes in the Company's business strategy or an inability to execute its strategy due to unanticipated changes in the therapeutic drug industry; (iv) the inability or failure of the Company's management to devote sufficient time and energy to the Company's business; and (v) the failure of the Company to complete any or all of the transactions described herein on the terms currently contemplated. In light of these risks and uncertainties, many of which are described in greater detail in the Risk Factors discussion contained in our Annual Report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission (“SEC”), there can be no assurance that the forward-looking statements contained in this report will in fact transpire.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of such statements. We do not undertake any duty to update any of the forward-looking statements after the date of this report to conform such statements to actual results or changes in our expectations.

General

The following discussion should be read in conjunction with the financial statements and notes thereto included in this report. Except for the historical information contained herein, the discussion in this report contains certain forward-looking statements that involve risks and uncertainties, such as statements of the Company’s plans, objectives, expectations and intentions as of the date of this filing. The cautionary statements made above should be read as being applicable to all related forward-looking statements wherever they appear in this document.

Material Changes in Financial Conditions

Liquidity and Capital Resources

As of September 30, 2012 and December 31, 2011, the Company had $74,934 and $20,424, respectively, of cash on hand. The Company’s working capital deficit increased from ($5,856,319) at December 31, 2011 to a deficit of ($6,140,059), as of September 30, 2012. Excluding the non-cash liability associated with the Company’s derivatives, the working capital deficit increased from $479,011 as of December 31, 2011 to $479,851 as of September 30, 2012. The increase in the working capital deficit was primarily the result of an increase of outstanding accounts payable and related party notes payable. SignPath had a deficit accumulated during the development stage of $8,200,804, as of September 30, 2012.

During the 12 months ended December 31, 2011, SignPath sold 1,448.5 Units (the “2011 Private Placement”) consisting of its securities at a price of $1,000 per Unit. Each Unit consists of (i) one share of 6.5% Series A Convertible Preferred Stock convertible into 1,177 shares of common stock (equivalent to $.85 per share of common stock) following the effective date of its Registration Statement (the “Effective Date”) subject to adjustment, and (ii) Warrants to purchase 1,177 shares of common stock at $1.27 per share for a five-year period following the Effective Date of a registration statement including the underlying securities. The Company received gross proceeds of $1,448,500 and incurred stock offering costs of $267,966 related to such offering.

During the nine month period ended September 30, 2012, the Company sold 931 Units of Series B Preferred Stock at $1,000 per share. The Company received gross proceeds of $931,000 and incurred stock offering costs of $186,325 related to the Offerings.

The Company has no agreements, arrangements or understandings with any officer, director or shareholder as to any future financing, either equity or debt. The Company expects to continue to incur losses for the foreseeable future and it is possible the Company may never reach profitability. Therefore, the Company will require additional capital resources and financing to implement its business plan and continue its operations. The Company’s current burn rate for salaries, research programs and professional fees averages about $65,000 per month. Thus, it is expected that the Company currently does not have sufficient cash on hand to operate through the next 12 months. Management believes it has enough funds to complete its pre-clinical trials. If the Company receives favorable results, Management believes it will have the ability to raise additional funds to complete INDs. In view of general market conditions, there can be no assurance that any additional financing will be available to us, that any affiliate will provide additional investments in the Company or that adequate funds for our operations will otherwise be available when needed or on terms acceptable to us.

Cash used in operating activities during the nine months ended September 30, 2012 (“Fiscal 2012”) was $710,240 compared to cash used of $569,259 during the comparable period in 2011 (“Fiscal 2011”). This resulted from a net loss of $800,202 offset by an increase of accounts payable of $35,272 and an increase in the fair value of the Company’s derivative liability of $32,923 in Fiscal 2012. This compared to a loss of $1,338,132 during Fiscal 2011 offset by an increase in the fair value of the Company’s derivative liability of $172,327 and an increase in accounts payable of $573,072.

The Series B Preferred Stock is substantially the same as the Series A Preferred Stock with regard to dividends and conversion price, however, is junior to the Series A Preferred Stock on liquidation and does not have anti-dilution price protection, nor do the Class B Warrants issued as part of the Units.

The Company had net cash provided by financing activities of $764,750 in Fiscal 2012 as a result of the $931,000 received in the 2012 Private Placement described above, reduced by $186,325 of offering costs. During Fiscal 2011, the Company had $844,533 of net cash provided by financing activities as a result of the $1,018,499 received from the 2011 Private Placement of Preferred Stock less the stock offering costs of $173,966.

As a result of the foregoing, the Company’s cash increased by $54,510 during Fiscal 2012 from $20,424 to $74,934.

The financial statements included in this report have been prepared in conformity with generally accepted accounting principles that contemplate our continuance as a going concern. The Company has had no revenues and has generated losses from operation. As set forth in Note 2 to the audited Financial Statements, the continuation of the Company as a going concern is dependent upon the Company obtaining adequate capital to fund operating losses until it becomes profitable, if ever. The financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Material Changes in Results of Operations

Nine months ended September 30, 2012, as compared with nine months ended September 30, 2011

The Company does not expect to receive any revenues prior to 2013. Total operating expenses during the nine months ended September 30, 2012 (the “2012 Period”) decreased to $760,904, as compared with $1,165,805 during the nine months ended September 30, 2011 (the “2011 Period”) primarily as a result of a decrease of $417,382 of research and development expenses related to the continued manufacture and preclinical development of its lead curcumin formulations. General and administrative expenses decreased to $29,889 in the 2012 Period from $113,916 in the 2011 Period, primarily as a result of a decrease in travel and other office related expenses. Professional fees decreased to $66,363 in the 2012 period from $116,917 in the 2011 Period, primarily as a result of consulting contracts that were not renewed.

Significant Research and Development fees paid in the 2012 Period included $81,052 to the University of Texas, MD Anderson Cancer Center (“UTMDACC”) for non-clinical and mouse pre-clinical non-GLP studies of lipsomal curcumin. Other research and development payments included $44,590 and $103,667 to Polymnun and Nucro Technology, respectively, for lab fees and other costs related to the Company’s research and development efforts as well as $54,190 in legal fees classified as Research and Development.

Significant Research and Development fees in the 2011 Period included $69,469 paid to University of Texas, MD Anderson Cancer Center (“UTMDACC”) for non-clinical and mouse pre-clinical non-GLP studies of lipsomal curcumin. Other major research and development expenses included payments to Polymnun, Nucro Technology, MD Anderson, Medizinche University and Regis Pharmaceuticals for $253,571, $200,750, $110,254, $62,319 and $76,905, respectively, for lab fees and other costs related to the Company’s research and development efforts.

The amount paid for research and development in the 2012 Period consisted of payments for overhead and patent fees for non-clinical studies and pre-clinical studies in the nanocurcumin compound and to produce polymer under the JHU Agreement for animal studies of nanocurcumin. During the 2011 Period, the Company paid UTMDACC for non-clinical and mouse pre-clinical pre-GLP studies of lipomal curcumin. It also includes expenses relating to development of depotcurcumin, a slow release formulation. Depotcurcumin was originally made at UNT under non-GLP conditions from curcumin extract (and PLGA, a chemical surrounding the curcumin) originally purchased from a U.S. chemical supplier, Sigma Aldrich Fine Chemicals (“SAFC”).

As a result of the foregoing, the Company had a net loss of $800,202 in the 2012 Period as compared to a net loss of $1,338,132 in the 2011 period. This translates to a loss per share of $0.06 in the 2012 Period compared to $0.11 in the 2011 Period.

Use of Estimates

Derivative Financial Instruments

Fair Value of Financial Instruments

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

The carrying amounts reported in the balance sheets for cash, accounts payable and accrued expenses approximate their fair market value based on the short-term maturity of these instruments. The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2012, on a recurring basis:

Description	Level 1		Level 2		Level 3			Gains (Losses)
Derivative Liability	$	-	$	-	$	(5,660,208	)	$	(32,923	)
Total	$	-	$	-	$	(5,660,208	)	$	(32,923	)

The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2011, on a recurring basis:

Description	Level 1		Level 2		Level 3			Gains (Losses)
Derivative Liability	$	-	$	-	$	(5,377,308	)	$	(245,087	)
Total	$	-	$	-	$	(5,377,308	)	$	(245,087	)

The following tables present the fair value of financial instruments as of September 30, 2012, by caption on the condensed balance sheet and by ASC 820 valuation hierarchy described above.

	Stock Warrant
Level 3 Reconciliation:	Derivative
Level 3 assets and liabilities at December 31, 2011		$	(5,377,308	)
Purchases, sales, issuances and settlements (net)			(282,900	)
Total level 3 assets and liabilities at September 30, 2012		$	(5,660,208	)

Plan of Operations

The Company's current focus is on the manufacture and preclinical development of its lead curcumin formulations (intravenous liposomal curcumin, oral and intravenous nanocurcumin and a slow release PLGA formulation) with a view toward filing two IND applications with the FDA. The Company's product candidates are still in the preclinical development phase.

The Company believes that a novel pharmaceutical preparation with enhanced absorption of the active compound with resistance to hepatic inactivation could potentially have greater clinical efficacy than the oral versions. The laboratory and oral administration studies by other researchers to date suggest that curcumin has high potency. The Company believes that an alternate route for administering this compound, such as the Company's parenteral (taken into the body other than through the digestive canal) formulation, could be more effective at lower dosages. SignPath intends to develop a parenteral liposomal formulation, and a nanoparticle formulation, nanocurcumin, to overcome the limitations of the oral form.

SignPath believes that the development and comparison of liposomal curcumin, nanocurcumin and PLGA formulation could expose potential differences in biological effects and distribution to different tissues. The Company intends to manufacture good manufacturing practice (GMP) grade of liposomal curcumin, nanocurcumin and PLGA formulation. These formulations will require outsourcing production to one or more commercial facilities. Our initial goals are to obtain sufficient material for in vitro and animal analysis and to develop these formulations in order to submit INDs to the FDA. Determination of safety, dosage, and efficacy of these formulations in a quantifiable manner will permit us to pursue clinical registration trials for a variety of malignant diseases. Following submission of the INDs, the Company plans to initially run Phase I studies with both of the parenteral formulations in patients with treatment refractory malignant disease. Subsequently, if the Phase I trials are successful, the Company plans to seek FDA authorization to run Phase II trials in selected malignancies.

Liposomal curcumin: The Company has agreements with contract manufacturers for the manufacture, chemistry. and controls for supplies of the drugs to be tested. Liposomal curcumin is manufactured by our contract manufacturer, Polymun, Inc. Initial quantities of GMP grade liposomal curcumin to conduct preclinical studies to corroborate previously published data from other researchers were obtained from Sigma Aldrich Fine Chemicals ("SAFC") or from Sabinsa. Final production of liposmal curcumin GMP was completed at Polymun in Vienna, Austria during 2009. Using Iipocurc, anti-cancer activity without toxicity in human colon and pancreatic cancer xenograft models were published. Following the determination of safety and the optimum dosage and schedule in the most sensitive of the three species, we will be able to estimate starting dosages for Phase I trials in humans. We plan to outsource corroborative studies of Iiposomal absorption, distribution, metabolism, and excretion (ADME), and pharmacokinetics in rats with the aim of estimating optimum dosage schedules, as well as dosage and safety in mice, rats and dogs to satisfy IND regulations to GLP laboratories in M.D. Anderson Cancer Center in Houston, Texas.

Nanocurcumin: The Company intends to obtain commercial volumes of purified curcumin from third party manufacturers, Sabinsa, and/or Regis Pharmaceutical(s) in quantities suitable to satisfy preclinical and clinical demands. The Company believes that the manufacture of Iiposomal curcumin and nanocurcumin can also be scaled up as necessary since these additional substances are readily available from commercial sources utilizing established production technologies. We plan to outsource nanocurcumin pre-clinical development to M.D. Anderson. We will continue non-clinical and preclinical analyses of nanocurcumin at the NCI Nanocharacterization Laboratory. The nanocurcumin program will be managed by M.D. Anderson through the filing of the Company's IND. However, we intend to develop direct injection nanocurc, a new clinical entity at Johns Hopkins Cancer Center for preventive therapy of inducted curcumin in situ in rats. Nanocurc, a parenteral formulation of nanocurcumin in human pancreatic cancer xenografts in nude mice has demonstrated anti-cancer effects. This formulation has activity against breast cancer-DCIS and passes the blood brain barrier. We intend to conduct a European Phase I dose funding in Parkinson's Disease for volunteers in collaboration with Polymun, Vienna, Austria. Upon completion, we will also continue studies of nanocurcumin, PLGA-nanocurcumin and lipsomal curcumin against L-DOPA induced dyskinesias in dogs. We will measure inhibiting effects of curcumin on disease progression in Parkinson's Disease patients at the University of Western Ontario, Canada. Contracts with these institutions will be initiated upon receipt of manufactured nanocurcumin.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

In the normal course of business, our financial position is routinely subject to a variety of risks, including market risk associated with interest rate movement. We regularly assess these risks and have established policies and business practices intended to protect against these and other exposures. As a result, we do not anticipate material potential losses in these areas.

As of September 30, 2012, we had cash and cash equivalents of $74,934.

Item 4. Controls and Procedures.

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, our management has validated the effectiveness of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the " Exchange Act"), as of September 30, 2012. Based on this evaluation, our principal executive officer and principal financial officer have concluded that, as of the end of such period, our disclosure controls and procedures were ineffective to ensure that (i) information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and (ii) our disclosure and controls are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. This conclusion is based on the fact that due to limited resources, the Company is unable to maintain adequate segregation of duties.

Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. As defined by the Public Company Accounting Oversight Board Auditing Standard No. 5, a material weakness is a deficiency or a combination of deficiencies, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected. A clear and concise segregation of duties is important to maximize checks and balances so that no single individual has control over two or more phases of a transaction or operation. A strong segregation of duty also is critical to reduce effectively the risk of mistakes and inappropriate actions preventing fraud and discourages collusion. It can be difficult for small businesses to always have a clear separation of duties because there simply are not enough personnel to cover each and every process and procedure. Ultimately, checks and balances need to be in place as a supportive measure to the business operations, but also as a fraud prevention measure as well. Because we have limited financial personnel, and limited resources, compliance with segregation of duties and proper oversight of control requirements is extremely difficult. In connection with the evaluation referred to in the foregoing paragraph, we have identified no change in our internal control of financial reporting that occurred during the quarter ended September 30, 2012, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

As of the date of this Quarterly Report on Form 10-Q, we are not a party to any legal proceedings.

Item 1A. Risk Factors

In accordance with the requirements of Form 10-Q, the Company, as a smaller reporting company, is not required to make disclosure under

-this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the three-month period ended September 30, 2012, this Registrant sold 507 units (the “Units”), of its securities at a price of $1,000 per Unit or $507,000. Each Unit consists of (i) one share of 6.5% Series B Convertible Preferred Stock (209 shares) convertible into 1,177 shares of common stock (equivalent to $.85 per share of common stock) subject to adjustment, and (ii) one Warrant to purchase 1,177 shares of common stock at $1.27 per share for a five-year period following the Effective Date of its registration statement. The Company received gross proceeds of $507,000 and paid 10% sales commissions of $50,700 to Meyers Associates, L.P. the Company’s placement agent.

The Units were sold to 7 different accredited investors who were customers of the placement agent. The Company claimed an exemption from registration pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated thereunder, based upon subscription agreements executed by each investor.

The net proceeds of the offering were used for working capital and research and development towards filing an investigational new drug application to commence clinical trials.

During the nine-month period ended September 20, 2012, the Registrant issued 7,500 shares of Common Stock to its attorneys for services rendered. There were no placement agents or underwriters involved and no commissions were paid. This Registrant claimed an exemption from registration pursuant to Section 4(a)(2) of the Securities Act.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibits.

Set forth below is a list of the exhibits to this quarterly report on Form 10-Q.

Exhibit Number	Description
3.1	Certificate of Incorporation of the registrant (1)
3.2	Certificate of Designation, Preferences and Rights of Series A Convertible Preferred Stock (1)
3.3	Amended and Restated Certificate of Incorporation of the registrant dated August 2, 2006 (1)
3.4	Certificate of Amendment of the Registrant dated May 27, 2008 (1)
3.5	Certificate of Designation Preference and Rights of Series B Convertible Preferred Stock (3)
3.6	Certificate of Amendment of the Registrant dated October 20, 2011 (2)
3.7	By-Laws of the registrant (1)
4.1	Form of Common Stock Certificate (1)
4.2	Form of Common Stock Purchase Warrant (1)
4.3	Form of Bridge Note (1)
4.4	Form of Series A Subscription Rights Agreement (1)
4.5	Form of Series A Subscription Agreement (1)
4.6	Form of Series B Subscription Agreement (3)
*31.1	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*32.1	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101 INS	XBRL Instance Document**

101 SCH	XBRL Schema Document**

101 CAL	XBRL Calculation Linkbase Document**

101 LAB	XBRL Labels Linkbase Document**

101 PRE	XBRL Presentation Linkbase Document**

101 DEF	XBRL Definition Linkbase Document**

* Filed with this Report.

(1) Incorporated by reference to the Company’s Registration Statement on Form S-1 (Registration No. 333-158474, declared effective on August 10, 2009.

(2) Incorporated by reference to the Company’s Form 8-K for October 20, 2011 filed on October 21, 2011.

(3) Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for September 30, 2011 filed on November 21, 2011.

** The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: November 14, 2012	SIGNPATH PHARMA INC.
	By:	/s/ Dr. Lawrence Helson
		Dr. Lawrence Helson, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial Officer)

SignPath Pharma Inc.

Quarterly Report on Form 10-Q

Quarter Ended September 30, 2012

EXHIBITS

Exhibit Number	Description

31.1	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

EX-31.1 2 ex31-1.htm CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. ex31-1.htm

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS

ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Dr. Lawrence Helson, Chief Executive Officer and Chief Financial Officer (principal executive officer and principal financial and accounting officer) of SignPath Pharma Inc. certify that:

1.	I have reviewed this quarterly report on Form 10-Q of SignPath Pharma Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.	I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 14, 2012		SIGNPATH PHARMA INC.

	By:	/s/ Dr. Lawrence Helson
		Dr. Lawrence Helson, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer)

EX-32.1 3 ex32-1.htm CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. ex32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q for the period ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dr. Lawrence Helson, Chief Executive Officer and Chief Financial Officer of SignPath Pharma Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(a)	The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)	The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 14, 2012		SIGNPATH PHARMA INC.


	By:	/s/ Dr. Lawrence Helson
		Dr. Lawrence Helson
		Chief Executive Officer and
		Chief Financial Officer
		(Principal Executive Officer and Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to SignPath Pharma Inc. and will be retained by SignPath Pharma Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 4 sppxbrl-20120930.xml XBRL INSTANCE 10-Q 2012-09-30 false SIGNPATH PHARMA, INC. 0001455694 --12-31 Smaller Reporting Company Yes No No 2012 Q3

0.10

5000000

5217

4286

0.001

45000000

12837500

15177

40723

29889

113916

1233932

20825

35685

66363

116917

920130

1063401

173108

161765

517590

934972

3034224

52486

153437

947432

261596

238173

767279

1165805

7199119

-261596

-238173

-767279

-1165805

-7199119

-18385

-177011

-172327

-1019246

81556

63995

-18385

-177011

-32923

-172327

-1001685

-279981

-415184

-800202

-1338132

-8200804

-279981

-415184

-0

12830000

12190000

12830000

12190000

-1338132

-8200804

6375

1272875

14443 17526 77021 1139001

949

948

4930

32923

172327

1019246

35272

573072

534707

-710240

-569259

-4153024

5390

-5390

931000

1018499

4326500

186325

173966

1013102

10000

55075

944950

-35000

764750

844533

4233348

54510

275274

74934

48993

324267

889875

249979 1531796 4640965

<pre>NOTE 2 - GOING CONCERN</pre>   The Company's financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. During the nine months ended September 30, 2012, the Company recognized sales revenue of $-0- and incurred a net loss of $800,202.  As of September 30, 2012, the Company had an accumulated deficit of $8,200,804.  The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's planned business. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.   In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.   The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 6 NOTE PAYABLE   In January 2012, the Company received cash pursuant to a short-term promissory note with a related party.  The cash was repaid in full in February 2012.  The note did not bear interest.   On September 27, 2012, the Company received $45,075 in cash pursuant to a short-term promissory note with a related party.  The note does not bear interest and is due on demand.  During the nine months ended September 30, 2012, the Company repaid a total of $20,000 of principal due on this note leaving a balance of $20,075.

NOTE 10 WARRANTS   A summary of the status of the Company's warrants as of September 30, 2012 and changes from inception through September 30, 2012are presented below:   <table border="0" cellspacing="0" cellpadding="0" width="633" style='width:474.95pt;border-collapse:collapse'> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Date of </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Warrant </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Exercise </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="113" colspan="2" valign="bottom" style='width:85.05pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Value if </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Expiration </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Issuance </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Shares </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Price </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="113" colspan="2" valign="bottom" style='width:85.05pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Exercised </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Date </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/25/08 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1,259,639 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1,599,742 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/25/08 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 530,314 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 450,767 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/26/08 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 449,220 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 570,509 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Outstanding at 12/31/2008 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 2,239,173 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.17 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 2,621,018 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 03/05/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 347,215 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 440,963 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 03/05/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 104,165 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 88,540 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 04/01/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 17,655 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 22,422 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 04/01/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 5,296 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 4,502 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/17/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 235,400 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 298,958 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/17/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 70,620 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 60,027 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/23/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/23/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/14 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/20/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/09/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 235,400 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 298,958 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/09/09 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 70,620 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 60,027 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Outstanding at 12/31/2009 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 3,478,554 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.17 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 4,074,909 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 02/11/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 29,425 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 37,370 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 02/11/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 17,655 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 15,007 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 05/21/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 29,425 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 37,370 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 05/21/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 17,655 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 15,007 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 88,275 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 112,109 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/10/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 52,965 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 45,020 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/15/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 264,825 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 336,328 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/15/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 52,965 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 45,020 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/24/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 105,930 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 90,041 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/14/15 </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/27/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 147,125 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 186,849 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 10/27/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 73,563 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 62,529 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/19/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 117,700 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 149,479 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/24/10 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 70,620 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 60,027 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Outstanding at 12/31/2010 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 4,546,682 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.16 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="92" valign="bottom" style='width:69.25pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 5,267,063 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 01/26/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 117,700 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 149,479 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 01/26/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 60,027 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 76,234 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 01/26/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 106,636 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 90,641 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 03/15/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 03/15/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 04/06/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 70,620 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 60,027 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 04/06/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 117,700 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 149,479 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/08/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 51,200 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 43,520 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/08/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 85,333 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 108,373 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/20/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 17,655 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 15,007 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/20/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 29,425 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 37,370 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/26/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 23,540 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 29,896 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/26/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 14,124 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 12,005 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/22/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 29,424 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 37,368 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/22/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 17,655 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 15,007 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/30/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 105,930 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 90,041 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/02/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 176,550 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 224,219 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/09/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/09/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/22/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 441,375 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 560,546 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 09/22/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 264,825 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 225,101 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/02/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 141,240 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 120,054 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/02/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 235,400 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 298,958 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/23/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 11/23/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 12/27/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 127,116 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 108,049 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 12/27/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 211,860 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 269,062 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Outstanding at 12/31/11 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 7,274,497 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.14 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="92" valign="bottom" style='width:69.25pt;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 8,301,757 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 01/31/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 117,700 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 149,479 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 01/31/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 70,620 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 60,027 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 02/02/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 76,505 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 97,161 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 02/02/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 45,903 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 39,018 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 02/10/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 02/10/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 04/10/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 41,666 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,416 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 04/10/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 69,443 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 88,193 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 05/11/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 05/11/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/04/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/19/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 35,310 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,014 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 06/19/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 58,850 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 74,740 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/24/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 44,138 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 56,055 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/24/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 30,896 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 26,262 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/30/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 235,400 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 298,958 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 07/30/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 141,240 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 120,054 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/28/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 258,352 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 1.27 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 328,107 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:12.75pt'> <td width="195" valign="top" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 08/28/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="105" valign="top" style='width:79.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 155,011 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="75" valign="top" style='width:56.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 0.85 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> 131,759 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> * </td> </tr> <tr style='height:13.5pt'> <td width="195" valign="bottom" style='width:146.0pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> Outstanding at 9/30/12 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'>   </td> <td width="105" valign="bottom" style='width:79.0pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 2.25pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> 8,879,161 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'>   </td> <td width="75" valign="bottom" style='width:56.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 2.25pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> 1.13 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 2.25pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'>   </td> <td width="92" valign="bottom" style='width:69.25pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 2.25pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> 10,076,519 </td> <td width="15" valign="top" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'>   </td> <td width="85" valign="bottom" style='width:64.0pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'>   </td> </tr> </table>   The warrants were issued in connection with the Preferred Stock Offering and were valued using the Lattice model and accounted for as described in Note 7.

NOTE 12 SUBSEQUENT EVENTS   In accordance with ASC 855-10 Company management reviewed all material events through the date of this report and there are no material subsequent events to report.

Derivative Financial Instruments The Company generally does not use derivative financial instruments to hedge exposures to cash-flow risks or market-risks that may affect the fair values of its financial instruments. The Company utilizes various types of financing to fund our business needs, including preferred stock with warrants attached and other instruments not indexed to our stock. The Company is required to record its derivative instruments at their fair value. Changes in the fair value of derivatives are recognized in earnings in accordance with ASC 815.

Fair Value of Financial Instruments  In accordance with ASC 820, the carrying value of cash and cash equivalents, accounts receivable and accounts payable approximates fair value due to the short-term maturity of these instruments.  ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

The carrying amounts reported in the balance sheets for cash, accounts payable and accrued expenses, approximate their fair market value based on the short-term maturity of these instruments. The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2012, on a recurring basis:   <table border="0" cellspacing="0" cellpadding="0" width="622" style='width:466.4pt;border-collapse:collapse'> <tr style='height:15.0pt'> <td width="241" valign="bottom" style='width:180.75pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Description </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="66" colspan="2" valign="bottom" style='width:49.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Level 1 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="60" colspan="2" valign="bottom" style='width:45.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Level 2 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="98" colspan="2" valign="bottom" style='width:73.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Level 3 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="98" colspan="2" valign="bottom" style='width:73.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Gains (Losses) </td> </tr> <tr style='height:12.75pt'> <td width="241" valign="bottom" style='width:180.75pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Derivative Liability </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="45" valign="bottom" style='width:33.55pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="24" valign="bottom" style='width:17.75pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="37" valign="bottom" style='width:27.55pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (5,660,208) </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (32,923) </td> </tr> <tr style='height:12.75pt'> <td width="241" valign="bottom" style='width:180.75pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Total </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="45" valign="bottom" style='width:33.55pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="24" valign="bottom" style='width:17.75pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="37" valign="bottom" style='width:27.55pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (5,660,208) </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (32,923) </td> </tr> </table>   The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2011, on a recurring basis:   <table border="0" cellspacing="0" cellpadding="0" width="622" style='width:466.4pt;border-collapse:collapse'> <tr style='height:15.0pt'> <td width="241" valign="bottom" style='width:180.75pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Description </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="66" colspan="2" valign="bottom" style='width:49.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Level 1 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="60" colspan="2" valign="bottom" style='width:45.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Level 2 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="98" colspan="2" valign="bottom" style='width:73.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Level 3 </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'>   </td> <td width="98" colspan="2" valign="bottom" style='width:73.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> Gains (Losses) </td> </tr> <tr style='height:12.75pt'> <td width="241" valign="bottom" style='width:180.75pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Derivative Liability </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="45" valign="bottom" style='width:33.55pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="24" valign="bottom" style='width:17.75pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="37" valign="bottom" style='width:27.55pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (5,377,308) </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (245,087) </td> </tr> <tr style='height:12.75pt'> <td width="241" valign="bottom" style='width:180.75pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> Total </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="45" valign="bottom" style='width:33.55pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="24" valign="bottom" style='width:17.75pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="37" valign="bottom" style='width:27.55pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> - </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (5,377,308) </td> <td width="15" valign="bottom" style='width:11.1pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'>   </td> <td width="21" valign="bottom" style='width:15.8pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> $ </td> <td width="77" valign="bottom" style='width:57.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:double windowtext 1.5pt;border-right:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> (245,087) </td> </tr> </table>

<div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="354" style='width:265.45pt;border-collapse:collapse'> <tr style='height:4.0pt'> <td width="172" valign="bottom" style='width:129.3pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'>   </td> <td width="90" colspan="2" valign="bottom" style='width:67.5pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'> September 30, </td> <td width="92" colspan="2" valign="bottom" style='width:68.65pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'> December 31, </td> </tr> <tr style='height:4.0pt'> <td width="172" valign="bottom" style='width:129.3pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'>   </td> <td width="90" colspan="2" valign="bottom" style='width:67.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'> 2012 </td> <td width="92" colspan="2" valign="bottom" style='width:68.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'> 2011 </td> </tr> <tr style='height:3.5pt'> <td width="172" valign="bottom" style='width:129.3pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> Computer equipment </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> $ </td> <td width="69" valign="bottom" style='width:51.7pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> 5,390 </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> $ </td> <td width="70" valign="bottom" style='width:52.85pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> 5,390 </td> </tr> <tr style='height:4.0pt'> <td width="172" valign="bottom" style='width:129.3pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'> Accumulated Depreciation </td> <td width="21" valign="bottom" style='width:15.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'>   </td> <td width="69" valign="bottom" style='width:51.7pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'> (4,930) </td> <td width="21" valign="bottom" style='width:15.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'>   </td> <td width="70" valign="bottom" style='width:52.85pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:4.0pt'> (3,981) </td> </tr> <tr style='height:3.5pt'> <td width="172" valign="bottom" style='width:129.3pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> Net Book Value </td> <td width="21" valign="bottom" style='width:15.8pt;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> $ </td> <td width="69" valign="bottom" style='width:51.7pt;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> 460 </td> <td width="21" valign="bottom" style='width:15.8pt;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> $ </td> <td width="70" valign="bottom" style='width:52.85pt;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'> 1,409 </td> </tr> </table> </div>

-800202

-32923

-245087

-282900

5390

-4930

-3981

85738 20000 931 1449 575 810 562 890 1082500

7500

6375

640000

151000

289000

104000

400000

340000

450000

382500

100000 $0.85 stock price, 10 years to maturity, 400% volatility, 2.02% risk free rate 12837500

74934

20424

74934

20424

460

1409

75394

21833

534710

499435

20075

5660208

5377308

6214993

5876743

522

429

12839

12831

2047844

1532432

8200804

7400602

-6139599

-5854910

75394

21833

0001455694 2012-01-01 2012-09-30 0001455694 2012-11-15 0001455694 2012-09-30 0001455694 2011-12-31 0001455694 2012-07-01 2012-09-30 0001455694 2011-07-01 2011-09-30 0001455694 2011-01-01 2011-09-30 0001455694 2006-05-15 2012-09-30 0001455694 2010-12-31 0001455694 2011-09-30 0001455694 2011-01-01 2011-12-31 0001455694 2008-11-25 0001455694 2008-01-24 2008-04-15 0001455694 2010-04-01 2010-06-30 0001455694 2010-12-01 2010-12-31 0001455694 2012-06-30 0001455694 2010-01-01 2010-12-31 0001455694 2009-01-01 2009-12-31 iso4217:USD shares iso4217:USD shares par value $0.10 $1,000 per share Series A $0.85 per common share Series B

EX-101.SCH 5 sppxbrl-20120930.xsd XBRL SCHEMA 000300 - Disclosure - Note 9 - Common Stock (Details) link:presentationLink link:definitionLink link:calculationLink 000190 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Derivative Financial Instruments (Policies) link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - Note 2 - Going Concern link:presentationLink link:definitionLink link:calculationLink 000160 - Disclosure - Note 11 - Stock Options link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000130 - Disclosure - Note 8 - Preferred Stock link:presentationLink link:definitionLink link:calculationLink 000150 - Disclosure - Note 10 - Warrants link:presentationLink link:definitionLink link:calculationLink 000280 - Disclosure - Note 6 - Note Payable (Details) link:presentationLink link:definitionLink link:calculationLink 000220 - Disclosure - Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Tables) link:presentationLink link:definitionLink link:calculationLink 000060 - Disclosure - Note 1 - Condensed Financial Statements link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 000270 - Disclosure - Note 5 - Accrued Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 000200 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies) link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - Note 4 - Equipment link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - Note 5 - Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000140 - Disclosure - Note 9 - Common Stock link:presentationLink link:definitionLink link:calculationLink 000180 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Use of Estimates (Policies) link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - Note 7 - Derivative Liability and Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 000240 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Details) link:presentationLink link:definitionLink link:calculationLink 000170 - Disclosure - Note 12- Subsequent Events link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - Note 6 - Note Payable link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - Balance Sheets Parenthetical link:presentationLink link:definitionLink link:calculationLink 000310 - Disclosure - Note 11 - Stock Options (Details) link:presentationLink link:definitionLink link:calculationLink 000260 - Disclosure - Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Details) link:presentationLink link:definitionLink link:calculationLink 000210 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 000230 - Disclosure - Note 2 - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 000290 - Disclosure - Note 8 - Preferred Stock (Details) link:presentationLink link:definitionLink link:calculationLink 000250 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - Note 3 - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 sppxbrl-20120930_cal.xml XBRL CALCULATION EX-101.DEF 7 sppxbrl-20120930_def.xml XBRL DEFINITION EX-101.LAB 8 sppxbrl-20120930_lab.xml XBRL LABEL Tables/Schedules Note 12- Subsequent Events Note 9 - Common Stock Purchase of equipment Purchase of equipment Total Operating Expenses Total Operating Expenses General and administrative Preferred stock shares issued ASSETS Statement Entity Registrant Name Preferred stock issued for cash NET LOSS BEFORE INCOME TAXES NET LOSS BEFORE INCOME TAXES Current Fiscal Year End Date Document Type StockIssuedDuringPeriodSharesIssuedForServices Note 10 - Warrants Net Cash Provided by Financing Activities Net Cash Provided by Financing Activities Statements of Cash Flows PROVISION FOR INCOME TAXES PROVISION FOR INCOME TAXES Professional fees Convertible preferred stock shares authorized Total Current Liabilities Total Current Liabilities AllocatedShareBasedCompensationExpense Convertible Preferred Stock issued for cash Change in derivative liability, net of bifurcation Common stock issued with bridge financing Total Other Income (Expense) Total Other Income (Expense) Interest expense Interest expense TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT Options issued to a director Use of Estimates Note 2 - Going Concern Derivative liability non cash financing activity Common stock issued for cash Common stock; $0.001 par value, 45,000,000 shares authorized; 12,837,500 shares issued and outstanding, respectively Related party note payable Entity Current Reporting Status AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets Warrants and options issued for services Preferred stock shares outstanding Entity Central Index Key Fair Value of Financial Instruments Derivative Financial Instruments STOCKHOLDERS' DEFICIT Common Stock issued Policies Note 1 - Condensed Financial Statements NON CASH FINANCING ACTIVITIES: Repayments of notes payable Net Cash Used in Operating Activities Net Cash Used in Operating Activities Depreciation expense Common stock issued for services Common stock issued for services WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING Research and development Deficit accumulated during the development stage Deficit accumulated during the development stage Additional paid-in capital Cash CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD Black-Scholes option pricing model assumptions Details Note 11 - Stock Options Note 8 - Preferred Stock Note 3 - Summary of Significant Accounting Policies Financing expense Common stock shares outstanding Total Current Assets Total Current Assets Entity Filer Category Amendment Flag SalariesWagesAndOfficersCompensation ConvertiblePreferredStockIssuedForCashNov25 ConvertiblePreferredStockIssuedForCash OPERATING ACTIVITIES CURRENT LIABILITIES Statement {1} Statement Purchases, sales, issuances and settlements (net) Note 6 - Note Payable FINANCING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities: OTHER INCOME (EXPENSE) Salaries and wages REVENUES Common stock par value Total Stockholders' Deficit Total Stockholders' Deficit EQUIPMENT, net Probable liquidated damages OPERATING LOSS OPERATING LOSS CURRENT ASSETS Document Fiscal Year Focus Interest CASH PAID FOR: INVESTING ACTIVITIES Grant income Statements of Operations Entity Well-known Seasoned Issuer ConvertiblePreferredStockIssued Schedule of derivative instruments Note 7 - Derivative Liability and Fair Value Measurements Note 5 - Accrued Liabilities SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: NET INCREASE (DECREASE) IN CASH NET INCREASE (DECREASE) IN CASH Stock offering costs paid Stock offering costs paid Net Cash Used in Investing Activities Net Cash Used in Investing Activities Change in accounts payable and accrued expenses BASIC AND DILUTED LOSS PER SHARE Net loss NET LOSS Net loss Gain (loss) on derivative liability Common stock shares issued Balance Sheets Parenthetical ScheduleOfPropertyAndEquipment Notes Income taxes Preferred stock; $0.10 par value, 5,000,000 shares authorized 5,217 and 4,286 shares issued and outstanding, respectively LIABILITIES AND STOCKHOLDERS' DEFICIT NotesPayableRelatedPartyRepayment Note 4 - Equipment Preferred stock issued for bridge financing Changes in operating assets and liabilities Common stock shares authorized Derivative liability Derivative liability Balance Sheets Document Fiscal Period Focus Entity Common Stock, Shares Outstanding Extinguished accrued officer salary PropertyPlantAndEquipmentGross Proceeds from notes payable OPERATING EXPENSES Convertible preferred stock par value Accounts payable and accrued expenses TOTAL ASSETS TOTAL ASSETS Entity Voluntary Filers Document Period End Date Document and Entity Information EX-101.PRE 9 sppxbrl-20120930_pre.xml XBRL PRESENTATION XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 R25.htm IDEA: XBRL DOCUMENT

Note 3 - Summary of Significant Accounting Policies (Details) (USD $)	9 Months Ended
	Sep. 30, 2012	Dec. 31, 2011
Derivative liability	$ (5,660,208)	$ (5,377,308)
Purchases, sales, issuances and settlements (net)	$ (282,900)

- Definition

Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FIN39-1

-Paragraph 10A, 10B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 7

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 4, 17

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13495-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

+ Details

XML 12 R9.htm IDEA: XBRL DOCUMENT

Note 4 - Equipment

9 Months Ended

Sep. 30, 2012

Notes

Note 4 - Equipment

NOTE 4 – EQUIPMENT

Property and equipment consists of the following as of September 30, 2012 and December 31, 2011, respectively. Depreciation expense was $949 for the nine months endedSeptember 30, 2012 and December 31, 2011, respectively.

	September 30,		December 31,
	2012		2011
Computer equipment	$	5,390	$	5,390
Accumulated Depreciation		(4,930)		(3,981)
Net Book Value	$	460	$	1,409

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details

EXCEL 13 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y8E]D9#@T M,C8S,#$W8SDB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K5]O9E]3:6=N:69I8V%N=%\\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DYO=&5?.5]#;VUM;VY?4W1O8VL\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,U]3=6UM87)Y M7V]F7U-I9VYI9FEC86YT7S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K5]O9E]3:6=N:69I8V%N=%\R/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,U]3=6UM87)Y7V]F7U-I9VYI9FEC86YT M7S0\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?,U]3=6UM87)Y7V]F7U-I9VYI M9FEC86YT7S8\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I7;W)K#I3 M='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C.6,P,V(Y-E\P8C@P M7S0S9#%?.#@Y8E]D9#@T,C8S,#$W8SD-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO8SEC,#-B.39?,&(X,%\T,V0Q7S@X.6)?9&0X-#(V,S`Q-V,Y M+U=O'0O M:'1M;#L@8VAA2!);F9O'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^4V5P(#,P M+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^9F%L2!#96YT3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,30U-38Y-#QS<&%N M/CPO'0^+2TQ,BTS,3QS<&%N/CPO2!#=7)R96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@ M("`@("`\=&0@8VQA2!& M:6QE'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO M'0^43,\'1087)T7V,Y8S`S8CDV7S!B.#!?-#-D,5\X.#EB7V1D.#0R-C,P,3=C.0T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C.6,P,V(Y-E\P8C@P7S0S M9#%?.#@Y8E]D9#@T,C8S,#$W8SDO5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!N;W1E M('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C.6,P,V(Y M-E\P8C@P7S0S9#%?.#@Y8E]D9#@T,C8S,#$W8SD-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO8SEC,#-B.39?,&(X,%\T,V0Q7S@X.6)?9&0X-#(V M,S`Q-V,Y+U=O'0O:'1M;#L@8VAA'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'!E;G-E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E*3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'0^)FYB'0^)FYB'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y8E]D9#@T,C8S,#$W8SD-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8SEC,#-B.39?,&(X,%\T,V0Q7S@X M.6)?9&0X-#(V,S`Q-V,Y+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2P@;F5T(&]F(&)I M9G5R8V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,BPY M,C,\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA2!&:6YA;F-I;F<@06-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y8E]D9#@T,C8S,#$W M8SD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8SEC,#-B.39?,&(X M,%\T,V0Q7S@X.6)?9&0X-#(V,S`Q-V,Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/"$M+65G>"TM/CQP('-T>6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z M;F]R;6%L/CQB/DY/5$4@,2`M($-/3D1%3E-%1"!&24Y!3D-)04P@4U1!5$5- M14Y44SPO8CX\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/B9N8G-P.SPO<#X@ M/'`@6EN9R!F:6YA;F-I86P@2!N;W)M M86P@'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE M:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP('-T M>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM M8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U M)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X M="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y8E]D9#@T,C8S,#$W8SD- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8SEC,#-B.39?,&(X,%\T M,V0Q7S@X.6)?9&0X-#(V,S`Q-V,Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI M9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET M93XF;F)S<#L\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT M.FYO2!A M8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@:6X@=&AE(%5N:71E9"!3 M=&%T97,@;V8@06UEF%T:6]N(&]F(&%S65T M(&5S=&%B;&ES:&5D(&%N(&]N9V]I;F<@2!H860@86X@ M86-C=6UU;&%T960@9&5F:6-I="!O9B9N8G-P.R0X+#(P,"PX,#0N)FYB2!T;R!R86ES92!E<75I='D@;W(@9&5B="!F:6YA;F-I;F2!A9&IU2!B92!U;F%B;&4@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC M97)N+CPO<#X@/'`@'0M86QI9VXZ M:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93Y) M;B!O6QE M/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T M=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM M87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH M96EG:'0Z;F]R;6%L.V)A8VMG2!T;R!S=6-C97-S9G5L M;'D@86-C;VUP;&ES:"!T:&4@<&QA;G,@9&5S8W)I8F5D(&EN('1H92!P6EN9R!F:6YA;F-I86P@3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y M8E]D9#@T,C8S,#$W8SD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8SEC,#-B.39?,&(X,%\T,V0Q7S@X.6)?9&0X-#(V,S`Q-V,Y+U=O'0O:'1M;#L@8VAA M'0^/"$M+65G>"TM/CQP('-T>6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/CQB M/DY/5$4@,R`F(S$U,#L@4U5-34%262!/1B!324=.249)0T%.5"!!0T-/54Y4 M24Y'(%!/3$E#2453/"]B/CPO<#X@/'`@'0M86QI9VXZ:G5S M=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93Y4:&4@ M<')E<&%R871I;VX@;V8@9FEN86YC:6%L('-T871E;65N=',@:6X@8V]N9F]R M;6ET>2!W:71H(&%C8V]U;G1I;F<@<')I;F-I<&QE6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM M8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U M)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X M="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO6QE/3-$;6%R9VEN+71O<#HP:6X[ M;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM M;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM M87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M M:&5I9VAT.FYO2!D;V5S(&YO="!UF5D(&EN(&5A6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ M=7-T:69Y.VQI;F4M:&5I9VAT.FYO6%B;&4@87!P6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ M=7-T:69Y.VQI;F4M:&5I9VAT.FYO'0M86QI9VXZ:G5S=&EF>3ML M:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^ M(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM M87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG M:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q M<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO'0M86QI9VXZ:G5S=&EF>3ML:6YE M+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z M,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[ M=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO'0M M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW M:&ET93Y4:&4@8V%R6%B;&4@86YD(&%C M8W)U960@97AP96YS97,L(&%P<')O>&EM871E('1H96ER(&9A:7(@;6%R:V5T M('9A;'5E(&)A6QE M/3-$=VED=&@Z-#8V+C1P=#MB;W)D97(M8V]L;&%P6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z M,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[ M;&EN92UH96EG:'0Z;F]R;6%L/B9N8G-P.SPO<#X@/"]T9#X@/'1D('=I9'1H M/3-$-C8@8V]L6QE/3-$)W=I M9'1H.B`T.2XS-7!T.R!B;W)D97(Z(&YO;F4[(&)O'0@,2XP<'0[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q,2XQ<'0[ M('!A9&1I;F6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIC96YT97([;&EN92UH96EG:'0Z M;F]R;6%L/DQE=F5L(#(\+W`^(#PO=&0^(#QT9"!W:61T:#TS1#$U('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,7!T.R!P861D:6YG.B`P M:6X@-2XT<'0@,&EN(#4N-'!T.R<^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/B9N M8G-P.SPO<#X@/"]T9#X@/'1D('=I9'1H/3-$.3@@8V]L6QE/3-$)W=I9'1H.B`W,RXS<'0[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.FYO'0@,2XP<'0[('!A9&1I;F'0M86QI9VXZ M6QE/3-$;6%R9VEN+71O M<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM M87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML M:6YE+6AE:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$,S<@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`R-RXU-7!T.R!P861D M:6YG.B`P:6X@-2XT<'0@,&EN(#4N-'!T.R<^(#QP(&%L:6=N/3-$6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN M;W)M86P^)FYB6QE/3-$ M;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G M:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG M;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I M9'1H/3-$-S<@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`U-RXU M<'0[('!A9&1I;F'0M86QI9VXZ6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR M:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)FYB6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT M.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN M92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^ M)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$-S<@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`U-RXU<'0[('!A9&1I;F'0M86QI9VXZ6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM M87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG M:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q M<'0[;&EN92UH96EG:'0Z;F]R;6%L/E1O=&%L/"]P/B`\+W1D/B`\=&0@=VED M=&@],T0Q-2!V86QI9VX],T1B;W1T;VT@'0@,2XU<'0[(&)O M6QE/3-$;6%R9VEN+71O<#HP:6X[ M;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM M;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM M87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE M:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$-#4@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`S,RXU-7!T.R!B;W)D97(M=&]P M.B!S;VQI9"!W:6YD;W=T97AT(#$N,'!T.R!B;W)D97(M;&5F=#H@;F]N93L@ M8F]R9&5R+6)O='1O;3H@9&]U8FQE('=I;F1O=W1E>'0@,2XU<'0[(&)O6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R M9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F M=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G M:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H M=#IN;W)M86P^+3PO<#X@/"]T9#X@/'1D('=I9'1H/3-$,34@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XQ<'0[('!A9&1I;F'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`Q M-RXW-7!T.R!B;W)D97(M=&]P.B!S;VQI9"!W:6YD;W=T97AT(#$N,'!T.R!B M;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+6)O='1O;3H@9&]U8FQE('=I;F1O M=W1E>'0@,2XU<'0[(&)O6QE/3-$ M;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G M:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG M;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I M9'1H/3-$,S<@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`R-RXU M-7!T.R!B;W)D97(M=&]P.B!S;VQI9"!W:6YD;W=T97AT(#$N,'!T.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+6)O='1O;3H@9&]U8FQE('=I;F1O=W1E M>'0@,2XU<'0[(&)O6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR M:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^+3PO<#X@/"]T9#X@/'1D('=I9'1H M/3-$,34@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q,2XQ<'0[ M('!A9&1I;F'0M86QI9VXZ6QE/3-$)W=I9'1H.B`Q-2XX<'0[(&)O'0@,2XP<'0[(&)O'0M86QI9VXZ6QE/3-$;6%R9VEN+71O M<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM M87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML M:6YE+6AE:6=H=#IN;W)M86P^)FYB'0M86QI9VXZ'0@,2XU<'0[ M(&)O6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE M+6AE:6=H=#IN;W)M86P^*#,R+#DR,RD\+W`^(#PO=&0^(#PO='(^(#PO=&%B M;&4^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I M;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH M96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP M,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYOF5D(&%T(&9A:7(@=F%L M=64@87,@;V8@1&5C96UB97(@,S$L(#(P,3$L(&]N(&$@6QE/3-$=VED=&@Z-#8V+C1P=#MB;W)D97(M8V]L;&%P6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT M.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN M92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/B9N8G-P.SPO<#X@/"]T9#X@ M/'1D('=I9'1H/3-$-C8@8V]L6QE/3-$)W=I9'1H.B`T.2XS-7!T.R!B;W)D97(Z(&YO;F4[(&)O'0@,2XP<'0[('!A9&1I;F6QE/3-$)W=I9'1H M.B`Q,2XQ<'0[('!A9&1I;F6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIC96YT97([;&EN M92UH96EG:'0Z;F]R;6%L/DQE=F5L(#(\+W`^(#PO=&0^(#QT9"!W:61T:#TS M1#$U('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,3$N,7!T.R!P M861D:6YG.B`P:6X@-2XT<'0@,&EN(#4N-'!T.R<^(#QP('-T>6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z M;F]R;6%L/B9N8G-P.SPO<#X@/"]T9#X@/'1D('=I9'1H/3-$.3@@8V]L6QE/3-$)W=I9'1H.B`W,RXS<'0[ M(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M:&5I9VAT.FYO M'0@,2XP<'0[('!A M9&1I;F'0M86QI9VXZ6QE/3-$ M;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G M:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG M;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I M9'1H/3-$,S<@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`R-RXU M-7!T.R!P861D:6YG.B`P:6X@-2XT<'0@,&EN(#4N-'!T.R<^(#QP(&%L:6=N M/3-$6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE M+6AE:6=H=#IN;W)M86P^)FYB6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z M,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[ M=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)#PO<#X@/"]T M9#X@/'1D('=I9'1H/3-$-S<@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I M9'1H.B`U-RXU<'0[('!A9&1I;F'0M86QI9VXZ6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM M8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U M)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X M="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)FYB6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R M9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F M=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G M:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H M=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$-S<@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`U-RXU<'0[('!A9&1I;F'0M86QI9VXZ M6QE/3-$)W=I9'1H.B`Q.#`N-S5P=#L@<&%D9&EN9SH@,&EN(#4N-'!T(#!I M;B`U+C1P=#LG/B`\<"!S='EL93TS1&UA6QE/3-$)W=I M9'1H.B`Q,2XQ<'0[('!A9&1I;F'0M86QI9VXZ'0M86QI9VXZ'0M86QI9VXZ'0M86QI9VXZ'0@,2XU<'0[(&)O6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN M;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$-S<@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`U-RXU<'0[(&)O'0@,2XP<'0[(&)O6QE/3-$)W=I9'1H.B`Q,2XQ<'0[('!A9&1I;F'0M86QI M9VXZ6QE/3-$)W=I9'1H M.B`Q-2XX<'0[(&)O'0@,2XP<'0[ M(&)O'0M86QI9VXZ M6QE/3-$;6%R9VEN+71O<#HP:6X[ M;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM M;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM M87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M M:&5I9VAT.FYO'0M86QI9VXZ:G5S=&EF>3ML:6YE M+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z M,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[ M=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO2=S('=A2!A<'!R;WAI;6%T97,@:71S(&-A'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H M=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP('-T>6QE M/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T M=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM M87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA M;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO2!P6EN9R!A;6]U;G1S M+B!4:&4@0V]M<&%N>2!B96QI979E6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R M9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F M=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G M:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I M9VAT.FYO2!C87!T:6]N(&]N('1H92!C;VYD96YS960@8F%L86YC M92!S:&5E="!A;F0@8GD@05-#(#@R,"!V86QU871I;VX@:&EE6QE/3-$;6%R9VEN+71O<#HP:6X[ M;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM M;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM M87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M M:&5I9VAT.FYO6QE/3-$)W=I9'1H.B`R.#0N,C5P=#L@<&%D9&EN9SH@ M,&EN(#4N-'!T(#!I;B`U+C1P=#LG/B`\<"!S='EL93TS1&UA6QE/3-$;6%R9VEN+71O M<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM M87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIC96YT97([ M;&EN92UH96EG:'0Z;F]R;6%L/E-T;V-K(%=A6QE/3-$)W=I9'1H.B`R.#0N M,C5P=#L@<&%D9&EN9SH@,&EN(#4N-'!T(#!I;B`U+C1P=#LG/B`\<"!S='EL M93TS1&UA6QE/3-$)W=I9'1H M.B`Y,2XU<'0[(&)O'0M86QI9VXZ8V5N=&5R.VQI;F4M M:&5I9VAT.FYO6QE/3-$)W=I9'1H.B`Q-2XX<'0[('!A9&1I;F'0M86QI9VXZ6QE M/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T M=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM M87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH M96EG:'0Z;F]R;6%L/E!U6QE/3-$)W=I9'1H.B`Q-2XX<'0[('!A9&1I;F'0M86QI9VXZ6QE/3-$)W=I9'1H.B`W-2XW<'0[('!A9&1I;F'0M86QI9VXZ6QE M/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T M=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM M87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH M96EG:'0Z;F]R;6%L/E1O=&%L(&QE=F5L(#,@87-S971S(&%N9"!L:6%B:6QI M=&EE6QE/3-$)W=I9'1H.B`Q-2XX<'0[(&)O'0@,2XP<'0[(&)O6QE/3-$;6%R9VEN+71O<#HP:6X[ M;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM M;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM M87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE M:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$,3`Q('-T>6QE M/3-$)W=I9'1H.B`W-2XW<'0[(&)O'0@,2XP<'0[(&)O6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM M87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG M:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q M<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^*#4L-C8P M+#(P."D\+W`^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ M=7-T:69Y.VQI;F4M:&5I9VAT.FYO6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM M87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG M:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q M<'0[;&EN92UH96EG:'0Z;F]R;6%L.V)A8VMG3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y8E]D9#@T,C8S,#$W8SD-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8SEC,#-B.39?,&(X,%\T,V0Q M7S@X.6)?9&0X-#(V,S`Q-V,Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/"$M+65G>"TM/CQP('-T>6QE/3-$;6%R9VEN M+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P M=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T M=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R M;6%L.V)A8VMG2X@1&5P2X\+W`^(#QP('-T>6QE/3-$;6%R9VEN M+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P M=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T M=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T M:69Y.VQI;F4M:&5I9VAT.FYO6QE M/3-$)W=I9'1H.B`Q,CDN,W!T.R!P861D:6YG.B`P:6X@-2XT<'0@,&EN(#4N M-'!T.R<^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT M.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN M92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/B9N8G-P.SPO<#X@/"]T9#X@ M/'1D('=I9'1H/3-$.3`@8V]L6QE/3-$)W=I9'1H.B`V-RXU<'0[('!A9&1I;F6QE M/3-$)W=I9'1H.B`V."XV-7!T.R!P861D:6YG.B`P:6X@-2XT<'0@,&EN(#4N M-'!T.R<^(#QP(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIC96YT97([;&EN M92UH96EG:'0Z;F]R;6%L/D1E8V5M8F5R(#,Q+#PO<#X@/"]T9#X@/"]T6QE/3-$ M)W=I9'1H.B`Q,CDN,W!T.R!P861D:6YG.B`P:6X@-2XT<'0@,&EN(#4N-'!T M.R<^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I M;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH M96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP M,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/B9N8G-P.SPO<#X@/"]T9#X@/'1D M('=I9'1H/3-$.3`@8V]L6QE M/3-$)W=I9'1H.B`V-RXU<'0[(&)O'0M86QI9VXZ8V5N M=&5R.VQI;F4M:&5I9VAT.FYO'0M86QI9VXZ8V5N=&5R M.VQI;F4M:&5I9VAT.FYO6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R M9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F M=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G M:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H M=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$-CD@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`U,2XW<'0[('!A9&1I;F'0M86QI9VXZ M6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT M.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN M92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^ M)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$-S`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`U,BXX-7!T.R!P861D:6YG.B`P:6X@-2XT<'0@,&EN M(#4N-'!T.R<^(#QP(&%L:6=N/3-$6QE/3-$)W=I9'1H M.B`Q,CDN,W!T.R!P861D:6YG.B`P:6X@-2XT<'0@,&EN(#4N-'!T.R<^(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z M,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[ M;&EN92UH96EG:'0Z;F]R;6%L/D%C8W5M=6QA=&5D($1E<')E8VEA=&EO;CPO M<#X@/"]T9#X@/'1D('=I9'1H/3-$,C$@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q-2XX<'0[(&)O6QE/3-$;6%R9VEN M+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P M=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T M=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H M=#ML:6YE+6AE:6=H=#IN;W)M86P^)FYB6QE/3-$;6%R9VEN+71O M<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM M87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML M:6YE+6AE:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I9'1H/3-$-CD@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`U,2XW<'0[(&)O'0@,BXR M-7!T.R!P861D:6YG.B`P:6X@-2XT<'0@,&EN(#4N-'!T.R<^(#QP(&%L:6=N M/3-$6QE/3-$ M;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G M:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG M;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)#PO<#X@/"]T9#X@/'1D('=I M9'1H/3-$-S`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`U,BXX M-7!T.R!B;W)D97(Z(&YO;F4[(&)O6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R M9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F M=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G M:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H M=#IN;W)M86P^,2PT,#D\+W`^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV M/B`\<"!S='EL93TS1&UA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT M.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN M92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO&EM871E9"`D,2XX(&UI;&QI;VX@87,@ M;V8@=&AA="!D871E+B9N8G-P.R9N8G-P.T1U65A2!T:&4@4T5#+B9N8G-P.R9N8G-P.T5A M8V@@:&]L9&5R(&ES(&5N=&ET;&5D('1O("0T-RXS,B!P97(@2!T:&4@;&EQ=6ED871E9"!D86UA9V5S(&EN('-H87)E7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4\8G(^/"]S M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE M:6=H=#IN;W)M86P^/&(^3D]412`V("8C,34P.R!.3U1%(%!!64%"3$4\+V(^ M/"]P/B`\<"!S='EL93TS1&UA'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P^ M)FYB'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN M;W)M86P^26X@2F%N=6%R>2`R,#$R+"!T:&4@0V]M<&%N>2!R96-E:79E9"!C M87-H('!U2`R,#$R+B8C,38P.R!4:&4@;F]T92!D M:60@;F]T(&)E87(@:6YT97)E'0M86QI9VXZ:G5S=&EF M>3ML:6YE+6AE:6=H=#IN;W)M86P^)FYB'0M86QI9VXZ M:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P^3VX@4V5P=&5M8F5R(#(W+"`R M,#$R+"!T:&4@0V]M<&%N>2!R96-E:79E9"`D-#4L,#2XF(S$V,#L@5&AE(&YO=&4@9&]E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y8E]D9#@T,C8S,#$W8SD-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8SEC,#-B.39?,&(X,%\T,V0Q7S@X M.6)?9&0X-#(V,S`Q-V,Y+U=O'0O:'1M;#L@8VAA'0^/"$M+65G>"TM/CQP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/CQB/DY/5$4@-R`F M(S$U,#L@1$52259!5$E612!,24%"24Q)5%D@04Y$($9!25(@5D%,544@345! M4U5214U%3E13/"]B/CPO<#X@/'`@'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[ M8F%C:V=R;W5N9#IW:&ET93Y4:&4@0V]M<&%N>28C,30V.W,@;VYL>2!A2!I;F1E>&5D('1O(&%N(&5N=&ET>28C,30V.W,@;W=N('-T;V-K M+B!!&5R8VES92!P'0M86QI M9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET M93Y!2`Q+"`R,#`Y+"`S+#4W,BPW,30@ M;V8@=&AE($-O;7!A;GDF(S$T-CMS(&]U='-T86YD:6YG('=A2!C;&%S'!I2`Q+"`R,#`Y+"!T:&4@9F%IF5D(&%N M9"!R97-U;'1E9"!I;B!A(&-U;75L871I=F4@969F96-T(&%D:G5S=&UE;G0@ M=&\@65A6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I M9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[ M;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T M=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO M2!A6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI M;F4M:&5I9VAT.FYO2!I2!I'0M86QI9VXZ:G5S=&EF M>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\ M+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I M;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH M96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP M,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO65A2!I2!A65A'0M86QI M9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET M93XF;F)S<#L\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT M.FYO65A2!I2!A65A M'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R M;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI M;F4M:&5I9VAT.FYO2!W96EG M:'1E9"!D:7-C;W5N=&5D(&-AF5D(&%N9"!I;F-O'0M86QI9VXZ M:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93Y4 M:&4@4V5R:65S($$@4')E9F5R'0M M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW M:&ET93XF;F)S<#L\+W`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`\<"!S M='EL93TS1&UA'0M86QI9VXZ:G5S=&EF>3MT M97AT+6EN9&5N=#HM+C(U:6X^/&9O;G0^)B,Q.#,[)FYB'0M86QI9VXZ:G5S M=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P^)FYB'0M86QI M9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET M93Y4:&4@=V%R'0M86QI9VXZ:G5S=&EF>3ML:6YE M+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C!I;CMM87)G:6XM;&5F=#HN-6EN.VUA'0M:6YD96YT.BTN,C5I;CMB86-K9W)O=6YD.G=H:71E/CQF;VYT/B8C M,3@S.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R`\+V9O;G0^5&AE('-T;V-K('!R:6-E(&]F("0P+C@U('=A6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I M;CMM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM;&5F=#HN-6EN.VUA'0M:6YD96YT.BTN,C5I;CMB86-K9W)O=6YD.G=H:71E/CQF M;VYT/B8C,3@S.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R`\+V9O;G0^5&AE('!R;VIE8W1E9"!V;VQA=&EL:71Y M(&-U2X\ M+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I M;CMM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM;&5F=#HN-6EN.VUA'0M:6YD96YT.BTN,C5I;CMB86-K9W)O=6YD.G=H:71E/CQF M;VYT/B8C,3@S.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R`\+V9O;G0^5&AE($AO;&1E6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C!I;CMM87)G:6XM;&5F=#HN-6EN.VUA'0M:6YD96YT.BTN,C5I;CMB86-K9W)O=6YD.G=H:71E/CQF;VYT/B8C M,3@S.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R`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`Q M<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO6QE/3-$)W=I9'1H.B`Q-2XX<'0[('!A M9&1I;F'0M86QI9VXZ6QE/3-$)W=I9'1H.B`U,"XX<'0[('!A M9&1I;F'0M86QI9VXZ6QE/3-$)W=I9'1H.B`U,"XX<'0[('!A9&1I;F'0M86QI9VXZ6QE/3-$)W=I9'1H.B`S,3DN,'!T.R!P861D M:6YG.B`P:6X@-2XT<'0@,&EN(#4N-'!T.R<^(#QP('-T>6QE/3-$;6%R9VEN M+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P M=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T M=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R M;6%L/D1E6QE/3-$)W=I9'1H.B`Q-2XX<'0[(&)O6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I M;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH M96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP M,#`Q<'0[=&5X="UA;&EG;CIR:6=H=#ML:6YE+6AE:6=H=#IN;W)M86P^)FYB M'0@,2XP<'0[('!A9&1I;F'0M86QI9VXZ3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]C.6,P,V(Y-E\P8C@P7S0S9#%?.#@Y8E]D M9#@T,C8S,#$W8SD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8SEC M,#-B.39?,&(X,%\T,V0Q7S@X.6)?9&0X-#(V,S`Q-V,Y+U=O'0O:'1M;#L@8VAA'0^ M/"$M+65G>"TM/CQP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I M9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[ M;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T M=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z;F]R;6%L/CQB/DY/5$4@."`F(S$U M,#L@4%)%1D524D5$(%-43T-+/"]B/CPO<#X@/'`@6QE/3-$;6%R M9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P M+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM M8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[;&EN92UH96EG:'0Z M;F]R;6%L.V)A8VMGF5D(&)Y(')E M2!P86ED(&%N9"!N;VXM87-S97-S86)L92XF;F)S<#LF;F)S M<#M!6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT M.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN M92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN M+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP M:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM M8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT M.FYO'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N M9#IW:&ET93Y4:&4@4')E9F5R2!I=',@=&5R;7,@:G5N:6]R('1O M('1H92!02!R86YK M:6YG(&)Y(&ET2!R86YK:6YG(&)Y(&ET2!C;&%S2!I=',@=&5R;7,@2P@=VAE=&AE'0M86QI9VXZ M:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF M;F)S<#L\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I M9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[ M;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T M=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO M6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G M:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z M,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[ M=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO6%B;&4@:6X@8V%S:"!O2!W:71H('1H92!H;VQD97)S(&]F('1H92!C;VUM;VX@2!A=F%I;&%B;&4@9F]R('1H92!P87EM96YT(&]F('-U8V@@9&EV:61E M;F1S(&%N9"!W:&5T:&5R(&]R(&YO="!S=6-H(&1I=FED96YD2!D96-L87)E(&%N9"!P M87D@9&EV:61E;F1S(&]R(&UA:V4@;W1H97(@9&ES=')I8G5T:6]N2!D:79I9&5N M9',@:6X@2!S:&%R97,@ M;V8@8V%P:71A;"!S=&]C:R!R86YK:6YG(&IU;FEO2!A'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[ M8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP('-T>6QE/3-$;6%R9VEN M+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P M=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T M=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T M:69Y.VQI;F4M:&5I9VAT.FYO'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE M:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93Y!="!T:&4@96QE8W1I;VX@ M;V8@=&AE(&AO;&1E2!S:&%R97,@;V8@:71S(&-O;6UO;B!S=&]C:R`H;W(@;W!T:6]N M2!T:&4@<')I8V4@<&5R('-H87)E(&]F(&-O;6UO;B!S=&]C:R`H;W(@ M=&AE(&-O;G9E'0M86QI9VXZ:G5S=&EF>3ML:6YE+6AE M:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S<#L\+W`^(#QP('-T M>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM M8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U M)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X M="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO6UE;G0@;V8@86-C=6UU;&%T960@86YD('5N<&%I9"!D:79I9&5N9',@=VEL M;"!B92!M861E('5P;VX@8V]N=F5R28C,30V M.W,@;W!T:6]N(&9O;&QO=VEN9R!T:&4@969F96-T:79E;F5S6QE/3-$;6%R9VEN+71O<#HP M:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G M:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I M;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI M;F4M:&5I9VAT.FYO6QE M/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT.C!I;CMM87)G:6XM8F]T M=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN92UH96EG:'0Z,3$U)3MM M87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M.BXP,#`Q<'0[=&5X="UA M;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYOF4L(&5F9F5C="!O2!C;&%S2XF;F)S<#LF;F)S<#M);B!A9&1I=&EO;BP@=&AE(&AO;&1E'0M86QI9VXZ:G5S M=&EF>3ML:6YE+6AE:6=H=#IN;W)M86P[8F%C:V=R;W5N9#IW:&ET93XF;F)S M<#L\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP:6X[;6%R9VEN+7)I9VAT M.C!I;CMM87)G:6XM8F]T=&]M.C$P+C!P=#MM87)G:6XM;&5F=#HP:6X[;&EN M92UH96EG:'0Z,3$U)3MM87)G:6XM8F]T=&]M.C!I;CMM87)G:6XM8F]T=&]M M.BXP,#`Q<'0[=&5X="UA;&EG;CIJ=7-T:69Y.VQI;F4M:&5I9VAT.FYO2!V;VQU;G1A2`H=VAE=&AE M2!A8V-R=65D(&%N9"!U;G!A M:60@9&EV:61E;F1S+"!S=6)J96-T('1O(&%D:G5S=&UE;G0@=7!O;B!T:&4@ M;V-C=7)R96YC92!O9B!C97)T86EN(&5V96YT2!W:71H('1H M92!02!I;B!A;GD@2!W:71H(&]R(&EN=&\@86YO=&AE6%N8V4@;V8@86QL(&]R('-U8G-T86YT M:6%L;'D@86QL('1H92!P XML 14 R29.htm IDEA: XBRL DOCUMENT

Note 8 - Preferred Stock (Details)

3 Months Ended

9 Months Ended

12 Months Ended

Apr. 15, 2008

Sep. 30, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Nov. 25, 2008

ConvertiblePreferredStockIssued

931

^[1],[2],[3]

810

^[1],[2],[3]

ConvertiblePreferredStockIssuedForCash

1,449

^[1],[2],[3]

575

^[1],[2],[3]

ConvertiblePreferredStockIssuedForCashNov25

562

^[1],[2],[4]

Convertible Preferred Stock issued for cash

890

^[1],[2],[4]

Common Stock issued

1,082,500

^[5]

[1]	par value $0.10
[2]	$1,000 per share
[3]	Series B
[4]	Series A
[5]	$0.85 per common share

XML 15 R28.htm IDEA: XBRL DOCUMENT

Note 6 - Note Payable (Details) (USD $)	9 Months Ended
Note 6 - Note Payable (Details) (USD $)	Sep. 30, 2012
NotesPayableRelatedPartyRepayment	$ 20,000
Related party note payable	$ 20,075

XML 16 R30.htm IDEA: XBRL DOCUMENT

Note 9 - Common Stock (Details) (USD $)

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Dec. 31, 2010

Jun. 30, 2010

Sep. 30, 2012

Dec. 31, 2011

StockIssuedDuringPeriodSharesIssuedForServices

450,000

^[1]

400,000

^[1]

7,500

^[1]

640,000

^[1]

AllocatedShareBasedCompensationExpense

$ 382,500

$ 340,000

$ 6,375

$ 289,000

SalariesWagesAndOfficersCompensation

151,000

Extinguished accrued officer salary

$ 104,000

[1]	$0.85 per common share

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References+ Details

XML 17 R31.htm IDEA: XBRL DOCUMENT

Note 11 - Stock Options (Details)	9 Months Ended
Note 11 - Stock Options (Details)	Sep. 30, 2012	Jun. 30, 2012
Options issued to a director		100,000
Black-Scholes option pricing model assumptions	$0.85 stock price, 10 years to maturity, 400% volatility, 2.02% risk free rate

XML 18 R8.htm IDEA: XBRL DOCUMENT

Note 3 - Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2012

Notes

Note 3 - Summary of Significant Accounting Policies

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

Reclassification of Financial Statement Accounts

Certain amounts in the September 30, 2011 financial statements have been reclassified to conform to the presentation in the September 30, 2012 financial statements.

Derivative Financial Instruments

Fair Value of Financial Instruments

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Description	Level 1		Level 2		Level 3		Gains (Losses)
Derivative Liability	$	-	$	-	$	(5,660,208)	$	(32,923)
Total	$	-	$	-	$	(5,660,208)	$	(32,923)

The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2011, on a recurring basis:

Description	Level 1		Level 2		Level 3		Gains (Losses)
Derivative Liability	$	-	$	-	$	(5,377,308)	$	(245,087)
Total	$	-	$	-	$	(5,377,308)	$	(245,087)

Derivative Liability: Market prices are not available for the Company's warrants nor are market prices of similar warrants available. The Company assessed that the fair value of this liability approximates its carrying value since carrying value has been adjusted to fair value.

The following tables present the fair value of financial instruments as of September 30, 2012, by caption on the condensed balance sheet and by ASC 820 valuation hierarchy described above.

	Stock Warrant
Level 3 Reconciliation:	Derivative
Level 3 assets and liabilities at December 31, 2011	$	(5,377,308)
Purchases, sales, issuances and settlements (net)		(282,900)
Total level 3 assets and liabilities at September 30, 2012	$	(5,660,208)

Recent Accounting Pronouncements

The Company has evaluated recent accounting pronouncements and their adoption has not had nor is it expected to have a material impact on the Company’s financial position, or statements.

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References+ Details

ZIP 19 0001096906-12-002851-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001096906-12-002851-xbrl.zip M4$L#!!0````(`(V,;D$/^5:;-F```-77!P`4`!P`&)R;"TR,#$R,#DS M,"YX;6Q55`D``^D!=,PCBC7SGP_N"$1X!8-^.&T&O`NG'$V MGD3:CT<_:::N]YJF;I@M[?;VMD7=,>$2;,L)IEJSB53=#;FGP3!\<>@'OA]/ M?WDWB:+P\.``N^#;5L#'!V[$#Z)92`^@41-:4P`[[^XQ)QF%T>_W#^3;M"G( M;=LTNF7`58MW(#__\3-V/122!U_I2).@#E%4?GDGV#3TD`3Y;,+I")Z%(0)K MIN-OW0GWG78@0<%0#X\#!Z3+CZX!@N8$?D3OHJ_8\1C:&[KQ?PG;/AAZ\[>? M#Y:[W(-S"9(:N">^>TRBPK'3,1<>)'YV1:3NG5V:?SR\'UK]KEKX.O7P:@_.='+86A"-82 MHB/`SXEWYKOT[I]T5HI)!QEOVW:GW\Z#7X*0P3^*.$0[T]*^"9L;S:! M[9:AX*^"L#2$4^91?@3/QP$O'\#5E'C05OM*PX!':%S1?!)_EA_/`KAE;BF* MLOY7$8EB48KS3RH6N%4(80G-[X$7^Q'ABI9R^.=!'OQ2SR6X?U#/^Z@12K/=EP!CUM.AH)="0F%K*B*@(LXPN`$H^1M&-$V M>YUR.G((JB.FB"7;DP)>:!KXCV5PP&O/R=H`5;6DE=B:J@BKPLRT[^EV"8)J M""F4H>K(V-ZX&&;/ZMJE1!0H]U8$%/&@(O0[&I8-J-A`G2LP*SL0\I7>4#^F MB^'1G\O6XNH8DC+!#GW,42,>TS0#6P/&J`+,4K!6`3Q#P3,J@J=W=-NPMZ'O M$_4I)$8#WQVX4^;+'"QB-_3D+J2^*#6;17/TP;"-;L[GK@%?'2GWY_E#6^^: MUI.34BHK'\Q^K]=_!II*Y.V#85A]H_/T1)4)+1@4R^I;YG947?)@1`66.(EW M2D%9'BK%IMXS[7R8M`AO!V0%AC9H1-CDM0R]-Z>K%'I5=!3HA=$QNAW[2>DH5QEP;79? M?V*"RK2I;[7[7?-I"2J5:4NWVJ;9WH:B*^(1SJ2P_T'&6]ALVVSG4]ME>%LC M*Y<)P[;:5O.I6@O0HJ^TA\G?-_"'W8,NY]C[CV(N^`K4'W3 MZH$5>A1\Y=/9[73-;O^1$*]QC'9/MQ\'/N8SWPFF]',@'BY. MS97R-`>Z&]("F6JN%*IJD)8+5G.E9%6%O4RZFJO%JR+TI2+67"UC*]!_\SDE M'M://A'FX^L+_YAR=B-C_BTDSNA9^2![#?SJ:"D21,B0=<-X!] M>\P=J]_/26X![$7%C2:4GP=^L*AAVR8#RXI3#KXR2C91FR1*9TJ$M`I=NO]\S\MKX:,3M!Q.*%+%MV$:O_6:8 ML,8$]'3=U,TWQ(URZV-!E&V](7:4&[X>;FC5GTU7H']B4C]2GXY8M.,BVV90 M'[KFM@G4'9;@-@._]8K<1N"W7Z`[I]%.F?:2PUH`MRVB39S":D0GA/L@MB+= M,?&1".9@@9!Y<;2P%F^N&6%^IT8S5YA=@Z$J:HP]HF:U?CPS6:OTJ@JR_J!X M<("Z@QLPGF-Z'D^'E%^,9+_<=H/5U*Y5HOS^AL4M+]OA?G3RC17D&_T70/Y* M(7YAT[!2ZA]U/C8VX`\-X2KP&0\-DU:C3%=!@3>XMT@N>'!9@CD->'HJZ8(? M>81-=UD>M[KYHLM#D#X2N6NV2W3-WFX4CYAWF+:!YA>AC$;5)K9I?$&FJYO&PVG*;;A3C?Y@T>2C/*UW"JF#[ZS9 MV+=&P`RK+[?";HIJ:4M%R`&S3'"V%Z!^.[>"D`>Y):[2I?5VKTI385KNKEXKW@X<`H=01$9-+'MPPE[H?9]\$=<_\;`5VX(`4[B@[S:ZAFVU] M(7[;$.FCT%H:W]J=OFGW]X76\L"X;=B6;K9W)A:D!3=>B>M@X/P5,TX!`'2) M9I<>Q!<@1"?P5.[-VD5V\YOC-L>X"5?/_!LJ*N/J(J6;HUS>G>I0ZLHZ[CS: M7CQ1!<-4#RB\E$]VB'XL8^E8WS;X'WT(IK%EFQZYZ'A)= M29*US3<8E^=;O8ZUL(N]!$M%Y)1';E:_TWE*P575I+QE8;9?%;#C*9E M+TS.*@R[DU'NO+8A8X6+RY+U*F+`;J?=M=>[U0*T+J>7N MQK0L*U^+V))6V4?>)K&<4NQ@'MIV_B:&U2@JH:1L0LTN)*_MIR*EO'K7[EO; M45)^ZO:^9/3Z?6L1T0-!%IU%,]MFIUL"-=UL<$F86]T"_4J8.ZS*KX*Y_5)\ M;D]&M<,O`[O[OH0BL-LS855,`MD2CQ@XGL7(=X<=M[U^;U7TL0'BK"Y^O](V M.P]\%.QEFSG;X5POI#6XN_^!"*LGLC0"MRVCV^\\/Y7E'J_3UOMX[F\;*C,O M2:*8@WC,MU653>:''[SH_=^:33J^:S9_&$?O\7>HB6CFT5]^(&$@WD\)'S._ M&07AH<[\]*>\N##_8!A$43`]-/26'D;I0X^.5"./^;0YD2N]AX9A_\]2K_MP M6GB;&0#*=_0##GQ55*6T#O&/\XOK$\W0FMK1Q?GQR?G5R;%V>G8^.#\Z&WS6 MKJX'UR=?3LZOK[#]P3#M>1#B7]J+&C"9AN_]H0CW>0`H:DWBL;%_^*]81&PT M*QC3^R%QOH]Y$/ONX>V$170^R.L)U8CCJ)O?<.5NI.2=>#!($E$9\6L3B,=_Q8A=Z^=Y,4X/1.'5BSI'67(>?-)\Z5`C" M@:X`R1189!P1QCU%Z7Q@,':&NMH`4"+V`!L0$V0:#,3XX,8PK!EYP:W02*1= MT1!X,:1TJ5:C@$O20QEZB10O\&<"80$#%'/638E+6Z]8E-Z$OAQ! M$$"8#X(YPJ9R058)0A#YD!9K+A..%PCP"B(16)"_1(Q=^*-8P3*U@@:HCMS% ML$-JE?P=^_*&QA#$WF&A![#'ZIX*``[O43IE7Q3T;^#FX)>\,TJ*]D#>24MR MH@@^RL4]I*X&\AM,600=BI4VTIC01#P>0XP+S:,)*`,@$30'HW!$0PK:1211 MT/)?L>](7LD1+:ICKA-R$KDHL`FGH,AYSN7LC9H0H4&2DZBE(=724`9H!5&% M0T0+6&@'I'(C3J7<&O61CON60,-KOX#JS`(Q.>,NL!P#"@2J#%^R=))A2^&/ M8K`@,TIXWCKD,O%[,<9""/*9_14S&//L.).\3P&@@8C5H=S'6LW#8Q).[[M\ M$US^IXNS\T_H^(].OIXO>WC5Z=6I_)NP:]?W=:M80T'6,V.E[N0NL$3%)FN= M?2)AZ,'_6+8$S2?:&,4891?E6%,!@93D:>B1Q$AHZI2F,L0`BPA!$T/B2<7( MWGBY=?.$DB2@`%JYD'HZQ!&!#K>T'#_`;@JIWS,::6`&@4`F)CA*@.LK(@6` M<"0(GEZ<)>+1B#D,HQ`8C1-`^J@QM#&9'7#DR@*2"MP+;N&M:BG/:D!8)I9Y MT-*.8QGX2.*!4FT*C2=BI6EJ+,1H$#@%8U_>Q2<(3DA"*Y+]]Z;>E*3`;.&M MO$`3V+-(\W##);[OZ7K#U,U"$SJ03=:AGQ#),I"->!K+ZV<@>4,61=![#NSO M/<"C-WIZ.X=+SD?"F6Q&\\#O,PL=ETM#9`U,01P&:LY3]BYXB#C$&XBU$:3\ M=!)Y+N5"#2))"G"!.&$@+!>&"WV#"73QV.TK31!47RBX11@IRK1N( M#7DP8I$4[KR+08P%?@T$W/:DT"0&5 MU]#D\9#8<]$;@[?!._)1PF3E<4Z%E':QPB6[@93]-!"7O,[%Z0!.::$4\)1+ M,H#V0!?92'I!-5_8B*.@2B75R%1N,%G1.*^N,NJ8RLO[82#S0%],Y.#R?('W M<[Z4J=(KMN5OPF%!.HG"Q-?,^BRYD2D%Q4$+A5?3H>^:>Q.:WM""^B0H_2X?*BL%CP[N6:J6]FMP2]$M MS1-Q(,I'=0_5LH]2=P$Q):8C(@O_%QD*.@?C1J6$2#;-8,!'@Y>463JT`X5& MJI%A8I]5[_7IV<.K08D-7W*PY6I6X&QQOG->`&F=[B-6!SFS+(`O++P$-S(J[!_G[T<.7D;12L M+4VJZW\;MOY>N_KVY8XEY>?#X[ M.CNIJ]C[9Z20^!C_^*:2MA.('J:8#\H!QGL^5U4DZBH!ST+E0GNEZFY8I$0# M7&TAD5.YTU;D`P<,3LAWB@FRF@UE>2%VF*H31E`D@@L MI^_S!"").EQ,;A*_M+)^N`ITFNQ*#Y+=9C?/IWGV'1Q5[VMI`P>]3%:N4YF4 MRV`$/$W<`I$;\I+ M8@'NE72,=>N#/.-N4FM0-BBM$R3K8XKQJY"8*XKW^\O^-YXV9+HUWT:14ZDS M7T1A2OG0\=ZYN0%45.9:[_C(^S46=S?F$ZC*A^/U+\%3)8B(J$Q&3 M)JY):YR)[P*+CS"$[S1JJM\J"2&SO)?%%7#M!K\<(](LO!#E8LD[CAC>?2B@ M)_C"&$#/PN7,"@@:P?`UR+JR.J4LKHA&DB:I2"/9+04SC-F&C$1ND_/&,C-S M5"W=3;*X/!M4QN72.V5,$).$LD@L$VE$(ENI,J,<:8[/>;`JG`"^S)G3THXF MQ!_/UP;FKW#4;NZ225P"R972H3U-[A(I6KT=7!UI/* MP]5`M0QO+D+F1#*'$ M"#8%B>"K:F/WQ*Q1`&,N=1L!3`56E>R2[6T*2R,UXNG2*?&7\&6=@J&@7'K` M1K*U1':4L33NO\`26H`?7.8\&`9<[@B1*Z1IMX0.%'O2>A.R\28&J13`6E2` MW*PGJS;C75`KB0@4Z$ZF0`""' MA3(+O965W5@&55**TYJPVJB2L]`S;4CDMEF5)`[QUMZYQD_FK8HO@_E+J9??D`?^EY7_VD.]3P1$K1#!6]"W*=T[\TM;FINT"$ MV382(FXD^Y+'BKTKR3-Z>JMK`WW)*'%F-!LIUK*_2JG8)]DI6W4[ENFV]$Q+ M@G$0N:MX:MC;L-1H&6^`H2L5K82?G4ZJ5P$J7,I0\M0Y>.R,%U"W-]9345@ZA4EZ7>O#L^F#7IT^ MV"VK5H<*U,&LU>&YU*'?JTP=NE:M#I6H@U6K0ZT.M3I$[_&[E$+[$;]<0,5/ M);-X$/%UZ9PI+,V+B_`N+2WX7QW9Y?YREC_`.MB M=;?@N-FMK4MM75Z>=:E#EZ([A/]J-3@>OD^F5I:VUE:FM MS"OB?&UEGMK*6&:C;UIU9>S9*V/7000_]]W2OPQ>/K4!3ZKRR(D5)?FDA1QV M02'?#6+;KJG)K MF_GZ&5Z'F6]@DI^H)%'/;5UC?4NLKVWG&YCDVG:^WKE]8.7X0)[DV\M*8GW4 M=\.COD]R'/;>UXKJT[!SFUF?AJU/P]:G8>O3L/4!CW1<]6G8Y]:'^C3LWJE# M?1KVV=2A/OZW?^I0GX:MU:%6AW%]&G;?-*H^#?O\= M(L/KT[`OP;K4IV%KZ_(2&5Z'+B_`N-3GU*I@^(]VP^IV&U:]4ZNV,F^&\[65 M>6HK8[;MAM[KUJ6Q9R^-U<=AZ^.P]7[,/:RFU9-;I]:OG^'U<=BW,,OU<=A7 M/+FUS7P)-K,.,U_6)-='NE[OW-9%UMIVUOI5V\YZ;A^_=+S'YV'KPZ_+@QQH M(^83WV'$RWU`5KT7FD,B.@XX^[?\J#&H331AZDNT>*Y5/9PPR@EW)C.-B>1K MM7&8?*_6"V[Q$\F>W*L>C-2GG=7A66@L@&HV8@[QX5D@.^3.S.8^?-_2%L_H M0E^BN?,C@\DW<'-$36DT"=S`"\8S_+"SB_`3@#D<#3R8>TL]#_]'`&/JPV`\ MS?&($)*T%+R(GSI"MM2[VO78 M'LO=$_/4`1(E"6,0X.`B6?/K3V85KB1XIR04F!&[TS))%*JR\O9E9F75;]A5 M9EF<9+69MQ"$+H&6?9&P'G]E-3/_]FV-&!O^]=?\&O+8GS!Q!7H8U:\2QZND MD:O>1].9&SX6\OC@QC&_LARF+HZ?-\9!/O6G,$1<_;(<4PA1/B`_UYYPP4!A MG!,]+DX@9-6UY[6;JA/%3Y/J;FSQ1.+C/=AS']Z!5(T9"Q770_(+*:Q>0^(A M^2*1GX2BS97Q&!L?C*-[Y,M'8,K(RX`K7`7;&X#2K+/8Q`TF62`4)F=!?`)E M8(P7F7M<\]YS3@R!OV,&T_PWEXR<0V/X["9@D^)7-UG:U.W)J7)UPYLKN)X? M/,(,\=IT6)XW=[\ZF[A35A,]&-J'!R=I!H9@QN(;)`-R]P.#%P`'W[NQ$`@& M5G,,0]_$T10%*IMR:Y1PBZ,V/N&K8T("8(6%0*@*D!0,RR3*`FP?D61!BI?+ MHYS%:)(]_^8&7ANB=//7H*1BFPEP5[V%"^J;(CYF@0^&5\AKOD]`J8(0^%QM M0]"FHI"#*L'KZ+&=Q01F[L,T8>?0\BL1O+R\G7[FQJD_\6)2\]X3=7&Q-7QHE,!V[D7+->MJ/U"[227GP`'A?05;AIZ:437K;/3I(@. M:+$_9P#6W(0EJI*X`?['3S">S\.QH&!`TZ0!$\#Q3SQ!B@IZ)'`;CW>MY1JZBQ:Q!"V['4GA/K+A>)-(E.`)F M;>]0- M3-G'MZB8,DQ2&('/HY91^?DL2TYN77?V]KJJ):HV\S/HRPE8W*\@`.^":/+M ME__S'W_ZN7@$=GK&XO3QKQ@>"[(K.#V(LV?%%5T5:)U6<:4#]!R MFT7,DIDHR0@>3^$'HD2"*PI4"6$"7@B,^6IDC\W9\ M78_W;2ES>O[]TJ#\<^1B3=M:#OD&X#;NG8NUUM^LH3N[M-S5C1'ON;N!Q]LV MARZQU\$;&Q^N[?U@XS8L[43N7<:IH=RVV)+5V<&MMF0H$C6T)U46L+(L>T7) M2%GU05D]14;]2"2)QS%?4JG1WNVS=ZNRYNNUWP8I@B?7?C*G#C`4DL$N5=#PW0%NV\1;IJ::/=BE'///]>$CN\91E, M50"X335?HPPP+Q=,/KN/2#1X%#Z),^9]J$KV^U\1N*P`T*X7`)Z_?__EM\L+ MY54O'F0/,NPRY/-F?;,X&O,11/<^;`D4!,K,?51>#6W5,8?8BB?P0>H\ M'F[SW*E[RQ;[Y,7LUD_26$R`TR_!=GO8,P@&*#K_Y*6("9MDL3@T`\C14WA/ MH&3B!LHC<^-$,31MR*L#X8]1/MH&JO+VN*L:?+_[AA MAIV=#$?EPYVV]6VK5T_?N#`D']N+8'H*UAP'RODLAO_-QU#S-D6\:6$K>6"A MQ@_89DK40!8+!PV8<)I/&/.2HDU4K0N;I[S23X?*%#8!5^+FU9NP-3A^Z]PO M@)38/0>&1^J):LOYNLHY,M8+LY>0;A+=LW+@VH;A!G@,MA8W@-WPUXP7D\,+_#2G\BO+.34-3JOD#IO?10\A\]9NTQUG!&"? M>S$,LBSO3;FX&;!%?&1.3'@>MD01_31X:R$/3VX!V36MFH2ZP.#874O4RL-F MW?L);VV5;^M[8&\A?KQ/T07#%IBNJ''_'+.RU1<^_47(!B_`C9&@YS"E\!Y' M0#$4/T?:\AFV%L7O:-H:YO&"C7M7$+^E.FU:Q$'=(O)//I__X_S=ATLI3.&V M2^^A=;P**UW/VW_5S08>@O'O>6^]Y*XAVRX(?!2G)RC?*-I3/TFBF#WE[ M1-#X4]MAV;^T`'YSS!01%+%EF(FQHP MM!YVS@O!8$_A@_KS-:]AX:A&:S.]YO(XI[NP"CP7#;;LE:&I0$W\$QRE$!M( M!L7+><]9/M>`N??\`$K9?J]XU+%;+=T2*S5GR8IN/PE8PE]=/^81WGZ8M,WM MEU.W7Q>77ZY^/_]Z]?ME">K^H9Q_O%!^/;_ZHOQ^_N&W2^6OE^?7OWVYQ(-? M!/>ZHV>]V8!@>0N>,(=7.53 M9;?;H(HXE`I#87/.K]',GR@?HU-EJ-LGEI8#*(_=`!V31@_``A[D,*5)ZX=RWN?2ZC&<7OX9WAZ`AP2!P*^TTZ'->0;P%YK2YE'#*PZO M^&#E"I$J*4CL+=@Y3Y![_ITWBAL$`IM%_&QB07`,;8PQ5H$-K-LAYGG"I0/1 MO1B\ZKB>=W/GYRH]%I==GQ=99PG2+IE'2$G1'?[F1K1]QJ@&B%L:`UORZQ%Z MK,J.0E\W>"EJ47.54B@""2U,DZ5)"OS"=5K!B^C2N$+/S3$_UPTU><%#]CZL M#23BL;S_`FU"@L$.\`IY>VW.>:IHA1ZSVL\P"M9B$WA'\KIHH::;5V+PS2WO M1HX-SH6DGP@Y%R>5O\]\U'`I=AP7@;0R:`5.FKE2P\[?:M"8##J5NCIP!NK` M-'-H-HEN0__?N/"P:#+./-%F/*\EQ`6*>%;>QYT;#"!`S)#6**!NC"07+[!, M=:@-16MV,&OA+0]TUN;E->-R27M@3M?S0*?.G>?1(EPY9;HJEG@BJ8BBGO+#=B2&"ZPY)A+ M%!>7:?W>AEP1;N2("K&O-?@3+H^7AV&++T1S`L,:@5R-B-4E7^1&Z0YL(]'" MXKKJ:)8Z'"XXX=SPN6GJ3NZ$T=-5RQK5L@9UWW=60AZ!!-9E*O*7NWAACL<[ MW[@!O$`S0-&;>F_E3=6'ENK8)DFO^#^D6VJIJ.M%;LA,,T3 MBITQ'*B($"V"T[N8E7Q7 M>ZJZ36K9;5;YE:CS+VIG7N2[XL(]O)XU$;DU^%>*H:!IY/&YN+D@)/D56-,9 MKKL*@U=C%Q>]\A2!J`S+W\2)A[_U$UY[4F32;X+H0;P(9^XG^4O]VDCY%7XP M'$:RZV4S]V[L1QG(>(27T2$EHBR%^;&<#*TSY.L1B@Q4S&,1TO'#213/HM@5 M89U2S*4K>\BO`BG!T'O\O)5_D[6$(4(^IB*2I17=,#!JS:7Z9V(RB)GU8 M)/)82R*KEE`6C)97B0GYFF^E6-YS.'\M4)\H]23L4/N$K_#4WJ:@O&5)_"-, MPX3IVY-3`X9K)LMO(G`CZO/%#TYNW*D?/+Z]?IR.H_F,\I_UH;GQY;^;_B5J M]_'=\_8&%;I9!.]XV'S,>,/>;!SXDP!S0ZZ7*[R:OW3VWZ*P\H'?H)E[3-'\H'GE$11^GSER@)/G"VHW8S:N M?ZTX@B=U'VE7GV)7:TEPGA[BZ2[<3;ZM M[A('LI&"KZ03OP$`=L^]H\9/8+/#Q.5N%.WC4^QC[J;"/MQ'F!3D[N\DB^]% M6+.Q12YH2T"EN)>ZS1UK-Q9=>7WP:/G]SRBSZ%^`:YQ&,4IL;=Q#>@RT@\4. M-HRAF\'*@=Q"51:F$8MK%B16/W4TO")\_K0)UFCX6$)YXV;!00OD:,]:]ZS8 M)8Y"_Y6Y<X/&9(\_H:-$^W7@_7KO MSGRL^HU=GP,B7FN6Y'L734!7`MG##`5.56Y9R(L,X'>B,B7_=:E'4?[P6Y2R M6ZQ\*DK#]-Q#%:$\Z;'V$4+K*OA<`]%XR+#($R*,X=OK"2GF,=M*X(O8ZPSP M>"3.`F)D+-`/`?L+CM(V2O:*`L5Z`6@]YUYPK-`MA2S6A<.:J M`VJU>L5:?695-%1$\=JB!((8W"DLUE?=-K\0[*.80O=4])I+5CJILPFA]'AC M=X0L-;Q2X10W$;6CGBB.;,:0ZFK,'4?WL@6(9-W@AG=DQ7`%`PGB"\O?2TQ$NB:65 MO_E<)L[/,7%>_E1DM/@9#!P[R29WQ7MS&U"Y3]B70-0*%-QU2#^?SAQ*>)4!Y!Q^61N7H-7\MI^M;S\SS9OGBTKPA7+C*<])&]#7CG MI>\QM?7E]YB:0_MT4'8NW?$:4]TX==9VY;8,>_DL]-&FC=+;W]4EMEG%(^]$ MOQ=U44;F>&:3'L+[W`BTC(P]ZRJ[3?OLX?+VOAJ1=?[J'\=136VX@KSK6_F3 MVMA4;5RTE;TCQBB]O?S<2>VP?9XNW$&O/,T=9$$-AN13#Y M#/_8Y-X%ONBLXQMZT///*XBAO,DYWW)^FJ=3_L7PIQ_YC1QCQD(L6+F+8MYM M_P2#3]FDS2*15XY$0EH[#Z,Z9<=+MRH MK6'YT[7EJ/QJF:HM"%!J@IT@8]Z\@7=2%`\'[@.O,P^5C]%]7I0^X)U!AL4% M+WF[SB2O[BY?EZCY53FJ,L."+/QO-7L5RRJ"\EH?L9K`G_JIVVBCL*P7\])> M*57Y^T+WYE@T07A41(/W$&\G"$^PN722H"URNLT@LD?9#-FP![5I M+%^!Y,(GF3[=.XL,Z_'QCR]N*%2H?P0J=%Z(8EA\\L;_$916Z&,]3+182,\; M0(-01"GV*.=]9K!7=B($87DWX$E>^B-&83Y_'$L4N)I`P<6W\[ST(V_4+JXM M^F=6G\G\A.$;+/Y9/TRU(/A?+!UR><5QJ2+G!E:5-SZ08>Z'96.='1:\?HJ; MS(IWUO5Q:A5=ELQJV]OE)F[":^SRBZMX-16\#?"%[['0XY,0 MWWIX-Y<_SDJ-SQO])THVBZJ+Q[C=\_#Z$&%H\7%$@3"]DVPV1UVU;(V/97VA ML&AX`UGN;5^<7:VKF1AF,E94;5H?AO-ZB4Y15A M:)3.LUM@$_R86PE^F/4-_].M7?]1R(#R.2<*>Q4%E#EI&S?*=%@AD&9?Z'(ZKPOFN8=?VN+R^RU+QR5W6.?197$_@]KR0SRV MS<%MJZZJSII76BJ94P_`=G/#SO\"56O.F.TWM58_G>2*F14B"&3,K^QY+&^& MX1@\)TNKT./#(L+`GQ.7Q:UY=7FU$-[.5N@YL3A^%VW]W2B;\),W]H\-O57* MZ,*D>",KD&]^ST[].CIQB:X(*N1=PT4_%=0#2Z(*$[S>@E?U1%68!?[3#"M, MW<>"ZN)V5O>QZ4=/W6\L-QUSSG3('?>FE\DOT\H-6\XF)S4V0?9IG>U5U?A6 M!0(VI]!\+\YX7+&*FN\SSM1C\QUH?#Y`>60BQAZTPH/F5]^*.X[O_3@5E?`- MEIQ_M6A+4"<<[C0B521:7<'R6NC"2*!WCS=(58:P0;&-##"\A3?A+(JTZ@H; M#);8'G[JI)I"S1B+IHOQE,^EZB]<38D?@W.GK)A%CK)S=HYNDL=/:IL` M#W&TBGT^V?3)5YR%`4H3HN5PM>/DWG#46_*7Y5_$[Q##TJN87;J5L MBKU00Q9E2<`5BEK93"$EU4VE73:8A(ZV04?ORP:.1P&/SH4E88'H*]R,2@BC M']VHPI?.KQ9?#'D7E\+5FY_S_L$+[CZ/3_B@8]R;E%]C+ASE$@I4U%>^@`CS M^(Z?%NJ^[+(I^C+B.*@X\+_HW7)C)V[/*!SBY6F*I9YXZ^+R2^O$J>'&66*^ MSL:%Z#RLA.T@`E:1%&U0T:\=E0>WD3A#WO,ZX%=+-4;AI$%"YL.5=/&+Z^:Y M#2N<+E"R;I"/)EXWBR-N>[)V8_MUD=JP%A];2'-$(7945W7'6=;KY\VK1D^? M'_ED.*=<+^&4=K,_;ZWYQ8H\'A4$R9P5X=Y&8Q(81IWEF:#J^K+F58L)'C7B M=[JKC<]QOM_%T26W9-KVU?ZHH"SX(6=@A0GY:O8R`*?Y#RZ<(ME]4CNGV!,5T1".3?#7UML[8]X MBR2WR-Q%6;>(%3UY_*`,X2PT M..,7!2Y!!_Q@8Y4%V2PC\U/I-^<^[M@O\O"P"GQ5DN4QRMXWRNH/U:/[L8GB.R>:W41.PK<**R.MF.C@'? M[\K[*.XNF&]+UZ9SW739#N4QR6;_:'&UI0^\PI(\8_.%FV)Q!V1U-Z0Z!T&7 M1F5YX^FBL5"]H?C\3"M5B4;6+<*-\&M#X]?I@AKD(>JB207&&$C%R;[(`I7\ M'O'N$Z(.YRB`"<^5WMSX\52D7NZCE#71B9#`%%0')@72A^@$_-[8*_5N_=;? MI1I$Q8%%?TF\QA;5JUJY1&6R%&U['JEF0HJ9YD8$6\V(ORJC M%EGU0!,BOKPR8+U\F+F$$1>?618C`PBO:#;#VP_0TM8#PTJS MF*!NN.:P]%5Y6]`V:%J02`@S;F\-1KE)S83SEA`5R.T=7,`Y4V1'BP0$K#*/ M#W*HP>U3"OK-C:N&6X6:;"N)6):06+"Q:[1_`7A:2DG*.H_E*V_F41L4PY@4 MOB%_-P:?RNU!3W^.NGEPID0,X'X`^?A210ZX';`M:<0M#`[WI[`K6EG-,@$] M[6(M'F^%MB2PIXJG]^4TI8735E"2QY.2#)S'"0]A\<;HWX1-YM?3U3R*9<0J M$^;;99%XG;T_A9V,B[F-N"YP==5EBVM31A-7\"6?$UHY,8$Z^F^6 MD>05(GF";U%D6WR"?`=\C.A%X`RD-7`O;@(LFW]50W(NK]T]44N_U]V65IYZ MWV`[5:D2A"Z'P5%0%%]A,IC%M\)5J/-'X9OR*($;YMM2^3)<@[@B.LP=DL#WY*7(OLCBW-S\D:MW6QRYZOIIN@,>OEI)EOK!I?+W=`IK^2FLZAR2 M471Q?,936`M[L\$IK&6//N5QK.KG=ZY7_2./G>CJ:*!O,$-2U;(O\BA/;"T5 MN,X?W5HZ\X.=X5KVAHX4EJN'^F&EBC&[=6II*Q_RZ8XO;7K09^,-/^(3/Z1#=SD$M)2SZ#30(4X# MT=$:F8_6+!6._I^QV7'I>QVV6?I..G5SU$:+3MUL<>IFM4'OR_&;IS^3L@E" MZ"_K'<4BEQT-.-I3`0K,1/$BEA0GV7@2O?1&\N,X<93F"@EPYN0.XW;Y?:9; M]<>CTP9TVJ!G"N4HM":=-MCXM,%BJS:93ALL]237'3M8$1J6X_S!"A^:#B+T M^B#"TIVG$PD=ULO'97?I1`*=2-CJ1(((XQ3KRLU631,O@VUTE(&.,M!1!CK* M0$<9R+UY^LJ$ZE[9$)Y3P-RE=XF"J6)O[8T7.1`^).AR.U*%C$Y=)OLAW+'W`P]__XX;BRA=+ M7"PSB_U`T5>Q'>B;H:':FE9&=1N%OV54+T4FS,O4ZK]<5D;W3G#>1TPAN;$GDR!*LKBZC?E(;EH>U6]: M?O_IKW_]]%'J:Y;[J(,.&R)SN.)94A:+=P)B-1],,@[98\+]I(3%]SZ6A13' M-DYSGAD`S]0JX1[PK`\WGCP+7AT@$V6#F'K0&E6W7%_6IQBS270;\N*.5P/5 M!#CJ\P*])`MXWH=]G[$P87U7:9U;TX8\N74X;6!IW/5>SHT1IK18WA,EYP3> MWAT3(GE+_B:3XK69OKQ=(9B-T4D#T_PJ@@QN\B`:8K`9I_G[^Y>@'G2I)-IWDW.7ZB*'73;/&<$_Z^UC6D MO,_'7=)J32@%+O1)?JUN.&'BH$QQK^[B4[R%!X@\R`K*.@NBA[>2$G8I9XBJ MHS&__?TO_Q=O:OI)$_]1)GAEULS%R&3+-S,L(%_XYL'WTKO\LX%IYI_6:<1_ M\=9RK-.1#9,6;SZ91$'@SA+VMOBCFKJ89MP8I""/<>K`(/._]1K3T$=V/HU[ M;JCRCP7QEDY0MP9\=_)E(MD5^]2:I4KYU^I9S)3ZVR;(0W'+VSICOL4,5Z.X MXEYKSDC1S1PKG:7>TCW8:0OT4YUV8#,Q7D5[;1?B.R-B_SGB_UU8&>)Z&;C> MV87V]N#4)MHW:'_YG<43'^SQGEP/BR66?V)%KQ?^%CA1X+@5!#%VD(2A?:J1 M*#3WY'?$_+76S'O[/R033RX3PUW,P,`BWV?!#,S\N#I,V$[[LS1^><`F`"4L M(&0%N,Q7S@_!\),CT0.N7M%IF^>VN;QEFGQ<"93;7LB.Y&2/W>+G[!.2$AFD M9!\D2$*RQV;Q3FGD(W=>0)X"-Y+@'"#FXI'P=%YX]@&8)"3[)J,ZCD7WV*_N M;,NJ3=#U,\,^TX:=]X3E(*>LZ3U.NR[K$_[*U9RL&O9('9BCSK-RSP@O:7*O M!Y373PU''@^S!P3?A=4-?6NRVZ=#(GN-[*\VI_9H%\P[&)T:I%F:QM0>C53' M,DB]=%R]="`_V@/*:\,S73O3+<*CA$?[1$["HR^F4FQ34\V5&J4;C-PSLA,: M?3$;>@J^"+F+W69U0J,O0G:"I0,[(1B*:=Z)`1_5A1+ED`>V$M[M7OLV=%46]N[ M$HKT&.%D"2A/.+DCP.Y3[=9K%[2R<68"T;X#AP813*1R[D6-^N$F[LN&)3]E0\&$^DK&SPP=%73]W8G2<\0KNT+Y0G9 M/@?RTLPSS3[;/Z)&0):`[,LJ%=-R5$/?NU"38&RW82Q1GA*Z$K$Z`5,"IO*2 MWK(T=338.S1,6H9@J024IW1K1U`4@5("I?U0*7@-JCX@4"J!#250>A`;2F=E MN\_J!$H)E,I+^N%0M:V]#^Z0DB%,*@'E"9-V!$1IUIFF$R8E3"J]2M$==6`3 M))7`A!(DI3RIA`0G2"H-V0F2'J:`UU`M@UH*=YW;"9(2).T1AB)(2I"T'RK% M5HW1H/-LW#.B$R*E).F1$)P0J31D)T1ZF,I=U=8(D':=V0F0$B#M$8+2!F>Z M0X"4`*GT*L4P;=72J#NP!#:4("DE224D.$%2:A#2#S15H\!7 MY[F=("E!TAYA*,TY,TR"I`1)I5QJ1JJK;21RX*DSP))1V?\_SKORLM!3H*D+Z92 MJ,&1-#:4,"EA4@D)3IA4&K(3)CV,3:4&1U*P.X%2`J4]0E$$2N4&I>,H]E@, M\PA9_G5`O[=7. M>T4]EZ00#T+)A))[!.L^96F2NB$N4G%!*1MGIGYF:`2;987-I&.*59FJY0Q5 MV][[A`X!X6X#X1:G$\E$'N?:W*]._F;7!8-RO_*A8")]L2I+U1Q+'>WO3I*> M(5S;%\H3LGV6_*]QINMG$K2\D8.82B"I`1)>Z)2''5@$R25P(02)#T$Y:G" M6`)6)TA*D%1>TNNVJFD4]^HZMQ,D)4C:(PREV6<&05*"I/*K%,J2RF)""9)2 MEE1"@A,DE8;L!$DI2RHGR0F2$B0E2$J0E"!I'U0*94DE,:$$22E+*B'!"9)* M0W:"I)0EE9/D!$D)DAX[)!67WQ(D)4@JN4H9#E7#(4@J@0DE2$I94@D)3I!4 M&K(3)#V,BM$-5:<.1YUG=\*DA$E[!*((DQ(F[8=*L0UU-"!,*H$))4Q*:5() M"4Z85!JR$R8]".DM6]7VOP&.E`Q!4@DH3Y"T(QA*&\$N$"0E2"J]2C$&ECJD MTZ0RV%#"I)0GE9#@A$FE(3MATL.<)C4'JFD,25D."$2:4A.V%2RI/*27*"I`1)"9(:%D%2@J0]4"FV.C*[ MS\@](SMA4L*D1T)PPJ32D)TPZ4%(/])4S=))R7257*9:CZE2[*X,-)4QZ$(:GVMWNLSIA4L*D\I)>'P[4H44]CKK.[@1*#T'Y M_T=HE-!HG\A):/3%=(ECJO;`[#P?]XSJ!$8I07HD!"A/0#0[4- MPJ)=YW;"HH1%^P">=/U,'Q$6)2PJO2[1=4=UM.XSJ&N$C%317=.#,!G6H$ M3F4%I^,H]E@,\PA9_CTXX+1CGW7J20!?TDP=MNG5\^$D6E_=NRYKQH#1]7V/\%# MVHM`=5\H3^CZ.="?!EAZ<*;OW0F.P#1E>JGN^`C)3JE>JCL^$H)3JE<:LE.J ME^J.):4YP5+*]1(:[;@3+P+:J3@=L*BA$7[`)X(BQ(6[8O]B(E`QA40DH3UCTI<$385'" MHOW0)4-;- MP.A+HR<`HX9&8)3`J/2Z1'?4@;UWJHC`*(%1.2A/B5$)6)W`*(%1>4FOVZJF M4<2KZ]Q.6)2P:!_`$V%1PJ+]T"7&2+4,PJ(2V$["HI08E9#@A$6E(3MAT8.0 MWG14TZ$BW:YS.V%1PJ)]`$^:J?!B M70*E753E!$HI02H_P0F42D-V`J4'*]8=#$G)=)S;"93*G2!=*2`$1#OFP,M! MS@,"T57L22B4VA=U@.J'0Z&KF)T@*.5%Y>-S@J`$0>4E/?4NDH+;"8(2!)4> M,P$$-:EQ$4%0R;4(T%`=F7145`*S21B4,*AL!"<,*@W9"8,>A/0C3=6LO;U" M4C*$026@/)T3?6G:W.ZS M.H%1`J/RDMXP+-701Z1E.L[NA$8)C?8!/B$:'1$:)30JO2ZQA^J0P*@,MI/` M*(%1"0E.8%0:LA,8/0CI'4MU]F]*3TJ&L*@$E*?J7`*B_2$G5>>^C!8Q;=74 M"85*8#6I.'=OLE-QK@1\3A"4(*B\I#UR&(U M"8)2&E0V@A,$E8;L!$$/0GJZI44*;B<(2A!4>LRD&V>&0Q"4(*C<6D0W'%77 M]V[D1QB4,*@$9*UH:I9(](R'6=W`J$$0J5'301"NPI" MUU"4<.C\"19=5X<#RH5*8#GIDA9*ATI(<(*BTI"=H.AA;.I@I&H#@[1,Q]F= MH*C<4'2=TWDL:/13EB:I&^(B%3=5`)R:.H%3:<'I.(H]%L,\0I;_SW_1FJIJ:KCDV!NZYK+X+4ST9Y2O,^.?33=(ZD]X[D$9*F M6N.7]/MU1W6H[6\GM3C5&E."5W*"4X)7&K)3@O`F$$@@E$-H/+>)HZL`@#"J!U20,NC?9Z;RK!'Q.&)0PJ+RD'VBJ1H&NSG,[ M05""H-)C)LW@UY\2!"4(*K,6<0:JK>WMEQ,$)0@J`=DI#2H!GQ,$)0@J+^E' MCJH/]CYF1DJ&(*@$E"<(2A"T/^0D"/HR6L2RU9%F=IZ)>T9U@J"4!3T&@A,$ ME8;L!$$/0GISI&KZD)1,Q[F=("A!4.DQ$^)/C2`H05"YM0A=?BJ+U20(2EE0 MV0A.$%0:LA,$/4Q5$5U^*@.W$P0E""H]9B((2A"T!UK$M%53)P@J@=4D"$I9 M4-D(3A!4&K(3!#V,/=54C5I[=Y[;"8(2!)4>,VD605""H-)K$4M7!X-!YYFX M9U0G"$H0]!@(3A!4&K(3!#U42-?2][:GI&0(@DI`>8*@!$'[0TZ"H"^C108C MU;+H+*@$5I,@Z-YDIT)<"?B<("A!4'E)/QRJ^FAO>TI*AB"H!)0G"/JR$-0^ MT^E2%H*@DFL1*L25Q6H2!*4LJ&P$)P@J#=D)@E(AKIPD)PA*$)0@:)>]=SG( M21#T9;0(M2.2Q6H2!*4LJ&P$)P@J#=D)@AZ$]-2.2`IN)PA*$%1ZS*0-SK`6 MER`H05"9M0AE066QF@1!*0LJ&\$)@DI#=H*@E`65D^0$00F"'BL$U4<$00F" MRJU%"(+*8C4)@A($E8W@!$&E(3M!4(*@Y2`G0="7T2)4 MB"N+U20(NC?9J1!7`CXG"$H05%[24R&N%-Q.$)0@J/2827/.#"K$)0@JN1:Q M+%4WAYUGXIY1G2`H0=!C(#A!4&G(3A#T,"'=@:K95&K1=6XG"$H05'K,1!"4 M(&@/M(BIJ<,1W0LJ@=4D"+HWV:D05P(^)PA*$%1>TAL#U1CL[122DB$(*@'E M"8*^-`0UZ5Y0@J"2:Q$#[]+6J!)7`K-)&)32H+(1G#"H-&0G#'H8@SH:JB-[ M[[HBTC($0B6@/(%0`J'](2>!T!=RRRU=-?8_OD(@E$"H!&2G1*@$?$X@E$"H MO*37#4W5;&I)U'5V)Q!*(%1ZU*0-SXPA@5`"H7)K$<,>JJ;=?2[N&=D)A%(F M]!@(3B!4&K(3"#W,Z19CJ.H::9FNLSN!4`*ATJ,F`J$$0GN@173;5C5=[SP7 M]XSL!$(I$WH,!"<0*@W9"80>QJ":NNK8(](R'6=W`J$=`*'FZ:X8=)W#N04, M;9N$++#I4Y8FJ1OB&A4W549=J\Z5F;8'A*1K")JCTG$4>RSFI$BBP,>10R]Z M0(%4]/HO^+K#*&3%!_FJO"@;!ZS^F"',<_ZS.%\G/+C[YO5,@PW5H3-2]4&' M(/!1T/UP"'@-X7,03,+U(DE?W>R()WP4]#XTRR^A M.C55[<>R&::(\L)@I?I)DS%.`E2=1&+))ZD"R9Q/Y8O/9CE#+%.:UH_/-9EISZH>F:_@?\9V1JKW_!2?WGR0F[_7YRPEFB8[N_DGUA MKF/\X^.GKY>*KBNO5IX_7G/+CXI%^\'E?9?=] M-)VYX6.^E=;@IT0Q-&VD7$YG0?3(6"ZF5^$$F-R_!P$.W%!Y@W)9/./\Q)_X M-..2CM\7WPQ_^A&40Z*XGCM#:1T_>>[R(T]);I1+OP85$84)PJ,]2L; MQYD;/RHC525< M<<0,Q-Z?X%S$ES"..[GS&2QLR'GWH6Y@:A&``V+V8NZ-O'_*/3FFR5?Y7\5VP?_#8(<'R/L2D, M5W%D;DCRW[WAY@`()HQ!6I"IQIX_(NGQBV*9(#8P%F[PU$]S1KT6EJN:D648 MN'I\[@H4?!S";GP!Q@DSY!L/-W`29"(:#QMVSTX>F0O[Z<.8R,SL.XLG?L*X MS=*U'Y`2MT`)&$K0,;]ER(3P[YA_ MQ=\$A&+ITOF/&4[O8Q2>_`V>]6_\R@X74K*6>J?`3KDQ7[8':)1A_JO>,P7] MA+O)%X>LDL(C%8UFL2]X,8Q2)4`JI'>NF,^-Z\>P<_$W6"?W%;BHE]Q9YTP< M%1])_:F0;\%,*";E>\/EK%3\!DB_:K]V6XK.A[Q9OB3\HEB66+F':@*^X2\Z M5?ICB/IH7*]NN`RX#ZAZL]#+A;14V5S'@UI/T5RP[S,?-SH+"[;Q5.0W8-0) M:N4@P`_J'#''Z,!2J?(090&H>?A9_("<=^<"2X\9"X5V1S,URV+4\UPL8@:, M_>`+K>K>NW[`?W+#WYM;@^KW0OT(783,S![$VN9-D1BQ7-RB&=='K0K_G"_J MFH&C,!T#L4R-_]@0`A(%0?2`NJLP!W>N)Y962%U%XAG,XFU_&*F/PO$I5/XG M"QX5W>";K-6=KP)`ZKGC4>PXNFK@VW'F`$Y!4S-,>\![<2+:=@T^0M,#W:&Q\G MUZ*ZU>;W##S04N$S\!"%51+?NV$(ABE.4'QP$'A)'$W;S$'-FR\P-/PJJ699 M(>IW@3OY=G(]`0N&ND081:0#_D#`[(J.E>RYL#%3,=C;W$4>`/83=!-ZB!-3 M;?L(-IE3CKON;IK%`*15Q=+`"MY'@9OZ`?_`.-6,'Y383[[!0L']BV&1I[67 MU5=Y!R2'?4=$`(2:1N!+_]OE:P%]RL)$[*INJ99E)>#@X_`MB@E'A#]T%6'%#-VM>Q8\ML8=MHTA-`,0V3AA M_\K@!Y?W_8DT;*L%F\$'HQY[^.W=]>7??KO\^%6Y_!W^E^(/DJSI*N21O-CC MK@:'/>?7[Y6A;9^`MBBD'`"W>\M0/D#.[GWV@,(.+L84/7&$Q(Q+!>F\!_:>L*:D9_O&;4,`E"3@ILSZ(Y8K5HWV:`>^X ML;!$0(!:\"8%.G!-GX?',9X$QB"'_"*JC986;"8\,4/K?,M"%@._/^+WC(?1 M#XF%`HG*4IJ*VZ5Y::4-@3X M`MYS[Z)53SY'@3]Y[(?AW4V8*V(H91)%J651CD:X"[-4R:47`:=B<"=+,#I9 MTJD2`;^B$PKB'?-N&3(YSSKQCR9NNR!&&0S].!,#Y`^CO$7*#2R?1WK'"!LP:A4R MYB5J+N243$9";H+F6V@T$A5Q$*7$'070K;K=&I696?MU6L+ZESWWU?ZK/#2@,6 M=[E>5\QPY19^8/)`XM`'RY`\1`/;DQPU/..W1N/,9\)S4W29KF:P/>>#D ML3NZZCA:!SWW676B?+&J5YL3W-J%U4WSU*:F<'6*GY!RD4"Y6+M0WMG;9/:, M]%MH%]/9@>*&0]J%M(M\VH5&3L:Y3"/[NNZ>6@90^Z,>JGN[?I.P[5]5S! M--I<0M;])_BSQ^U(K+JM,_<*$=+FDL[L/\')S3R"37ZFD`3M+<58CXGTI#N/ M8)-)=_9W;[>,''>X:_R3'5[LTR*?[3CL!9ODIV%U->_P1J=A"YU)IV'I-"R= MAJ73L'3`HU@7G89]:7F@T["=$P?6,H9EJ]K0H=#8BX?&Z#@L'8>E>LP.1M-H'-)9\J@,\G-E&N3Z4A7?_>6@JRD.TF^2'?2WCY]Z+@Z#UM= M9GO@JVGYM;M1.Y=\7MC7N4M]@2XW!;,CP=T)XT"]RKP_Q[Y51)6?5!63W%V9TCD22\ M%_Y%E1KMW3Y[M^J`^GKM9YZNK2=YSI2RM9.U M9^!XB\#'8+1+X$,_=8C30YWM%TXW#@=;@@MCH+>ZUB<$,53 MV]3SR22;9H&;,D^Y8+.837QWN\Y4^^F MMD4BEL1)$G':RP&@G=JY7ZTZ&NK[G>P@'+Z?S_"1IOZ]J.)97VG# M"W**8A^PA5?A))HR[,:F>`"?84K)7UY???SU]:J2'"4+??'%;]<7KW\Y&6J: MH1E5$5%CW,8;?PMC!A3Y-_.P#QQ^_2FL"HWVF8-IC`RSFL*:%QUJ4O_0]869 M&):M#9WMIH(;]SF+)W=NPI)K-V#)59)D;CAA">S>-4O3@!==)>B^[$XD8VB, M-$WPR::O:Y"J8*G/@1NF=;[ZKW@-"UWJQM_,^0G9YDBK"+5Z\(/-8V''=IY% M+?Y4#S_!WP'#/^#I\VD4I_Z_^>=+1[[\/@DRU(+OW9F?NL$'!OOBG8L;#;:E MZ8D%.U\MYSGFV#&B+(JD";#K!4C"Q2R.QJBM/_CPF,??Z4[=V]5JI75CA[9C M#G/9739H^=J/4?.S\;V_O(;'_ECSV!_-F?[A>QLNY/K. MC5GR^I>1J8N5K'G1INOX-8K?N\F=ON-ZBL?_`+NRL)BFK2E6H%O6:*,E%&,_ M_U(6]P4^:UF*[=A/LI)=F>L?VFAQYMJH9>9#77L*-OH8W1OV?O3G0_QQI0UU M'?X[OYK\\[:]&!C;[`5_S9:KVV]A.ZQI.-ILE_(WU)8SG4;A1@PU]\,_+K2A MIAO6'_`?2U^<:_/K-NG6AH:ME=.>&[YA=VN?7V1X2=%G\#$C3XQ4+NR:Q??^ M9-'ZX!+RD?[8;J2]=;##%[C;,IJ>1Q!$$[1!_,?OT!ACU0T+$V['+[_CGVQW MPSM^@.T`7.'&/DO^CHX)^$V?;F[@-W%2I]*6V$JW M]>;L-GC%@5FD958&*);ZK+;@#!3KR^\IT#7S$\#MX)K&0-)\'7QYC]O22+-* M_VS=T%WA3NUO1IN/\#>CA4,Y@W9%8!._EV/;F+`I:('W^.?3SD]=?(8P'`SVPJAEAYJNZ5=CJTE02W1YG!\TQ5 M=$UY9&Z<*&FD3-T4MBM]5!5@YA^4^PC`';\;0%6,4\WX08G]Y)MR$S.FQ$`S M,?6-9\;7XC'_[668PI@UQT90Y%.6)JD;(K9>1:X0!]K-+),>_\9+@FB M[4$[0]/J2&7M"QK3J5(3A]C%P4`SM&$UEU6C'V@:+?%]QS%WFL0!*#`P=&"4 MFAP=^)6+JQTZ`\?:_(7-"`BOBME^FPVCKNX6!MSOA8N29XPV?UW-[.^V./0E M:N^;'V^/ERW:#7B5ON&KSCV/-UUP@\^N[UV%>1)B!V5A.4.K;C_:!][_Y2UP MWC0LT]CNU1=XGU[$[>=U"KC_$L^^@0>;L`L&T-9/Z^D=#CGFG]@^\P(*=:A9 M=06R[QR>=4D+A'?`J1_4,_8'7A!G68`!'HL3]';2E4&,]C3F0#=']F@T!R4; M@^[USL4LH3VTK9$^#UZ7O[&F6#%KOO^:YQRY=>,?<#+KG+^-II(/R<,/\W`3 MOO_3SXSC,/[WGW[V/?SGC<]B)9G'@X3=CD]#:Z/WM_ M];^O?\%Z&LNV!TB`,?^@@>73S0=_N_GL^I3 M\2L6>K7?C$XP=UY\)EY0#?KS6;[$A>462/0EUNF'B&)3L0)=/]'!]2L^VWP% M@B%??/[Y#NPR?_VE9P^D-T[0?F\_^W^\&/7GI<1Y0BGYAZYW897Z!JO4=U_E MA:X+U:=W0_7I&ZB^?98+GH2MVUW1]-K@1+.Y#GP:'K[47V:--3VC[:YG+E], M`AMZ8*VMXZ0V#I<"&81QZ M^8;A;RRN-G8Q:Y@$?.E5@EJ`%:QA2_C-8&>SUDBF=6"YW*E?L]R=I5"DZE[> M'Q[LK"E?WA8CNZW5E'OL$1;CO?0:P92M72/\9JLU(A3G"^10G/]VRMPDB]DO M?A)9ANZ\A6]^/BL^Y`/@0\VGBV1H8X"$?[CVV=\2[S.+^0CY`)Y_#Q3*UX:_ M^YA-6>SFF>D_;3#'/^5OFGN0#W;!PFCJAVW#MW M-U&4AE'*/L`_E._\H_1Q!KP!5(=M8=[K_-,X"IH<\WTX==G M^,.<+OR9()HTQN25!%%<#'D78V#ESSM6-XHQ`G?,@ITJ).')U\K9CK/=H**Q M97YKGMIQ1H9/X[VW#RU4"=U&)YJ M#+N7Y&Y]?G>N-2*;V_B:+J[ M912MTU_KIUHG5N7TKE^MI\ MK(XM='O+UGGAN[#/L5*[;\O:R;3)L*J=G2N]F^IQ-_[K]IKV\:NZNZ2].*^# MPK0WYW5P3?MR7C>7M(/9+?%PEY:RHZWMY%IV,[`;+Z6Q#G`7HRR>E+,IXB)M M?#(-X.OP]B^O67CRV_4VN8-RS;_,W!C;K&5,>:6=8N%I8VJ'FJUQH-F^TE5- MTY09IM70M7ZBZ3H'FB[X^SY+E/,GFN:OAZ(J/X>)1)WPR,'3T;;0"@&)R;"TR,#$R M,#DS,%]C86PN>&UL550)``/I'*10Z1RD4'5X"P`!!"4.```$.0$``-5;76_; M-A1]3H'^!S9[R`9$EC^6-3::%9GM%`'2V8C;;F\#+5U91"52)2E__/N12FU9 MB1W(,",J+S)$D><>GD-1)"_\X>,RCM`=%U6FOGUS3!5\XBN(<`Z=^O][=ENN_JNB[Q^7\#YJ4Q4+G^O:;^D$HB5["Q$D$Z[*00Z#*DB3S9XVO3?FE-+R;]\7#D9=&6?&=NB\$ MAJ4$ZH._#JW[\`*=SP,C'WQ*]4R#X6X4W$ M%J9TS/&LR)B'?W$5!T1X$1,IA[^9A%:?J5Y0`?X-H>H5(3C*>1WS+3H@2G6? MI`-(5>Q#^Q-3ZU3%R`-^U!K@&51+.A=)5*QK9Y+&,>:K43!1C4F@IGRU%/$\ MEJJU")V-640\`N9&>MEXEKPH2Z]BEWX?_DA)HE\\8T9L05K2>HM!Q7)>*$=Y M"OX=P5,2$6ER@._"MB3P+BH5*_V'OHSQ"D]S.8^6N`!J2=L"AXI%?3\`3O0Q MS!S6UJ[4[O$&$_X-1RE\!JRKFEVB'!34DBD'<:S8M,NQ4ALX!W\BF??=F"^/ M<2U)_YA&Q>IV^RR.&34K;0'4DJX%#E7O?9K_8,ZQT8U.#FEK5Y,SJ%K.5N;B M*#GV?.-96%NR%EE4+6U[DDX%_$C5S#ZXZ!D)^HY+C;K[5%0 MIX%1EE:]1T;97M1S:.C[?I5C:S+<,0&(2F3-H)W@=LB]K+J]R\C3MDEE6KWKZ MK/>XL&3\ZW#6DG5E9W?3WAT:M^8?/TON[N[!KD+BRI'0Q)V%:Z]WHM4B_E-+[ MYP-]T7\I4"7_`U!+`P04````"`"-C&Y!UD)J+-(.``"R^0``&``<`'-P<'AB M`L``00E#@``!#D! M``#M7=]SVS82?DYG^C_HT@??S526[=1MG&FN(UNVJQDWTEC)Y=XZ$+F2<*$( M%2`5NW_]`?PAD2)!@A8C`AJ^)#:-!;[=#U@LE@#XZV]/2Z>S!LHP<=^?G)^> MG73`M8B-W?G[$\Q(]^W;RZON^UVQI38O@5V9_K?KUZ^G8,\1#:H] MM&4P)?W\3%SWO__>-A8BU@B;K899Z`'PHR_(X%SQ^(%2B@T&1' M6D+\UHV+=<6C[OE%]\WYZ1.S$T!GV-DTP_#<72%OL5H@ND3"'#UAI[.K-V<) M"5%G16-D1")SG%]=7?6"OR9+\^IL;U,\6?ME+_SC3FE<`&=C8D[KJY!71"U* M''B$62?Z\=/C,-L>=KV>C9>]J$P/.<[K3@#VG?>\@O>O&5ZN'(B?+2C,I#AB MX(*'2\'`#Z*VWMZ8%AP(M?PI=/E3<,6(JQ%C7NW[8][4U;5AAGS'JQ%QMNY: M\9(EPG4:.%-U#6B#BKI+6$Z!U@DU56\"9PQR%V&!,^D%2+%-_QP0R^QZZ,\+%/*4.S5:KP-O%]0>`E:M/Z,([#7:Q>/K`?TVU"T\>N#;8 M<.Q^$F@<_?L/)HR?X@>_SGQD`>"OX]H MZD#<@H.FX+P_D13J-0R54P%#_B,K@[LMV!#D/F.119G@3N3J$DU&WW MZ],T:.X@X^HB7YG&7.I,8^D9)QSU\^7HDA^P%D-!2*&.!OBE7.9^A-TR.C<$B8 M8/58C7S[_M2(EI-9+F<0A0I&T"[F&P#%XEW,&I0'8*&( M0705JZY=[*?,C]FLJ'/18)Q8.3(T.Q:L'OW]TN0J%F;`.TX8L_X'.;XL!9Q7 MLF$VRKI5>NV:HZAVD<$-62Z)6\I%IIA!1&15U&Z:[]LV#M&,$;:'[@U:84]` MRP^Q):4-XD2JL';S^@#6X)`@Z<2]\1QN70_HBF(&`VYB"WM\'>`O_2"<'/@4 MN_-="6FAQD-B#.4XPN3N,M34^>L4FY"[(4YP:9YJB,7*&/K[0Y; M]:J''&>E@:\T[BW`G\N3=.D&Y]R<,YLN/;.9)>L'"^1S0`9P=1\QCHA'<6M<6: M5-@`;ZIJ!NV6T6>WF`AXSYE3B*!`SE M)U97N]5>'MB1[XD=\.+T106"DE*&LI127+O%5R*M4W&N4I$T@#(E`VBW3DN@ M5IRBBB3,HDEU',)"MM(BW%V0R)!4>*HLA:;[-8!Q?!N,1UN#Z(`.Z^;,!'G"KBG9Y MAF@0N?/;IQ6X#,H.&\G+&\!#@;+:)1;NP>5@';$WT5YR8PJ@8O]4!%U"3YE4 MHR25]K4D5Z7Z:S>4QI3,@+$`SQU('5>FF#F<9#74;M@,8.I%^T%%W(D]X10$ M5MZ1Q-_$PD"\![DA3'JXHUH=YM!7T3;:Y?,>@0&WS2*`N]E/4.P0BV7,X:Y$ M=^T2>A/D(!J^P_Z,YE)GF"EF#B-9#;5+SV7T40WJ#*(A1T?M\G`;C$.7+VOA M@;!2)A(E30JLDPIJ-W]\("Y)`XWZ3,F:IUS.`(H4E-=N$OGD4D".2*[?9O MB,M!^QSW]H7$-B0-2]1G$?=)@]]?< M(<_A@R],,)H%Z!.[/=08?&%E!A#[4C/E\WW5[I&I?8^,N*7OSB%?Z]HBLZVO MB1TRV];;#3+'MT&&S]^"X#$E:\R[S/7S)P;VT-WD8ON6A]?A0<*2_&;UB@QP MMB\QCW9Y-,,"SY=WRJI3!?"D;IL8$L)2AQ"&%$,%G["VN@R\O MW6&7=Z?L^0QE,<,Y4C.-=FG4`:PH6#C(#TLW^B6*&,Q2OLK:95'YW$P!B;=Q MX?_#Q$OLQ+4G\D2WDO01\*AL*.URMEGD&]6C6\%*`MX*%1PET7)S:9?TS8)7 MN5=9F7>ERHZR#ZB942TIK&4^:N\\U#'P7L5T0F=.G8ZJ8"[M`K"##7/;A&CZ8BCNDL('("Z& M%$]D?OQEE>DXSA4Z^943O_'D].45)I-PQ<%EN'*U==/)S1@H\IHH?&7UI4VBW^?\15AN_H<":M/@1L"8WA78O M@]05WCO4/09FJYA+N]=,`7*@F-B[J54)MP4"!BQ7BM35SGMJ_2UO=7MKZ.$F M_FH5[J1&3KSO=^C."%T&KX/+OIFF*&T`/\J&J-%QR;>5]">_C_O#P=WH4<*` MK)3&EI8JIN'KZ/"4G_@NE?3%8Z)((T8OZ2=YQYI#?;1+,B3.7Q9:/%U*?Z/O M:*5=:B!V<^*(*_]QFX5V[9R0;8"9Y1#FT[)[3_:N5F,?5I_IM-N7(32;<&$\PY;8!A+N[>.@QL3! M%O=>M=E;M;UFF%!%=UB.?MKLR:F-AD25S5@Z`>"PQKS,;E.MS:IY=3=CWCPD MA[7SS^*?Z%U+;09.5=J,95,0#FO27W(B1!%L(DR#;W#]`4@4K3)79.U&;85*7-6#4%X<`KG;/XK&M]RYIM ME0VM8;8`#FS,\X#"Z,AP?09-5]N04=,@#FS8BXD_9?"7+SXNL*YW$9ZMNB$# M9X%HN3#\Q&`TNV4>7B*QMZ:AY:($A=:+2`EF+5G>!EB;/-#091[U@YBJ*=85 M46G="Q1UT+)7;`+LT4RG;J$*2^M^H:J$EAUC8BW`]AV.?=N]$^"#_/_!NX4: M**T[A9H*324GM^CB,X7)XX0UDUZQV::3G$H@&WR?,@`/8:<^>G(KU^#M2@RE MO6I4%>J#25>-FG0-98WWGS>XFR[QG3^NT!QNQ>:_%<5B@S>?QK"8Q?RE'WS/ M<>!3/A)W)21,U5"Q`?368;YV*XAI`7#=LVV]J$P.@=OY_7CG]]SKY6Y\2N5W MNQ2*&#$]%*FL73!PA)]"5./IA=\^;.?H1G/:C4S"1LRR[33:3J/M-%KCD8BQ M3ZT%8CQ^10ZP^*2&N%%\`IX7^D_&U_HYYR&4134FHIH)VLE2O_1]W;-EU7;U M3N"W\^7QSI?2"S+OJ3S/7"*DL:M655N[Q6WEYL_B%M*[#YC(+V$[B!-&]!G#D.!=B?;I7ID`SHE$0.8+E99 M[1:[-H#[1N>9ZH[5"IK0YG13&X'I&(')U\.43(45'C!W''8P8:`EFN=^84Q> M5F-'6:*D6O34>LBZ3R+6[1KSZF[^7&+K#(URALEK21\A")_'B`=7FZM+V6F!+,I?GSQD<=T3FZ1Z+HN%GLO+KU-Y)FL[`U0(WYQ#W9^$#6%Y3,IQ\-'0Y\USK;Y;1GL#9Y12NY:]#9/KOB2F[A@Y MK^[FKXQIHV,=H^.Z(&_<2'@:*/RFQH3WE'!+5>"Q)T#7V)+NMZY8B<;^]:5F MT2ZQU'>"RB&$?"W>=O,1O0*7!2_*;Y_$C[+1I"AL`(^J9M!N!\`$.8AB8)_% MVYV^:X]F,][3*$NBEXU&%5$#N%,SP2$B^MLGL97=QVP!\3?I(S`!QKP[QTM% M-"9`366U^+V-.>N_^*WNJ#._=AVN@6LC3QTC3ZF?C%@+XZ./I#_`%*R$>,(_ M2HMJ[A?E*AXB!7OM(.O+Q%IP=5B(9$RQ^(S#'\0&I\]!+4-\.197E]6<@@I& M:%\?RN:HZ+GX9\JC8O[D_U!+`P04````"`"-C&Y!_[/T,<,;``!;6`$`&``< M`'-P<'AB`L``00E M#@``!#D!``#575^3VS:2?\Y6[7?`9;?.3M7(,V/'B>TDNZ61*%L56=))&CO[ ME.*0T(@;BM22U'@F5_?=#P!)B1()`F2#)/Q@6Y:`[D;C1Q#H?_CYGX];%SW@ M('1\[Y=GUR^NGB'L6;[M>/>_/'-"O_?FS>NWO>MG__S'7__R\W_U>F@>^/;> MPC:Z>T)+?Q]M`L>^QVB)@P?'PB':AZ0K,H;O^XMP[T08A?XZ^F(&^`+U[0?3 MHUT'_G:WCW"`QI[G/Y@1X1U>D/]8+R[(;[NGP+G?1.CYX#OT\NKJ3>_EU?7+ M%^C+ER\OL'UO!HSL"\O?HEZ/2N4ZWA_OZ%]W9H@1&8\7_O+M)HIV[RXO::?' MN\!]X0?WEX38J\NTX;=__XX41 M%3_N&#KO0O;]Q+?8`"18(FX+^K]>VJQ'O^I=O^R]NG[Q&-H90=>.>V`3.O?> MSHPVNXT9;$VJCDNJIZNWKZXR/2C-BLK(=4G4JO M+^,?SUH[)>(<5$RF]9N?`]_%"[Q&C.>[Z&F'?_DV=+8[%W^;?+<)\+J8G!L$ ME[3_I8?OS0C;5*=OJ4ZO?Z`Z_5OR]<2\P^ZWB+:\78RYDKT]H15WNFQ+QCD. M'-\VO'K"GO5N6>IE9`810.Y,_]8D7Y'%$->2.=.S/6G]R'3K27OL&4L;KZ/T MBPGY="(T?HRP9V,[%9O2*7F.&1NV4E#"*67?RM)\YM*%TP^>937Q++N.K,WP MCM'T2NU&8?L/>#+VKZV2E_%OR]>\K\\[%*R+T#6'RQW*_(QK? M8B_JWX518%I1RI,-]I=GTMTNL\.A?4\&%.#0WP<6/J-._OF]JF!,O\\$^J7D MG]'W'>%$W];8Z]TNG_V#\0@OZ5O+WI-//U\>I3F7OQ]8R`]L'"2O_NQPS,!* MOR`?!1(E+2XMGRS?NZB7"L>ZKP-_6T'+J11^1=U==@.VY?XNQ/_9$TF,!_)7 M>!"1@S)^>S"\A*)`<#7UR6:.:``=N:"8C6X($ZKA'%J24](BIB+"?..[1&^A M\1^RWWVBVA\ZH>7ZX3[`0HQ)]X=CKJJH8`R^13UZ@MCZ'F+,M8-?58WDX%AO M]MJ#Y]Q\VK+GQ.];1+X`DT/A#@?1TYS,5M3W;"KUCC;AX+,"`3!`JPL+0>B< M2+.A9SU_C7!*N`RA'0^GX&BC8E1=/'?5-7/^X-6%97M/WHR(8T:.=V\\[K`7 MXI#S@.7;@9\C+FO09I4>0M"!-$IIJWQB0()'AU.2(NF[>#*X&CA_``2P:0_G M[[%')'')(]>WMX[GT"U^Y#S@1"X.ZD6]P,^`I%B0)R)A@4S/1N8)$]U0):F, MAM\!OF<1"@/:HZ3444C)HY#1 M1PYCH!O*Q*K(O<4E)Z8];/7#$$>AP/ITU@B,H6*F$-STETMCM=0-(,7C/`=% MF7;;/->373;=/S)C%O?P?M)(P0F]B"D$"`>*NF&A>*CY\S5?P56Q$&+KQ;W_ M<&EC)X8!^7`^^^2KWPTO(N?X!;YG[SLOFIK;\SGC-JN-`!%C"`9BNNA(&%'* MN@!"-/(4$G(Z;W,7XEL8V^&(C(*^LZ@W=+8^?:.1G5/\!28_LF^X.Y1:Q!3L M7B"#4+FSB;Z_L!D8GCTD.\:"[1JW*6C+)A(` M\B`GM%%,'%'JB)!'E+XNX)71078#)S<+3<%EZ%M[=I@@9`L@T-AG!%,>$! M3U>HASZ;`34,:(?/BLHX!V:M26L/D5,<#S9H98OE12\4XNW@R MJ^OJ_.&L"]X.G!FS-95TY/I?1#ZNTB[J'!TE`BEQ>X0T#HKADO'0#7PR>N#Z M1(0ST[:)<&4^)J$!-]C#:Z?S#Z-E^/9%(UFBX:-:O4& M(!D?6&LVB-0YJK:;HCS-WXY)JI<.D4,H8Y:XXTT1KK M]Q+G#;K`\5*B[FY#F/K[:.,'SI^5PI@RG1H)9C4D.:+2R`=DG,#]7>:RR9&=X M&&`E(4'A@5*<=`->-?WDP@IKS*(,0,/=CM6$2$LZ,-RM'??WS,ON]"5P,"33 MX]L9'BITK(VWZL*I>N:?W*5ZJSC)5Q$3!-`-^1]&CH?L`POD)CR>+I"'(VI$NG/61&:V5NB" MTYK**C@Y5Y]4X-)(CC M%\(*W<4UFM8I,UV@5E4YIPMBU6EK,4LSVN!@ZGM^FDX7FY'*-X2"3O#\32FA M%"1S4CXH)HZ>)^2_4YK0J6PD,MF=E8?328:GE$IRZ9X5(-?F9B*.]DO$&.([ MOLD_WU+!)H'+'O)PI&01%I^#VA)9SKA?1?)N-BKD0+5>SP:\?9I.AL5C^M[GS MPY_0T!B-!^-50]8V\/C*WQ\*!]FQ2:Y4424&.@F(@K;\LQT+*(\W@"N_/W0" M;&6Z9[;YW*:@K;U(`,A#DM!.=_*1CTQD)_1UP8J,#K*[=KE9:&\5O@WQ;&V$ MD;,E;T">?>*L$7B%+68*@)2/^'SA*--SFR]FLDK99)TZAD*^ M]\G>>$"'&7@T*I3[;A;W5/!ZEA8/'/SZ$O40(XX2ZKKAJH(R\F^IBI,%>E'E M;5]/Y-S%(JW.`OK.-WY5>X->9S7$!&6@%)A&D>=[S&Y_-%?7C MQ>OCKPD::8TP?Q_1HOGTPH8+1'[;8;IL8%>;Q5*DUW-$EL]HB^DG9`<0SLTG M6B-F@5U6E-X,Q,%-XG[P9!-9T2"830A3F+*W,MD/[F*6NB%+6AVY'(MJ4]5L M;:"$Y0+O_(#:XFE$_O[\2"ILKJ!64+D@"FH&I>%H!PXH9J$+KF15D2\B)#,I M+<:G6=9^NV>P'N)=@"V'!1J0SRZF'V@)QBT5]$_V/;?8K?%HN7OZ@AF8.X<: M/*D_WXXKJG$6P598PV/C6E00*+*N!3EU>?BZF)M<5%_KZ`49%]+T9,+ZQ+[* M+T`@VPMD3*@@%N3A2-G$N^%3FSD]KH6:%1>HJ)JLT:#RE'6;>S(['DVXIH+R M7HUDGQ2(!4MC*DPYR9S+=$%>1:7())UP)ZOAO3)97`-:M\#&C[_BC$VCA'FNS<='E_F+`P![=#`S>$*2W*\=7$4XGU(+X(K'Y)#OFT MB8*S8KZ-VH0(A3Z6;`Z8+@@H'7-I4D-GQ[G3=4RP>O!:PX]OY6*`CFV4M(:) MT((AYPYE,JIOT6EF1ON`[+B.Q7YY7K)\0[A;C,L<'`EUS>Z<)*<9+R0'_>,^ MYE@22C<<\961\X()IJ)%GW]2>8I6?R8?QQ[945$W2M^S"^J>'0.W!,L3F"P\ MID#1P$`XGDW1H+_\@$;C:7\Z&$_?H_Y@-?[$0M/?Z09?51K+11=W(1T7ESU<`%D MW>*J102:*JY:(BQHH4R+CE(N-(/_>,%GJX55@<.3*ZQ:=XR=;&DJZTFRJ*H0 MM&T:!H_^9JXI,--$@?$OSQ!F[CO2TS5CM&C,>:,>3\LM9D(?`G+3RYM2#W#& MXSL+!J[I;+G%52K1@&=/UQ&YB2AM&;>_-H-[P,&='V+>:@T98R<9V77TE,O5 MK@_<]I[0S]BYWT38[I,9-._Q=+^]PP&1F#K',[[Q&S-T+#*"H>/N(VXISIK$ MP,\L;!"@V!UC_/[#RABB_B=CT7]OH.GMQQMC@68CM/S07QA+-+M=+5?]Z9`< M5W5#.4QMYW!7,?EM'D=#3%2UH9+@!^SZ2;Q;68&;\CX*#J82(L%.IS$#%FAF M'UGHADLI1>3/I]*3T^9F^"#),B(/A4'+=^P"AU;N6#N6$V4#-=G5.N<]N%MH M,&$%&V]5@X-MUQDO9!Z9(9MQ0]$&9V%.MA^$I\KM5$L:D*MRHU(1W9QI5"DS M?Q)2^["TF`!AVT[$RK+/38><\Y,P;,ZBP&L-3S,H%P.4&7`@C7:$=L^AN=., MNF[X%"@A%X(O,QGM>J9*O$MJ/$1*CL."Y.2FY=K%=]M%9A!Q3[/4"=5?H1OC M_7@ZI7XHLMV?&XOQ;-BEY*7VTE1F8SJ4D[8KGUF9WTMAT-"-:UI_+*T-D2R, M4Q'F@4-]9Q]]FPR>'-VWNR+W?[6^H""CRB)"'CO&K)=P2[)0T"[FA[:4(3*/ M''4!3BTU9>.5:DYE>^NV;`13`[%+C40M#7%D.JXV`!*.]7P9TB90B=E53D,K MO4P1_WGBK!6%95@2>TJYTX$55YK MQ3EVZH'WAN#N[(X'W9`G4$%Y)EWG.%HZ]YY#3O(T>]FR_+U'7>%I?*QP!93K M#%_W*@D)!MTKNMCMMULS>**Q2!GNZ,@>Z1I$7$U9N?6OQI2V:12^BY)B+=0O MZD1T,:;7[C'3]5V4^@T'?L@M3U&-A@)3;PV10;E^A])YVD9@U-!(WC!9>Q8[ MJ6,FFQ5?VD5E?;-&\N%/@A7T3X:744=)B3+%:?``6S>K*E)>FNRT#=RN7<02 M`IW3VPK%=6E:$[C"'8N:5M,I&GG.YLZ'1[/E'$:.BX,!6=723.VY6GKT6;E"=^@\O7QZC[^@!W71]LUUV]?^5SHP2^U!J$6LP05.F- MGU<]`Q(Z6*_O?Z_U1: MV6#B1F3GSTV$.Y#6#>/\,>=K>I4#!+2SG).IV9@A#LF9"H>I_X-=PXBCR(TK MU9!UO&!K*=T5M+>L*B"HPE/*ZP*%E-L%2YUD_%@*3WCDB)Y[.-+F4NW&-E%7'ER^+62KRR)6*`0PA^0#W$/LSU+&$B&'^1MU4X#YT?5PJ* M^-0[KI01:NJX(B$\*"J@H/"3;J"LKQG)XXKTO+:9IO3O?1C%,87^`E,M.2XF M\H\]R]_BB1^2[]6#5#)$=@N(K(/L6_J9W5>Y M3TKI^(=2.N9!*NWJJS6I\GPN5].@:_-6..\PO['X28ZTZ"TC[*?@5CA)T4`F MK]4'8X'&T\'LHX&>&[_-C>G2T&;G7%D5^1OA*DU3^]Y15@;EGEN5+==,F=?S MG+$*#R<[AGVA5'4#$&_4/-]EL;[;K,?Q@+T]%Q:'GQ54V3AE!"JH87PRIK?Z M[4'/QYBOE5&DS4Y"2N=F,`N82\Y9UJ2X*,O#$`H'B6O_G=CS_:$Q7%_2TJQN$9$9? M<.V]Y'S`_#&!?T=-OQ.'T+=9@1QS6[!]+V\+\[B(1`"Y6!+BR#U01W9,7A>4 M2.G@Q'LB-P_M+3>STP,I-9=P5IFBEN#%I82]FMB9R6Q9>@1H6>#2UZN\U%VL MA"4C/U\`A5#I*'-)9+\N;*LVDZF)\)S^C MV8+SMN"U@H7%\]F"WA"TLAREBPAA;=R$@@&?A+6+%-UY3,CQDB=@3$@9H:9B M0B2$!ZTOTT_&\NL,89?0C&1,B/2\MN[0&1%%O&>7'I1[=C+M5+EX\JPA.&.4 MD,,.&[KABSM@CN.'I^PVMS54CX=08L%JQFNM8+-3*H:2Z'1V%=SQ:DK=L"-0 M07Y+)#$5S19;^(Q=]U?/_^(ML1GZ'EG_:/I9<#;-XO8*"C`(1%%0BH%RZ/U! M6:"4!XJ9Z`(D:6WD"S1(S4R3F:I%VVY!CR8S4]5XE4M9Z(*:"MJHD(+:F3O9 MVF![[^+9>H@#YX&L]`]X[)&ED9D2PK%W6#!GZ\/=RW,_9!7B1Z83,*>XL%*A M8BYP1W8SPP:]=A.1Z$O7/@A%]FT'J71Y`AI68L[[W"1XVDR]286G(6O2CXZP MFX)D'#G!P%DY/Z(>.C)#::KI$XM%I'P18XP^DG?J/M#S;G=99>53>*I,8XL> MH+C*:'HG,I&-?!.0%U(F$5@^8:PN-;@7"38,,+1?$V@G'%&&I6[H!:HIYY=2 M,=TM[G7VNUV<@FFZZ67T8V_M!UMVP!4"AH1("P>RT-/S> M7Z\QNRK1HG39570JGQ7P(.2N@*PUEDXB7B7TD8MXE8:9COY:L)^V3?^LDC<1 MCA!EAVZ3K.(#'W1DI/(9:V9XY>\GZ!CU=D;#G=`=NA=/WJ9C3^:0Q?<^UB&F MPCD)&`3(A[`A_Z-&4WJ9,.-(WB*,)3,RFP&"!!U`Z)$3 M1D6`4C$'G;`CIXLL;JK,3(LA0WG?N[:O9]YCK="T1^VV'J,L"N=J>Y$OWF*_((YK>3ZV-H MS?Q/=5QD07 M;%722':/7W&6-"AJ)Q]X78E$=QC'-UMS<-CY:*U%1`=@Z8BO\Q6J?786@(YCK:*L!S M_5GN,N+F4*!M8.Z+G-7\O:`\"W19 M%X6YJGR!("`;5O33MRZ_7.1*U6%TFTG+5P4_BU8$K@[NIRW(/A>E%,IT57>' MK82`ZCS+NL&MBA:X%\=*SU,[Y5CC!"RY@JS9M@I+LA:(`%I_SXJRQN1U+\M: MH`1^85;N1#1;>RJWNY@=/1D%X)'HI*`*E8Q0"DI1)5M'QN<"Q9Q0AI5.R))7 M3+XJE?QT@4SDQB,]!.V=<(/3_('9>NU8.&!W MB1]SH9=<$S:ZP*B*2K(&\FJ3I(%]_'W`#]D7=&K.!GXB%,R"6,9!%[!5TX>T MS;M@EKJQ]1A+F[)/F2NW618(`X<5H(SJ/R*/4TUPY#;%5JH8RRS-_0CJX M1B:YT514`YO?7MV5,CQ1()`Z7M&2W$ZK73UKX?"YE[643T5785L5+Z&4[*PX MN*O9JR@/[B2T.W.Y:7LS937UE(=KZ78_I4R*<;D%N0J%5@K'*;0O][_&K/0: M.JI3*:YC.VY\R1(/D_&/BFZ[4H&DU8S6;!-?;M6\A.67HDJ*V0FN3X9:?.E6 MFR:Z3[Y+GA%RT!XY+@Z*3+K%[108XCBL%=C>#I113%H7$`C'GC>OE>J]:8M_ M;#8V/'M(7O4EUO[3=DHL_86LE5CY$_,^(8TH;9VP43KX(NM^B>)!UM:4/K6. M,!B*2Y9*=P-97:L(I@0M=*^4K"H95KJ`IJI*LI97^Z>,C"YDG"E"`4@%;M_ M_0&D/O@%$A1I$5#YYTED`9)N[[H[/CTZ,.N!:Q ML3M]?X09Z;Y]^^:B>W;TR[^^^_;GOW6[G1$EMF^!W7E\[HR)[\THMJ?0&0-= M8@M8QV>_Y_K./O^=\6SQ1/9U[G'U?_[)R?GK[MGI^>G1]WOG[]>@SV%-&@VV.+S#O= MKN#*P>X?[\3_/"(&'2Z/R]Z_FGG>XMW)B2!Z>J3.,:'3$][9ZY-UPU????O- M-T'C=T\,QPB^OEXW/SOYSV^W8VL&<]3%+O,$^R$AP^]8\/LML0(!%#[9D;80 M_Z^[;M85/W7/SKNOSXZ?F!UA=(*=S6<8GKH+Y,T6,T3G2*CC1.CI].+U:81" M]%E2&2F2E3K.+BXN3H*_1EOS[FQOTSS:^YN3\(^)UCB'G8V*.:S?A+A2XL`] M3#KBOQ_O!RKBGXBV)]BFG_O$\N?@>NO_]ES[VO6P]SQP)X23"=Q>=0*9WGG/ M"WC_BN'YPH'U;S,*$_[;8A'@L^Y?@/)WY>Y/MK(L*##>+/C]EO\0^S(\>>#: M8*^_+81X`6D%-RMV'&)%.3ARQ$@F]"@J_%&F\'P119WKHK!SV" M\_Y(F>RD+)?1XG=H M#@F&IMUK1EV[#7UA))Y"06N MF2`Y,G!/S;DA"T&(G*,.H3;0<`K8B_[7@CSP;C/T'ONS8?J.BY:MY_-]ZWD$ M%!,N@]U'7I["X^T,U7Q"V&P(7N\+@AYGR19LW3AHFJ'Z^-\-4WE"N&Q5_[`O M58=L7W%V*'(&?$)]^A6>I6X]VCS^0&DMW< M2#ADHF?CJ.`3'B M@CU@S`-SP7[(L1-;2,#RD`DN0V/LJ.V0L7'ZJ M81%M:S0:,:$E>&R6W#^?9*9$:TK\7B)'Y)'',P"/5" MV&,P%'S6G2*T"`AZ%(>`P8]'AI"T+(I['J,<=]4X`@2C73!+#7HUUEE!NC M\(1D\H%==FX@'G(:G1M&E"R`>L\C'L4&"XHO/EX(@[\#&82Y)$;XJWRA7V@' MLJI=Y1J4&7I?"R+?>#3.?FXQ>L0.C^^!\8$4;%C,B,/E86)0><\%D[XRN1'X MJBOCA?8]:\%1+5S+(3`-*\7`K?).:`4/:%G$=STV0L]B#<<'%_^%^MQ+I*20 MNX1H,9S%=$:!J*`&[193?:!8 M%(0O0=D(.TB2&6$3,=%'0TCH\W2\:7I$67Y&+)R%5"5M?1J-`5< M_XX<7[9ID=6R<3R*AE9\!9TAJG;11:2*+`^-5#.CH$@+J5VHT+-M''(S0M@> MN%=H@3W!6G:H+FEM%"I2D;6+#?JP!(<$Z2_NDZ=P[7I`%Q0SZ,,$6]CCZPE_ M[@=!:=^GV)TF*:317N6.C8*\#D56CU4NPEC%A:GXCF;1BG*48A;R68+*,US& M19U%:;T=^TH9*L.!.UG:F5 M?R/G1*T"4=/E/?J76I73?EMDU199-;#XYV-R2`.)[6!1-@(:G&-2R@=(B77! M.'?"5%6$=M879SP\=M;SO1FA^$^PE9!+$1F(6%IP[?()60P'YSS*H+0B,!:A MM<#:)12RF)6?8E6E,A8GA9.KE8_GM?D[_;01@P\EP M`32\8+!"`DK2X?Z23Q(&FAGN`Y;C&J347O! M[AZ6X/H@0VSS9UUPRIV^ML)H9R,K!^].KY\6X#(H.F0I;V\$$CGB:IJ0A=+!^P%%X=`L`$N_B96=V+[[8HPZ;&TU0#/*"`RI)2G58TK8]M(%Z[2;PDK1#'2TJP`/2JB?`8R#L([XI*XB*N1 M6K#N*J8S`EX%\;6;P#ZZ%)`C]F@^(.R*$3ETMZ?G9!981-4P7,KC,(I>H2:T M6X^M,B\W7/8/XC&*@GQ2I)V)^&1(J]W2;"#.%`!;!ZQBO2%-YJ=;FHA*IL35 MIS2-CDD,O1E0J6YD(4H^D8E(%^GA@,[Q;L,SX6VNB,O%];G$VPW#2Y@0"F&[ M!_0$[/J)*X[+C%U$GX,(@:O*XI1<)"=05F@GN7M[+_-%(V*G%U7Y`1WVV\\39&@)<02UYI9)P%7B/J-[T@*R(BHC0"T4_84>']D=K$\@'D`%N[?DT\@4[OSY(]#A M).`^4F:EAN&.G1D![:Z**GC69'_E:>+2U1N'?*VK.FW;7S/%:=OO-WYI_885 M]"H&X8B2)>:^[?+Y(P-[X&YV,GJ6AY?A M\?N"''_YCG3!OBC0+:T@[2S4N$7([L.R]"*ER1O;[?_Y+"A@80_D'BSB6MB! M&-1D0]-NZ6-5%\9A?G$0)BCUHL,]R0^@8Z!);P(;TRD%8 M.G^7Z^,@1D=)M=6VV<^7:8]DY]A`>F_*FGDNQS#@=OC?0:0<)'+MF'SK18GZ()!45I5V)X[3G&]$7]T) M6GPJ4[6#`X5:KC#MM@/2S*N\SZ",O%)G!SH*U!3Y0J^@[R._53FO=1C(EU%8 MSH/KQFW[2N0>N$M@=21"\SHR.1&:JR#MLB#<>ZTR/3WKBX\I2-^BDZ!;H@,] MW8'"@(Z=ERRAL.K;(GK5[2BJK[(?.(R14D9A!_2"IT3L33*BZKR1UY')\T:N M@K0[M>&%<;`RJ'\G-)#@/=7*54]_H:Q0?9`SF2GBYE_%&ZPQ@)Q>K1VLE'GX14 M0#+6_.``C"M#NS.N][#8^!T%W*3-#P(WN3*TVQ13%[ARR'P8V)91V`'='!'( M#!03.YF6EHR+'`(CEDQY`A_0,4PA9@Z"YF!5XPG$10`[_S3U=,;F\YDYZ'!> M#\D;COW%P@DD1\[Z_,#`G1`Z#]5?<(9#D=H(=)5546-9@KQLJS?^]Z@WZ-\, M[W/>(,MJI;6NI:)IN/D?G@<7+[Y*M_0C31I\0"UGK&1=OA%*I%T*+')6/U?G M\58FJ#TAEW;;F&MG)RY$X/_<[K&X=L9BH(^9Y1#FTZ)[NBIWJ[4GJT]YVE6Y MR+)M7#3J8;[ZCR?82Z8F9;TTC'9=1J"2MI0JLD:G+(TLTK66SUSF0/R$G,FW M@,M2'Q"BI157X.1?]J3[5A:1LSOC`\X65Z*LQ4;.]NAXA?/O9;ZROU/Q9;AJ MJ'I_P^$#%_?2$7N4^3-I'D53V5;D<7:BK^+(LJKIA@W[!07]Q]*D&9(6^.E] M6O?Y!R**J;F/`^K69LWQ7INRWC@7K;7N+,0M_N)CFT],6]ZBJA6ZE@BC0FF6 M/2OI0B,#?SWVYW-$GX>3,2?&$VR)4LFP?IZS/2(.MGC\4IOIJWZO*:>@RE_K M+G9/"NL1FR6TU#5B$9^XX=-+75MKB'295/6'V&A-?`J&9[LLOL, M7N7I'?4NS#+V&F]P>X7!RD1(V^UV6^LTZ:, M-\9$:[D5;D_G3,R(P\E-LO*E76BDXV?!;YI=4MP?78>[[8Q M6X^ST=K[[C.[>%PI-H/Q)>?Z82VP-U=K%4WP9;LQRP.4UY).KN!\[#\R^.+S M+UTOZRW/37?=F$M(L]*ZA0H'...Z++1_:7O##%TNMT86K5BL]I'!<'+-/#Q' MXHZ-ADKZ)%QH7N@GX;JAQ)GX_+.J.Y&U;LB5Q#4IX3G1J&&G4:#OJ,-(2F>> ME]CN-F2MY%%*5HO4J5G<($9\5[A$D"<[Q-GM3F>9[-SN9PHI/K M465+<]^C*D;K?,HG2154FSSF7([6')>DJ`OSO-/8FH'M.URNK=>-"!8\QKMW MWZ3&E.:>24V(9DP[^/AFX&\O;RIP4(5D3>5Q\E4]<",/?6_,=T08%N-%N?ZJ M[J\T[/U4QT`L<52WHC5RF-O345LIUZ=9H@=9:G:))3_;_-DQ)3;_XFY->H%, MOO(R[HPI(##(AZB(KY$[B-V?T`>:\T2CIFU6K>0K+I=V-Q[*+YB3*7_;4)>[\6)C)E/[$>&J/^FUOC<7Z,ZO MF==VVWQXL>,M83D7RD?:Z()8:K`E[H2/BG50;[#U80D.">,_#TWA6MR'NJ!8 MW(?.%\!8K'_]N>\(1OL^Y?-)DD*:L*[?[>G(S0U7/J7I7(82B2YX%LSD>4(?5-3WT:6`'/PGV!\0 M=D58.W0CF_.R*J<"*B-0+A3=O&"LH6C+D'"JC9?:>*F-E]IXJ8V7_HKQDG3# M;N13:X887VXC!]CZ(0IQ8\D8/"_<[6)WD+5UITRJ-8SEE*!15*2Z8UUW6%3V MN[KOZ+>!41L8M8%1&Q@UXQ!IX,[[U\VHA1LQ\0 MM'MK42I'.OY6(C$"ZWRALS%ZK%!UD^YW$.P*!TAOF"YAT5X85S&_%5,HPM0TGE,06SM+$?"<^$F M9#&=UG"5$%^C_:O$E?QU1R&2[C5Y@*"-1=I8I(U%VEBD9"QR1=PE<(_.!8K[ M$U&S`'9&)%)$H0M(TCBD4.0:;697O=\0>H78[*R\_C>4IN.P54&-VRH5\;@C MR_,W.V,24A\(+BM5%&RG[!&;G6$Y%$1D8/Q0,QB;EW-RIHAD&P-4G!(K6YMO MFGZ)J>YE35;?.KS+U"YHV@5-NZ!I%S0O_GY9Z._#*P1&0#$)7_!@F\EU#'2) M+>GIO9*=Z()Y;N*OK&*TL\J>$W0.D==8^-RR`)<%RKY^$O^4N4E%8B.05%6$ M=K5K8^0@BH%]$EO=/=<>3B9\K%$6Y5YFD2JD1J"GIH1]+,*NG\393Q^S&=BK M"JX5,P&/R6N-E4BTAD!-Z((E5W-/N]6]3,CN78^'WMJE0KM4:)<*[5*AY)2V M\AYA./M`>GU,P8J01Z8R:5-=8)%.87(A]['-<>D@ZX^Q->/2L)"3$<46GU-_ M(S8X/<[4/.0O0^?JM-J#4$(-.]=3K/XB_N>11_G\E_\#4$L#!!0````(`(V, M;D$CITP$F`@``!E0```4`!P`&)R;"TR,#$R,#DS,"YX`^Q_X,F+ND!M67;3QD;< MA9M+-T":&'%W][P5M$3;1&51)2DG_O<[U,62'9&6&B0]YN0M&GDK'"C6 M,[8,(TDXN@H"ML(2=(NW\,-MOX5OX9K3^4*B-V>_H6ZG<]+J=IQN&]W?W[>) M-\<\%MMVV1*U6LHJX2[($B-P)!"#@`5!M!Q:"RG#@6TKIHNE?!M,=SW8G+0[=C_^W(]B>5;F8+]TK\Y6-GPH:;.'1XV6PNCT^WT[ M_EHTWY/;PE/;C^WDHP4=ZY=3#-U3QMU3_83?84B#&8M__'*J1`XR+.[(#,5* M!JH/#(\$788^.4K?+3B9P;LP5-);F:??0D[:8%)&Q9D/G-I659]M8!&`>&S4 M=:X[$X&Y^TC*HW8`(2PD7%(B-GWIR#Z85QZ9U?4*6&A`7[%//I[6]0E8B/]* MW7&Q7]<=8'$C_YG[G9+Q%=Q`ZN'/NZN-/$.\2,RC'O]V3H7K,Q%Q%2--#$KM2OOGQ\[T"*=#FJA7`3\4%)0'QX222@6 MA=ZDPGX[M7?%%*5'@GBWP7=\IYPIB8YK>_Q4X]D!M(0I?96!\EQ`]2;1 M(AEH%1(@XD!$\>)X^-M&&?^.E!V MJ$QC[GTY*HZC!ETFX=#MQ"V,9;P.@>>4 M%26\37,;1L')&)(SPCGQXBZJ&P:[9*9QT"L?!R=(K=M3*Y)/;V3A9[JU'@;?Y^E6UJ1;#FE),\';+X7T'#QLQ M`V16@]XDBAKHC=$24EZ/!*!XLU#99`3Z`&ID,J4ORB'C7%$^I M3V5,H7LUGW,5'''@H$84*LAJPM&GH M+:S`\$Y-6//=!,@[7IN^:>`?.]"2`KA MAAPJE=0(-4&NJ:_5S1Q!LZ+;Z&[2Q&J]Y4.^@9QE"JJVM5D3?"%8D1J+-+5D MF/J"IACW0;W-][DW.N*9L[!D*.II0']ZB,BKGGGK%U9B>^H-AU5B6GQJ9HVZ M(22S1!%[>7>CQ;5G4]VH4NGM3J*I(#\B\/MB92SO/J8TQ0=-+:1FXCGH[O(>(.N*,>4FFFW(FOO+#?HOEM6:3QX< M5(>IWVA"PW/DM,WAA9K'@_>$CU):$]::XWB/#@LW<>!G#DSN04M#;<)+LR-6 MRP5SL.47"H@K#F0&:]Z-N`?TCPGXBZ<<%TD!KTOP?D4[MP@Q5^;%UO M/:7+D'&)DNO4U\R-OQAN^<97"K.KOBWUJN5T6SVG_2`\"P6/[OP:[@G;/V%` M=E57:3[6Z2R]VUM;6_'B^$URNUMI[2M_G?>5_"V]>_X$0YYJ10T+8N[26^LV M\:7(WK3R.]DZ6XQ7WRN;LGL/7#U44&Z\0YXH3Z_3(SR%+!J[4$U]7V7>&;LS9U$XM!)R*LG20O'UW_0-B(,(=@7OE9!=]S)W"INW5T)$Q/N;RL6G^.\Y MI">T@KG.G6J\B373I$H%OI`I/9R3H!^F8;[6N:E#\6PT^6,\NCJ_O+W;!UHI MZ8MB5+(#=\."^$!NULPC%S[#>VW/JR/B52*F+Y?N`[`*YXOBF=WZ@3"0E@"3 MX7/)>/8G5'2^5&+=P<^%%K(3R1_#&4CR(#_Y*E+O@XVSJ3+SFH(1'I;$.\=+/-=W M20-#96"2)%`^"RXJVQ?I-M4=\96!$`3D^HZ$>&V"I@+C_S52YE-XL%)_40/, MW"YW;$*#BO/Z2;P:]V%`$[!TA,%<-RFIG($<+I)7,O3B0:T2(RI@$*=GS>S_?ZXAI6W/,5S8ZIYRXDG&=7WKZE^P^GWSL?H?`"LM>D5@T MAG4.-/@7YA%_!,8M$SNU&4-U`2^,]4"CO.T>.6\2J=NV*I[ M_#3'4A'/-YQ.[63=#8__`%!+`0(>`Q0````(`(V,;D$/^5:;-F```-77!P`4 M`!@```````$```"D@0````!S<'!X8G)L+3(P,3(P.3,P+GAM;%54!0`#Z1RD M4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(V,;D&E%`HE1P0``%TR```8 M`!@```````$```"D@81@``!S<'!X8G)L+3(P,3(P.3,P7V-A;"YX;6Q55`4` M`^D`L``00E#@``!#D!``!02P$"'@,4````"`"-C&Y!UD)J+-(.``"R M^0``&``8```````!````I($=90``&)R;"TR,#$R,#DS,%]D968N>&UL M550%``/I'*10=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`C8QN0?^S]#'# M&P``6U@!`!@`&````````0```*2!070``'-P<'AB`Q0````(`(V,;D%] MQ^,V\Q(``/=3`0`8`!@```````$```"D@5:0``!S<'!X8G)L+3(P,3(P.3,P M7W!R92YX;6Q55`4``^D`L``00E#@``!#D!``!02P$"'@,4````"`"- MC&Y!(Z=,!)@(```94```%``8```````!````I(&;HP``&)R;"TR,#$R M,#DS,"YX`L``00E#@``!#D!``!02P4&``````8`!@`L )`@``@:P````` ` end XML 20 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6

Balance Sheets (USD $)

Sep. 30, 2012

Dec. 31, 2011

CURRENT ASSETS

Cash $ 74,934 $ 20,424

Total Current Assets 74,934 20,424

EQUIPMENT, net 460 1,409

TOTAL ASSETS 75,394 21,833

CURRENT LIABILITIES

Accounts payable and accrued expenses 534,710 499,435

Related party note payable 20,075

Derivative liability 5,660,208 5,377,308

Total Current Liabilities 6,214,993 5,876,743

STOCKHOLDERS' DEFICIT

Preferred stock; $0.10 par value, 5,000,000 shares authorized 5,217 and 4,286 shares issued and outstanding, respectively 522 429

Common stock; $0.001 par value, 45,000,000 shares authorized; 12,837,500 shares issued and outstanding, respectively 12,839 12,831

Additional paid-in capital 2,047,844 1,532,432

Deficit accumulated during the development stage (8,200,804) (7,400,602)

Total Stockholders' Deficit (6,139,599) (5,854,910)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 75,394 $ 21,833

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 6

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FIN39-1

-Paragraph 10A, 10B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 7

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 4, 17

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13495-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

+ Details

Name: us-gaap_DerivativeLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Cumulative net losses reported during the development stage.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 210

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472335&loc=d3e37729-110921

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 7

-Paragraph 11

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount for notes payable (written promise to pay), due to related parties. For classified balance sheets, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date).

+ References

No definition available.

+ Details

Name: us-gaap_NotesPayableRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 1 - Condensed Financial Statements
9 Months Ended

Sep. 30, 2012

Notes

Note 1 - Condensed Financial Statements
NOTE 1 - CONDENSED FINANCIAL STATEMENTS

The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at September 30, 2012, and for all periods presented herein, have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2011 audited financial statements. The results of operations for the period ended September 30, 2012 are not necessarily indicative of the operating results for the full year.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6003-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Tables)
9 Months Ended

Sep. 30, 2012

Tables/Schedules

ScheduleOfPropertyAndEquipment

September 30,

December 31,

2012

2011

Computer equipment

$

5,390

$

5,390

Accumulated Depreciation

(4,930)

(3,981)

Net Book Value

$

460

$

1,409

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: fil_ScheduleOfPropertyAndEquipment

Namespace Prefix: fil_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_TableTextBlockSupplementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Details) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended 77 Months Ended

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2012

Sep. 30, 2011

Dec. 31, 2011

Sep. 30, 2012

Derivative liability $ (5,660,208) $ (5,660,208) $ (5,377,308) $ (5,660,208)

Gain (loss) on derivative liability $ (18,385) $ (177,011) $ (32,923) $ (172,327) $ (245,087) $ (1,019,246)

X

- Definition

Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FIN39-1

-Paragraph 10A, 10B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 7

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 4, 17

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13495-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

+ Details

Name: us-gaap_DerivativeLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_UnrealizedGainLossOnDerivatives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 24 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "
"+ text.join( "

\n" ) +"
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
" + text[p] + "
\n"; } } }else{ formatted = '
' + raw + '
'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+'
'+formatted+'
'+ "\n"+'
'+ "\n"+'
'+raw+'
'+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 2 - Going Concern
9 Months Ended

Sep. 30, 2012

Notes

Note 2 - Going Concern
NOTE 2 - GOING CONCERN

The Company's financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. During the nine months ended September 30, 2012, the Company recognized sales revenue of $-0- and incurred a net loss of $800,202. As of September 30, 2012, the Company had an accumulated deficit of $8,200,804. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's planned business. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

If there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date), disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 948

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6490092&loc=d3e47214-110998

+ Details

Name: us-gaap_LiquidityDisclosureGoingConcernNote

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6

Balance Sheets Parenthetical (USD $)

Sep. 30, 2012

Dec. 31, 2011

Convertible preferred stock par value $ 0.10 $ 0.10

Convertible preferred stock shares authorized 5,000,000 5,000,000

Preferred stock shares issued 5,217 5,217

Preferred stock shares outstanding 4,286 4,286

Common stock par value $ 0.001 $ 0.001

Common stock shares authorized 45,000,000 45,000,000

Common stock shares issued 12,837,500 12,837,500

Common stock shares outstanding 12,837,500 12,837,500

X

- Definition

Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 27 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 12- Subsequent Events
9 Months Ended

Sep. 30, 2012

Notes

Note 12- Subsequent Events
NOTE 12– SUBSEQUENT EVENTS

In accordance with ASC 855-10 Company management reviewed all material events through the date of this report and there are no material subsequent events to report.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6

Document and Entity Information
9 Months Ended

Sep. 30, 2012

Nov. 15, 2012

Document and Entity Information

Entity Registrant Name SIGNPATH PHARMA, INC.

Document Type 10-Q

Document Period End Date Sep. 30, 2012

Amendment Flag false

Entity Central Index Key 0001455694

Current Fiscal Year End Date --12-31

Entity Common Stock, Shares Outstanding 12,837,500

Entity Filer Category Smaller Reporting Company

Entity Current Reporting Status Yes

Entity Voluntary Filers No

Entity Well-known Seasoned Issuer No

Document Fiscal Year Focus 2012

Document Fiscal Period Focus Q3

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

+ References

No definition available.

+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.

+ References

No definition available.

+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Details

Name: fil_DocumentAndEntityInformationAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 3 - Summary of Significant Accounting Policies: Use of Estimates (Policies)
9 Months Ended

Sep. 30, 2012

Policies

Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

X

- Details

Name: us-gaap_PolicyTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 94-6

-Paragraph 11, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6

Statements of Operations (USD $)
3 Months Ended 9 Months Ended 77 Months Ended

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2012

REVENUES

OPERATING EXPENSES

General and administrative 15,177 40,723 29,889 113,916 1,233,932

Professional fees 20,825 35,685 66,363 116,917 920,130

Financing expense 1,063,401

Research and development 173,108 161,765 517,590 934,972 3,034,224

Salaries and wages 52,486 153,437 947,432

Total Operating Expenses 261,596 238,173 767,279 1,165,805 7,199,119

OPERATING LOSS (261,596) (238,173) (767,279) (1,165,805) (7,199,119)

OTHER INCOME (EXPENSE)

Gain (loss) on derivative liability (18,385) (177,011) (32,923) (172,327) (1,019,246)

Grant income 81,556

Interest expense (63,995)

Total Other Income (Expense) (18,385) (177,011) (32,923) (172,327) (1,001,685)

NET LOSS BEFORE INCOME TAXES (279,981) (415,184) (800,202) (1,338,132) (8,200,804)

PROVISION FOR INCOME TAXES

NET LOSS $ (279,981) $ (415,184) $ (800,202) $ (1,338,132) $ (8,200,804)

BASIC AND DILUTED LOSS PER SHARE $ 0 $ 0 $ 0 $ 0

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING 12,830,000 12,190,000 12,830,000 12,190,000

X

- Definition

Represents the charge against earnings during the period for commitment fees and debt issuance expenses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 5

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 34

-Paragraph 21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_InterestExpenseDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-07.2(a),(b),(c),(d))

-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section 45

-Paragraph 3

-Subparagraph (k)

-URI http://asc.fasb.org/extlink&oid=6488370&loc=d3e13550-115849

+ Details

Name: us-gaap_ProfessionalFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph g

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 86

-Paragraph 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 2

-Paragraph 12, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_RevenueFromGrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Expenditures for salaries other than officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_SalariesAndWages

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_UnrealizedGainLossOnDerivatives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).

+ References

No definition available.

+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 31 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 7 - Derivative Liability and Fair Value Measurements
9 Months Ended

Sep. 30, 2012

Notes

Note 7 - Derivative Liability and Fair Value Measurements
NOTE 7 – DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS

The Company’s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with its Series A Preferred Stock and associated warrants to purchase common stock. On January 1, 2009, the Company adopted ASC Topic No. 815-40 which defines determining whether an instrument (or embedded feature) is solely indexed to an entity’s own stock. As of January 1, 2009, the Company had issued 3,572,714 warrants which have exercise prices that are subject to “reset” provisions in the event the Company subsequently issues common stock, stock warrants, stock options or convertible debt with a stock price, exercise price or conversion price lower than $0.85 and $1.27, respectively. If these provisions are triggered, the exercise price of all of those warrants will be reduced. As a result, the warrants are not considered to be solely indexed to the Company’s own stock and are not afforded equity treatment.

As a result, on January 1, 2009, 3,572,714 of the Company’s outstanding warrants containing exercise price reset provisions, originally classified as permanent equity, were reclassified to derivative liability. These warrants had exercise prices ranging from $0.85 - $1.27 and expire starting in December 2013. As of January 1, 2009, the fair value of these warrants of $1,676,633 was recognized and resulted in a cumulative effect adjustment to retained earnings of $43,808. The change in fair value during the years ended December 31, 2011 and 2010 of ($272,970) and ($538,010), respectively, is recorded as a derivative loss in the accompanying Statements of Operations.

During the nine months ended September 30, 2012, the Company issued 626,576 warrants as stock offering costs to the Company’s placement agent. The combined fair market value of the derivative liability associated with these issuances at the date of issuance was $249,979.

During the year ended December 31, 2011, the Company issued 1,704,884 warrants which were attached to 1,449 shares of convertible preferred stock. The Company issued an additional 1,022,931 warrants as stock offering costs to the Company’s placement agent. The combined fair market value of the derivative liability associated with these issuances at the date of issuance was $2,184,753.

During the year ended December 31, 2010, the Company issued 676,775 warrants which were attached to 575 shares of convertible preferred stock. The Company issued an additional 391,353 warrants as stock offering costs to the Company’s placement agent. The Combined fair market value of the derivative liability associated with these issuances for the year ended December 31, 2010 was $852,346.

During the year ended December 31, 2009, the Company issued 953,370 warrants which were attached to 810 shares of convertible preferred stock. The Company issued an additional 286,011 warrants as stock offering costs to the Company’s placement agent. The Combined fair market value of the derivative liability associated with these issuances for the year ended December 31, 2009 was $988,552.

The Company classifies the fair value of these warrants under level three of the fair value hierarchy of financial instruments. The fair value of the derivative liability was calculated using a lattice model that values the compound embedded derivatives based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The embedded derivatives that were analyzed and incorporated into the model included the conversion feature with the full ratchet reset, and the redemption options.

The Series A Preferred Derivatives were valued using the following assumptions:

· The Company was 3 months from being publicly traded and the Company/Holder would convert the Preferred Stock based on 200% of the adjusted conversion price;

· The Preferred maturity date used was 7 years following the Company being publically traded (rolling 6 years from the Valuation Date);

· The stock price of $0.85 was used as the fair value of the common stock based on the previous common stock transaction;

· The projected volatility curve was based on the average of 15 comparable biotech companies historical volatility:

· The Holder would automatically convert at a stock price of $1.70 if the Company was not in default;

· The Holder would convert on a quarterly basis in equal amounts to maturity if in the money; and

· Capital raising events would occur annually, generating reset events based on pricing not greater than 100% of market.

The warrants were valued at issuance and marked to market quarterly for the period 2009 through December 2011. The five-year warrants are options to purchase shares of common stock at an exercise price of $0.85 per share and $1.27, subject to adjustments. The following assumptions were used for the valuation of the derivative:

· The stock price of $0.85 was used as the fair value of the common stock based on the previous common stock transaction;

· The projected volatility curve was based on the average of comparable companies as provided in the Preferred assumptions above;

· The Holder would exercise the warrant at maturity if the stock price was above the exercise price;

· The Holder would exercise the warrant at target prices starting at $1.58 for the Investor Warrants and $1.40 for the Placement Agent Warrants, and lowering such target as the warrants approached maturity.

· The Holder would automatically convert all of the shares at a stock price of $1.58 for the Investor Warrants and $1.40 for the Placement Agent Warrants;

· The Holder would convert on a quarterly basis in amounts not to exceed the average quarters trading volume based on historical performance, assuming the volume would increase by 5% each quarter; and

· Capital raising events would occur annually, generating reset events based on pricing not greater than 100% of market for the Placement Agent Warrants and for the Investor Warrants the reset would be 150% of the Preferred.

The Company determined the fair value of the preferred stock to be $3,352,205 and $3,146,367 and the fair value of the warrants to be $2,296,444 and $2,230,941 at September 30, 2012 and December 31, 2011, respectively.

The following shows the changes in the level three liability measured on a recurring basis from December 31, 2011 through September 30, 2012:

Balance, December 31, 2011

$

5,377,308

Derivative liability for warrants issued during the period

249,977

Derivative loss

32,923

Balance, September 30, 2012

$

5,660,208

X

- Definition

The entire disclosure for derivatives and fair value of assets and liabilities.

+ References

No definition available.

+ Details

Name: us-gaap_DerivativesAndFairValueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 6 - Note Payable
9 Months Ended

Sep. 30, 2012

Notes

Note 6 - Note Payable
NOTE 6 – NOTE PAYABLE

In January 2012, the Company received cash pursuant to a short-term promissory note with a related party. The cash was repaid in full in February 2012. The note did not bear interest.

On September 27, 2012, the Company received $45,075 in cash pursuant to a short-term promissory note with a related party. The note does not bear interest and is due on demand. During the nine months ended September 30, 2012, the Company repaid a total of $20,000 of principal due on this note leaving a balance of $20,075.

X

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 2 - Going Concern (Details) (USD $)
3 Months Ended 9 Months Ended 77 Months Ended

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2012

Dec. 31, 2011

Net loss $ 279,981 $ 415,184 $ 800,202 $ 1,338,132 $ 8,200,804

Deficit accumulated during the development stage $ 8,200,804 $ 8,200,804 $ 8,200,804 $ 7,400,602

X

- Definition

Cumulative net losses reported during the development stage.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 210

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472335&loc=d3e37729-110921

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 7

-Paragraph 11

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 34 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 3 - Summary of Significant Accounting Policies: Derivative Financial Instruments (Policies)
9 Months Ended

Sep. 30, 2012

Policies

Derivative Financial Instruments
Derivative Financial Instruments

The Company generally does not use derivative financial instruments to hedge exposures to cash-flow risks or market-risks that may affect the fair values of its financial instruments. The Company utilizes various types of financing to fund our business needs, including preferred stock with warrants attached and other instruments not indexed to our stock. The Company is required to record its derivative instruments at their fair value. Changes in the fair value of derivatives are recognized in earnings in accordance with ASC 815.

X

- Definition

Disclosure of accounting policy for its derivative instruments and hedging activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph n

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 39

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41675-113959

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(n))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

+ Details

Name: us-gaap_DerivativesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PolicyTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 10 - Warrants
9 Months Ended

Sep. 30, 2012

Notes

Note 10 - Warrants
NOTE 10 – WARRANTS

A summary of the status of the Company's warrants as of September 30, 2012 and changes from inception through September 30, 2012are presented below:

Date of

Warrant

Exercise

Value if

Expiration

Issuance

Shares

Price

Exercised

Date

11/25/08

1,259,639

1.27

$

1,599,742

08/10/14

11/25/08

530,314

0.85

450,767

08/10/14

11/26/08

449,220

1.27

570,509

08/10/14

Outstanding at 12/31/2008

2,239,173

1.17

2,621,018

03/05/09

347,215

1.27

440,963

08/10/14

03/05/09

104,165

0.85

88,540

08/10/14

04/01/09

17,655

1.27

22,422

08/10/14

04/01/09

5,296

0.85

4,502

08/10/14

06/17/09

235,400

1.27

298,958

08/10/14

06/17/09

70,620

0.85

60,027

08/10/14

07/23/09

58,850

1.27

74,740

08/10/14

07/23/09

35,310

0.85

30,014

08/10/14

08/20/09

58,850

1.27

74,740

10/14/15

09/09/09

235,400

1.27

298,958

10/14/15

09/09/09

70,620

0.85

60,027

10/14/15

Outstanding at 12/31/2009

3,478,554

1.17

4,074,909

02/11/10

29,425

1.27

37,370

10/14/15

02/11/10

17,655

0.85

15,007

10/14/15

05/21/10

29,425

1.27

37,370

10/14/15

05/21/10

17,655

0.85

15,007

10/14/15

08/10/10

88,275

1.27

112,109

10/14/15

08/10/10

52,965

0.85

45,020

10/14/15

09/15/10

264,825

1.27

336,328

10/14/15

09/15/10

52,965

0.85

45,020

10/14/15

09/24/10

105,930

0.85

90,041

10/14/15

10/27/10

147,125

1.27

186,849

*

10/27/10

73,563

0.85

62,529

*

11/19/10

117,700

1.27

149,479

*

11/24/10

70,620

0.85

60,027

*

Outstanding at 12/31/2010

4,546,682

1.16

$

5,267,063

01/26/11

117,700

1.27

149,479

*

01/26/11

60,027

1.27

76,234

*

01/26/11

106,636

0.85

90,641

*

03/15/11

58,850

1.27

74,740

*

03/15/11

35,310

0.85

30,014

*

04/06/11

70,620

0.85

60,027

*

04/06/11

117,700

1.27

149,479

*

06/08/11

51,200

0.85

43,520

*

06/08/11

85,333

1.27

108,373

*

06/20/11

17,655

0.85

15,007

*

06/20/11

29,425

1.27

37,370

*

07/26/11

23,540

1.27

29,896

*

07/26/11

14,124

0.85

12,005

08/22/11

29,424

1.27

37,368

*

08/22/11

17,655

0.85

15,007

*

08/30/11

105,930

0.85

90,041

*

09/02/11

176,550

1.27

224,219

*

09/09/11

58,850

1.27

74,740

*

09/09/11

35,310

0.85

30,014

*

09/22/11

441,375

1.27

560,546

*

09/22/11

264,825

0.85

225,101

*

11/02/11

141,240

0.85

120,054

*

11/02/11

235,400

1.27

298,958

*

11/23/11

35,310

0.85

30,014

*

11/23/11

58,850

1.27

74,740

*

12/27/11

127,116

0.85

108,049

*

12/27/11

211,860

1.27

269,062

*

Outstanding at 12/31/11

7,274,497

1.14

$

8,301,757

01/31/12

117,700

1.27

149,479

*

01/31/12

70,620

0.85

60,027

*

02/02/12

76,505

1.27

97,161

*

02/02/12

45,903

0.85

39,018

*

02/10/12

58,850

1.27

74,740

*

02/10/12

35,310

0.85

30,014

*

04/10/12

41,666

0.85

35,416

*

04/10/12

69,443

1.27

88,193

*

05/11/12

35,310

0.85

30,014

*

05/11/12

58,850

1.27

74,740

*

06/04/12

35,310

0.85

30,014

*

06/19/12

35,310

0.85

30,014

*

06/19/12

58,850

1.27

74,740

*

07/24/12

44,138

1.27

56,055

*

07/24/12

30,896

0.85

26,262

*

07/30/12

235,400

1.27

298,958

*

07/30/12

141,240

0.85

120,054

*

08/28/12

258,352

1.27

328,107

*

08/28/12

155,011

0.85

131,759

*

Outstanding at 9/30/12

8,879,161

1.13

10,076,519

The warrants were issued in connection with the Preferred Stock Offering and were valued using the Lattice model and accounted for as described in Note 7.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.

+ References

No definition available.

+ Details

Name: us-gaap_FinancialInstrumentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 8 - Preferred Stock
9 Months Ended

Sep. 30, 2012

Notes

Note 8 - Preferred Stock
NOTE 8 – PREFERRED STOCK

Series A Convertible Preferred Stock

The Series A Convertible Preferred Stock (“Preferred Stock”) has been authorized by resolutions adopted by the Company’s Board of Directors and set forth in a Certificate of Designation, Preferences and Rights (“Certificate of Designation”), filed with the Secretary of State of Delaware on November 26, 2008, which contains the designations, rights, powers, preferences, qualifications and limitations of the Series A Preferred Stock. The shares of Preferred Stock are fully paid and non-assessable. As of September 30, 2012, the Company has issued 3,256 shares of Series A Preferred Stock.

Rank

The Preferred Stock ranks(i) senior to the common stock and any other class or series of the Company’s capital stock either specifically ranking by its terms junior to the Preferred Stock or not specifically ranking by its terms senior to or on parity with the Preferred Stock, (ii) on parity with any class or series of the Company’s capital stock specifically ranking by its terms on parity with the Preferred Stock, and (iii) junior to any class or series of capital stock specifically ranking by its terms senior to the Preferred Stock, in each case, as to payment of dividends or as to distributions of assets upon liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary. The approval of the holders of a majority of the Preferred Stock is required in order for the Company to issue any capital stock with rights on parity with or senior to the Preferred Stock.

Dividends

The holders of the Preferred Stock are entitled to receive annual cumulative per share dividends of 6.5% of the liquidation preference of the Preferred Stock, out of funds legally available, prior to any payment of dividends on the Company’s common stock or any other class of stock ranking junior to the Preferred Stock. Such dividends are payable in cash or shares of common stock, at the option of the Company, semiannually on the last business day of February and August of each year (each a “Dividend Payment Date”), commencing in February 2009 with respect to the period from issuance through such date. The holders of the Preferred Stock are entitled to share ratably with the holders of the common stock in any dividend declared on the common stock.

Dividends on the Preferred Stock will accrue whether or not the Company has earnings, whether or not there are funds legally available for the payment of such dividends and whether or not such dividends are declared. Dividends accumulate to the extent they are not paid on the Dividend Payment Date to which they relate. Dividends that are due in cash and which are not paid within (5) business days of the Dividend Payment date shall bear interest until paid at the default rate. According to Delaware law, the Company may declare and pay dividends or make other distributions on its capital stock only out of legally-available funds. In addition, no dividends or distributions may be declared, paid or made if the Company is or would be rendered insolvent by virtue of such dividend or distribution. The Company may not (i) pay any dividends in respect of any shares of capital stock ranking junior to the Preferred Stock (including the common stock), other than dividends payable in the form of additional shares of the same junior stock as that on which such dividend is declared, or (ii) redeem any shares of capital stock ranking junior to the Preferred Stock (including the common stock), unless and until all accumulated and unpaid dividends on the Preferred Stock have been, or contemporaneously are, declared and paid in full.

Conversion

At the election of the holder thereof, each share of Preferred Stock will be convertible into common stock, at any time after issuance, at the Conversion Rate, as it may be adjusted from time to time in accordance with the Certificate of Designation. The Preferred Stock will not convert automatically into Common Stock upon completion of this offering and only the underlying Common Stock issuable upon conversion is registered for the resale under this prospectus. The Conversion Rate initially will be 1,177 shares of common stock ($.85 per share) for each Share of Preferred Stock. If the Company issues or sells any shares of its common stock (or options, warrants or convertible securities, convertible or exchangeable into shares of common stock) hereinafter, a “Subsequent common stock Issuance”), then the Conversion Rate will be adjusted so that the number of shares of common stock issuable upon conversion of each share of preferred stock shall be equal to the quotient obtained by dividing $1,000 by the price per share of common stock (or the conversion price per share in the case of a sale of options, warrants or convertible securities) sold in such Subsequent common stock Issuance.

The Conversion Price is also subject to adjustment from time to time in the event of (i) the issuance of common stock as a dividend or distribution on any class of the Company’s capital stock; or (ii) the combination, subdivision or reclassification of the common stock. No fractional shares will be issued upon conversion. Payment of accumulated and unpaid dividends will be made upon conversion to the extent of legally-available funds. The shares of Preferred Stock may also be converted into common stock at the Conversion Rate at the Company’s option following the effectiveness of a Registration Statement, if the Company’s common stock trades above 200% of the Conversion Rate per share for a period of 20 consecutive trading days.

Voting Rights

The affirmative vote of the holders of at least two-thirds of the outstanding shares of Preferred Stock, voting as a class, shall be required to authorize, effect or validate (i) any change in the rights, privileges or preferences of the Preferred Stock that would adversely affect the Preferred Stock, or (ii) the authorization, creation, issuance or increase in the authorized or issued amount of any class or series of stock ranking on parity with or superior to the Preferred Stock with respect to the declaration and payment of dividends or distribution of assets upon liquidation, dissolution or winding-up of our Company. In addition, the holders of Preferred Stock shall have the right to vote, together with holders of common stock as single class, on all matters upon which the holders of common stock are entitled to vote pursuant to applicable Delaware law or the Company’s Certificate of Incorporation. The Preferred Stock shall vote on an “as converted basis” with each holder of Preferred Stock having one vote for each Conversion Share underlying such holder’s shares of Preferred Stock.

Liquidation

In the event of any voluntary or involuntary liquidation, dissolution or winding-up of the Company, before any payment or distribution of the assets of the Company (whether capital or surplus), or the proceeds thereof, may be made or set apart for the holders common stock or any stock ranking junior to Preferred Stock, the holders of Preferred Stock will be entitled to receive, out of the assets of the Company available for distribution to stockholders, a liquidating distribution of $1,000 per share, plus any accrued and unpaid dividends, subject to adjustment upon the occurrence of certain events. If, upon any voluntary or involuntary liquidation, dissolution or winding up of the Company, the assets of the Company are insufficient to make the full payment of $1,000 per share, plus all accrued and unpaid dividends on the Preferred Stock and similar payments on any other class of stock ranking on a parity with the Preferred Stock upon liquidation, then the holders of Preferred Stock and such other shares will share ratably in any such distribution of the Company’s assets in proportion to the full respective distributable amounts to which they are entitled. Certain events, including a consolidation or merger of the Company with or into another corporation or sale or conveyance of all or substantially all the property and assets of the Company will be deemed to be a liquidation, dissolution or winding-up of the Company for purposes of the foregoing.

Series B Convertible Preferred Stock

The Series B Convertible Preferred Stock (“Series B Preferred Stock”) has been authorized by resolutions adopted by the Company’s Board of Directors and set forth in a Certificate of Designation, Preferences and Rights (“Certificate of Designation”), filed with the Secretary of State of Delaware on September 2, 2011, which contains the designations, rights, powers, preferences, qualifications and limitations of the Series B Preferred Stock. The shares of Series B Preferred Stock are fully paid and non-assessable. As of September 30, 2012, the Company had issued 1,961 shares of Series B Preferred Stock.

Rank

The Series B Preferred Stock ranks(i) senior to the common stock and any other class or series of the Company’s capital stock either specifically ranking by its terms junior to the Series B Preferred Stock or not specifically ranking by its terms senior to or on parity with the Series B Preferred Stock, (ii) on parity with any class or series of the Company’s capital stock specifically ranking by its terms on parity with the Series B Preferred Stock, and (iii) junior to Series A Preferred Stock, in each case, as to distributions of assets upon liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary.

Dividends

The holders of the Series B Preferred Stock are entitled to receive annual cumulative per share dividends of 6.5% of the liquidation preference of the Series B Preferred Stock, out of funds legally available, prior to any payment of dividends on the Company’s common stock or any other class of stock ranking junior to the Series B Preferred Stock. Such dividends are payable in cash or shares of common stock, at the option of the Company. The holders of the Series B Preferred Stock are entitled to share ratably with the holders of the common stock in any dividend declared on the common stock.

Dividends on the Series B Preferred Stock will accrue whether or not the Company has earnings, whether or not there are funds legally available for the payment of such dividends and whether or not such dividends are declared. Dividends accumulate to the extent they are not paid on the Dividend Payment Date to which they relate. According to Delaware law, the Company may declare and pay dividends or make other distributions on its capital stock only out of legally-available funds. In addition, no dividends or distributions may be declared, paid or made if the Company is or would be rendered insolvent by virtue of such dividend or distribution. The Company may not (i) pay any dividends in respect of any shares of capital stock ranking junior to the Series B Preferred Stock (including the common stock), other than dividends payable in the form of additional shares of the same junior stock as that on which such dividend is declared, or (ii) redeem any shares of capital stock ranking junior to the Series B Preferred Stock (including the common stock), unless and until all accumulated and unpaid dividends on the Series B Preferred Stock have been, or contemporaneously are, declared and paid in full.

Conversion

At the election of the holder thereof, each share of Series B Preferred Stock will be convertible into common stock, at any time after issuance, at the Conversion Rate, as it may be adjusted from time to time in accordance with the Certificate of Designation. The Conversion Rate initially will be 1,177 shares of common stock ($.85 per share) for each Share of Series B Preferred Stock.

The Conversion Price is subject to adjustment from time to time in the event of (i) the issuance of common stock as a dividend or distribution on any class of the Company’s capital stock; or (ii) the combination, subdivision or reclassification of the common stock but does not contain the same price protection ratchets as the Series A Preferred Stock. No fractional shares will be issued upon conversion. Payment of accumulated and unpaid dividends will be made upon conversion to the extent of legally-available funds. The shares of Preferred Stock may also be converted into common stock at the Conversion Rate at the Company’s option following the effectiveness of a Registration Statement, if the Company’s common stock trades above 200% of the Conversion Rate per share for a period of 20 consecutive trading days.

Voting Rights

The affirmative vote of the holders of at least a majority of the outstanding shares of Preferred Stock, voting as a class, shall be required to authorize, effect or validate (i) any change in the rights, privileges or preferences of the Series B Preferred Stock that would adversely affect the Series B Preferred Stock, or (ii) the authorization, creation, issuance or increase in the authorized or issued amount of any class or series of stock ranking on parity with or superior to the Series B Preferred Stock with respect to the declaration and payment of dividends or distribution of assets upon liquidation, dissolution or winding-up of our Company. In addition, the holders of Preferred Stock shall have the right to vote, together with holders of common stock as single class, on all matters upon which the holders of common stock are entitled to vote pursuant to applicable Delaware law or the Company’s Certificate of Incorporation. The Series B Preferred Stock shall vote on an “as converted basis” with each holder of Preferred Stock having one vote for each Conversion Share underlying such holder’s shares of Preferred Stock.

Liquidation

In the event of any voluntary or involuntary liquidation, dissolution or winding-up of the Company, before any payment or distribution of the assets of the Company (whether capital or surplus), or the proceeds thereof, may be made or set apart for the holders common stock or any stock ranking junior to Preferred Stock, after payment to the holders of Series A Preferred Stock the holders of Preferred Stock will be entitled to receive, out of the assets of the Company available for distribution to stockholders, a liquidating distribution of $1,000 per share, plus any accrued and unpaid dividends, subject to adjustment upon the occurrence of certain events. If, upon any voluntary or involuntary liquidation, dissolution or winding up of the Company, the assets of the Company are insufficient to make the full payment of $1,000 per share, plus all accrued and unpaid dividends on the Preferred Stock and similar payments on any other class of stock ranking on a parity with the Preferred Stock upon liquidation, then the holders of Preferred Stock and such other shares will share ratably in any such distribution of the Company’s assets in proportion to the full respective distributable amounts to which they are entitled. Certain events, including a consolidation or merger of the Company with or into another corporation or sale or conveyance of all or substantially all the property and assets of the Company will be deemed to be a liquidation, dissolution or winding-up of the Company for purposes of the foregoing.

During the nine months ended September 30, 2012, the Company issued 931 shares of its par value $0.10 Series B Convertible Preferred Stock for cash at $1,000 per share.

During the year ended December 31, 2011, the Company issued 419 shares of its par value $0.10 Series A Convertible Preferred Stock and 1,030 shares of its par value $0.10 Series B Convertible Preferred Stock, for a total of 1,449 shares of Preferred Stock, for cash at $1,000 per share.

During the year ended December 31, 2010, the Company issued 575 shares of its par value $0.10 Series A Convertible Preferred Stock for cash at $1,000 per share.

During the year ended December 31, 2009, the Company issued 810 shares of its par value $0.10 Series A Convertible Preferred Stock at $1,000 per share.

On November 25, 2008, the Company issued 562 shares of its par value $0.10 Series A Convertible Preferred Stock for cash at $1,000 per share.

On November 25, 2008, the Company issued 890 shares of its par value $0.10 Series A Convertible Preferred Stock to extinguish bridge debt financing totaling $889,875.

Between January 24 and April 15, 2008, the Company issued 1,082,500 common shares of the Company at $0.85 per common share in accordance with the Bridge Note agreements.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.

+ References

No definition available.

+ Details

Name: us-gaap_PreferredStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 9 - Common Stock
9 Months Ended

Sep. 30, 2012

Notes

Note 9 - Common Stock
NOTE 9 – COMMON STOCK

During the nine months ended September 30, 2012, the Company issued 7,500 shares of common stock to its attorneys for services rendered. The shares were valued based on the price of $0.85 per share and the Company recognized $6,375 in consulting expenses.

During the year ended December 31, 2011, the Company issued 640,000 shares of common stock to officers and consultants in exchange for services provided. The shares were valued based on the price of $0.85 per share and the Company recognized $151,000 in salaries and wages, $289,000 in consulting expense, and extinguished $104,000 in accrued officer salary.

On September 16, 2010 the Company issued 400,000 shares of common stock to officers and consultants of the Company in exchange for services provided. The shares were valued based on the price of $0.85 per share and the Company recognized $340,000 in consulting expense.

On December 28, 2010 the Company issued 450,000 shares of common stock to officers and consultants of the Company in exchange for services provided. The shares were valued based on the price of $0.85 per share and the Company recognized $382,500 in consulting expense.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section B

-Paragraph 7, 11A

-Chapter 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 23: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 11 - Stock Options
9 Months Ended

Sep. 30, 2012

Notes

Note 11 - Stock Options
NOTE 11 – STOCK OPTIONS

The Company’s 2009 Employee Stock Incentive Plan (the “2009 Option Plan”) was adapted by the Company’s Board of Directors on February 9, 2009 in order to motivate participants by means of stock options and restricted stock to achieve the Company’s long-term performance goals and enable our employees, officers, directors and consultants to participate in our long term growth and financial success. The 2009 Plan, which is administered by our Board of Directors, authorizes the issuance of a maximum of 500,000 shares of our common stock, which may be authorized and unissued shares or treasury shares. Employee options shall be deemed Incentive Stock Options (as defined in the 2009 Option Plan) to the maximum extent permitted by Section 422 of the Internal Revenue Code including a five-year limit on exercise for 10% or greater stockholders with any excess grant to the above individuals over the limits set by Section 422 being Non-Qualified Stock Options as defined in the 2009 Option Plan. Both the Incentive Stock Options or any Non-Qualified Stock Options must be granted at an exercise price of not less than the fair market value of shares of common stock at the time the option is granted and Incentive Stock Options granted to 10% or greater stockholders must be granted at an exercise price of not less than 110% of the fair market value of the shares on the date of grant.

If any award under the 2009 Plan terminates, expires unexercised, or is cancelled, the shares of common stock that would otherwise have been issuable pursuant thereto will be available for issuance pursuant to the grant of new awards. The 2009 Plan will terminate on February 9, 2019. As of September 30, 2012 the following options had been granted under the plan:

On July 12, 2010 the Company issued 100,000 options to a member of its board of directors under the 2009 plan. The options have an exercise price of $0.85 per share and have a life of ten years. The options vest as follows: one third on the date of grant, one third on each of the second and third anniversary dates from the date of grant. The Company valued these options using the Black-Scholes option pricing model under the following assumptions: $0.85 stock price, $0.85 stock price, 10 years to maturity, 400% volatility, 2.02% risk free rate. The Company has recorded amortization expense of $14,443 and $17,526 related to these options for the nine months ended September 30, 2012 and 2011, respectively.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Also includes disclosure of compensation-related costs for equity-based compensation which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details, and employee stock purchase plan details.

+ References

No definition available.

+ Details

Name: us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Tables)
9 Months Ended

Sep. 30, 2012

Tables/Schedules

Schedule of derivative instruments
The carrying amounts reported in the balance sheets for cash, accounts payable and accrued expenses, approximate their fair market value based on the short-term maturity of these instruments. The following table presents assets and liabilities that are measured and recognized at fair value as of September 30, 2012, on a recurring basis:

Description

Level 1

Level 2

Level 3

Gains (Losses)

Derivative Liability

$

-

$

-

$

(5,660,208)

$

(32,923)

Total

$

-

$

-

$

(5,660,208)

$

(32,923)

The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2011, on a recurring basis:

Description

Level 1

Level 2

Level 3

Gains (Losses)

Derivative Liability

$

-

$

-

$

(5,377,308)

$

(245,087)

Total

$

-

$

-

$

(5,377,308)

$

(245,087)

X

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 205G

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44C

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_TableTextBlockSupplementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Details) (USD $)

Sep. 30, 2012

Dec. 31, 2011

PropertyPlantAndEquipmentGross $ 5,390 $ 5,390

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets (4,930) (3,981)

EQUIPMENT, net $ 460 $ 1,409

X

- Definition

Cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land or leased assets).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Gross amount of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 41 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

Statements of Cash Flows (USD $)
9 Months Ended 77 Months Ended

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2012

OPERATING ACTIVITIES

Net loss $ (800,202) $ (1,338,132) $ (8,200,804)

Common stock issued for services 6,375 1,272,875

Warrants and options issued for services 14,443 17,526 77,021

Common stock issued with bridge financing 1,139,001

Depreciation expense 949 948 4,930

Change in derivative liability, net of bifurcation 32,923 172,327 1,019,246

Change in accounts payable and accrued expenses 35,272 573,072 534,707

Net Cash Used in Operating Activities (710,240) (569,259) (4,153,024)

INVESTING ACTIVITIES

Purchase of equipment (5,390)

Net Cash Used in Investing Activities (5,390)

FINANCING ACTIVITIES

Preferred stock issued for cash 931,000 1,018,499 4,326,500

Stock offering costs paid (186,325) (173,966) (1,013,102)

Common stock issued for cash 10,000

Proceeds from notes payable 55,075 944,950

Repayments of notes payable (35,000) (35,000)

Net Cash Provided by Financing Activities 764,750 844,533 4,233,348

NET INCREASE (DECREASE) IN CASH 54,510 275,274 74,934

CASH AT BEGINNING OF PERIOD 20,424 48,993

CASH AT END OF PERIOD 74,934 324,267 74,934

CASH PAID FOR:

Interest

Income taxes

NON CASH FINANCING ACTIVITIES:

Preferred stock issued for bridge financing 889,875

Derivative liability non cash financing activity $ 249,979 $ 1,531,796 $ 4,640,965

X

- Details

Name: fil_CASHPAIDFORAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: fil_CommonStockIssuedWithBridgeFinancing

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: fil_DerivativeLiabilityNonCashFinancingActivity

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: fil_WarrantsAndOptionsIssuedForServices

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

No definition available.

+ Details

Name: us-gaap_CashPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 27

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInDerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The fair value of restricted stock or stock options granted to nonemployees as payment for services rendered or acknowledged claims.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net cash inflow or outflow from financing activity for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash inflow or outflow from investing activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for cost incurred directly with the issuance of an equity security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18, 19, 20

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfStockIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from a borrowing supported by a written promise to pay an obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow for a borrowing supported by a written promise to pay an obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 20

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 42 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 5 - Accrued Liabilities
9 Months Ended

Sep. 30, 2012

Notes

Note 5 - Accrued Liabilities
NOTE 5 – ACCRUED LIABILITIES

Pursuant to the applicable Codification literature, the Company has concluded it is probable that it will pay $85,738 in liquidated damages pursuant to the registration rights clause in certain of the securities sold in fiscal years 2008 and 2009, the Company was required to file a registration statement by January 27, 2009. The Company failed to do so until April 7, 2009, resulting in liquidated damages of 2% per month of the gross proceeds, which approximated $1.8 million as of that date. During the year ended December 31, 2009, the Company’s registration statement covering the securities was declared effective by the SEC. Each holder is entitled to $47.32 per share owned. The Company has resolved to pay the liquidated damages in shares of Common Stock valued at $1.00 per share, pursuant to the terms and provisions of the Certificate of Designation, Preferences and Rights of Series A Convertible Preferred Stock.

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a),20,24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 24

-Article 5

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 5 - Accrued Liabilities (Details) (USD $)

Sep. 30, 2012

Probable liquidated damages $ 85,738

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: fil_ProbableLiquidatedDamages

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 18 105 1 true 0 0 false 3 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://signpathpharma.com/20120930/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - Balance Sheets Sheet http://signpathpharma.com/20120930/role/idr_BalanceSheets Balance Sheets false false R3.htm 000030 - Statement - Balance Sheets Parenthetical Sheet http://signpathpharma.com/20120930/role/idr_BalanceSheetsParenthetical Balance Sheets Parenthetical false false R4.htm 000040 - Statement - Statements of Operations Sheet http://signpathpharma.com/20120930/role/idr_StatementsOfOperations Statements of Operations false false R5.htm 000050 - Statement - Statements of Cash Flows Sheet http://signpathpharma.com/20120930/role/idr_StatementsOfCashFlows Statements of Cash Flows false false R6.htm 000060 - Disclosure - Note 1 - Condensed Financial Statements Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote1CondensedFinancialStatements Note 1 - Condensed Financial Statements false false R7.htm 000070 - Disclosure - Note 2 - Going Concern Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote2GoingConcern Note 2 - Going Concern false false R8.htm 000080 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote3SummaryOfSignificantAccountingPolicies Note 3 - Summary of Significant Accounting Policies false false R9.htm 000090 - Disclosure - Note 4 - Equipment Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote4Equipment Note 4 - Equipment false false R10.htm 000100 - Disclosure - Note 5 - Accrued Liabilities Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote5AccruedLiabilities Note 5 - Accrued Liabilities false false R11.htm 000110 - Disclosure - Note 6 - Note Payable Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote6NotePayable Note 6 - Note Payable false false R12.htm 000120 - Disclosure - Note 7 - Derivative Liability and Fair Value Measurements Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote7DerivativeLiabilityAndFairValueMeasurements Note 7 - Derivative Liability and Fair Value Measurements false false R13.htm 000130 - Disclosure - Note 8 - Preferred Stock Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote8PreferredStock Note 8 - Preferred Stock false false R14.htm 000140 - Disclosure - Note 9 - Common Stock Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote9CommonStock Note 9 - Common Stock false false R15.htm 000150 - Disclosure - Note 10 - Warrants Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote10Warrants Note 10 - Warrants false false R16.htm 000160 - Disclosure - Note 11 - Stock Options Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote11StockOptions Note 11 - Stock Options false false R17.htm 000170 - Disclosure - Note 12- Subsequent Events Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote12SubsequentEvents Note 12- Subsequent Events false false R18.htm 000180 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Use of Estimates (Policies) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesUseOfEstimatesPolicies Note 3 - Summary of Significant Accounting Policies: Use of Estimates (Policies) false false R19.htm 000190 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Derivative Financial Instruments (Policies) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesDerivativeFinancialInstrumentsPolicies Note 3 - Summary of Significant Accounting Policies: Derivative Financial Instruments (Policies) false false R20.htm 000200 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsPolicies Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies) false false R21.htm 000210 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Tables) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesScheduleOfDerivativeInstrumentsTables Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Tables) false false R22.htm 000220 - Disclosure - Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Tables) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote4EquipmentScheduleOfPropertyAndEquipmentTables Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Tables) false false R23.htm 000230 - Disclosure - Note 2 - Going Concern (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote2GoingConcernDetails Note 2 - Going Concern (Details) false false R24.htm 000240 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesScheduleOfDerivativeInstrumentsDetails Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Details) false false R25.htm 000250 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesDetails Note 3 - Summary of Significant Accounting Policies (Details) false false R26.htm 000260 - Disclosure - Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote4EquipmentScheduleOfPropertyAndEquipmentDetails Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Details) false false R27.htm 000270 - Disclosure - Note 5 - Accrued Liabilities (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote5AccruedLiabilitiesDetails Note 5 - Accrued Liabilities (Details) false false R28.htm 000280 - Disclosure - Note 6 - Note Payable (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote6NotePayableDetails Note 6 - Note Payable (Details) false false R29.htm 000290 - Disclosure - Note 8 - Preferred Stock (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote8PreferredStockDetails Note 8 - Preferred Stock (Details) false false R30.htm 000300 - Disclosure - Note 9 - Common Stock (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote9CommonStockDetails Note 9 - Common Stock (Details) false false R31.htm 000310 - Disclosure - Note 11 - Stock Options (Details) Sheet http://signpathpharma.com/20120930/role/idr_DisclosureNote11StockOptionsDetails Note 11 - Stock Options (Details) false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 000030 - Statement - Balance Sheets Parenthetical Process Flow-Through: 000040 - Statement - Statements of Operations Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: 000050 - Statement - Statements of Cash Flows sppxbrl-20120930.xml sppxbrl-20120930.xsd sppxbrl-20120930_cal.xml sppxbrl-20120930_def.xml sppxbrl-20120930_lab.xml sppxbrl-20120930_pre.xml true true XML 45 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6

Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)
9 Months Ended

Sep. 30, 2012

Policies

Fair Value of Financial Instruments
Fair Value of Financial Instruments

In accordance with ASC 820, the carrying value of cash and cash equivalents, accounts receivable and accounts payable approximates fair value due to the short-term maturity of these instruments. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

X

- Definition

Disclosure of accounting policy for determining the fair value of financial instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2155942

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 8, 10, 12, 13, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PolicyTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

Balance Sheets (USD $)	Sep. 30, 2012	Dec. 31, 2011
CURRENT ASSETS
Cash	$ 74,934	$ 20,424
Total Current Assets	74,934	20,424
EQUIPMENT, net	460	1,409
TOTAL ASSETS	75,394	21,833
CURRENT LIABILITIES
Accounts payable and accrued expenses	534,710	499,435
Related party note payable	20,075
Derivative liability	5,660,208	5,377,308
Total Current Liabilities	6,214,993	5,876,743
STOCKHOLDERS' DEFICIT
Preferred stock; $0.10 par value, 5,000,000 shares authorized 5,217 and 4,286 shares issued and outstanding, respectively	522	429
Common stock; $0.001 par value, 45,000,000 shares authorized; 12,837,500 shares issued and outstanding, respectively	12,839	12,831
Additional paid-in capital	2,047,844	1,532,432
Deficit accumulated during the development stage	(8,200,804)	(7,400,602)
Total Stockholders' Deficit	(6,139,599)	(5,854,910)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 75,394	$ 21,833

Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended	77 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011	Sep. 30, 2012
Derivative liability	$ (5,660,208)		$ (5,660,208)		$ (5,377,308)	$ (5,660,208)
Gain (loss) on derivative liability	$ (18,385)	$ (177,011)	$ (32,923)	$ (172,327)	$ (245,087)	$ (1,019,246)

Balance Sheets Parenthetical (USD $)	Sep. 30, 2012	Dec. 31, 2011
Convertible preferred stock par value	$ 0.10	$ 0.10
Convertible preferred stock shares authorized	5,000,000	5,000,000
Preferred stock shares issued	5,217	5,217
Preferred stock shares outstanding	4,286	4,286
Common stock par value	$ 0.001	$ 0.001
Common stock shares authorized	45,000,000	45,000,000
Common stock shares issued	12,837,500	12,837,500
Common stock shares outstanding	12,837,500	12,837,500

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2012	Nov. 15, 2012
Document and Entity Information
Entity Registrant Name	SIGNPATH PHARMA, INC.
Document Type	10-Q
Document Period End Date	Sep. 30, 2012
Amendment Flag	false
Entity Central Index Key	0001455694
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		12,837,500
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3

Statements of Operations (USD $)	3 Months Ended		9 Months Ended		77 Months Ended
Statements of Operations (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
REVENUES
OPERATING EXPENSES
General and administrative	15,177	40,723	29,889	113,916	1,233,932
Professional fees	20,825	35,685	66,363	116,917	920,130
Financing expense					1,063,401
Research and development	173,108	161,765	517,590	934,972	3,034,224
Salaries and wages	52,486		153,437		947,432
Total Operating Expenses	261,596	238,173	767,279	1,165,805	7,199,119
OPERATING LOSS	(261,596)	(238,173)	(767,279)	(1,165,805)	(7,199,119)
OTHER INCOME (EXPENSE)
Gain (loss) on derivative liability	(18,385)	(177,011)	(32,923)	(172,327)	(1,019,246)
Grant income					81,556
Interest expense					(63,995)
Total Other Income (Expense)	(18,385)	(177,011)	(32,923)	(172,327)	(1,001,685)
NET LOSS BEFORE INCOME TAXES	(279,981)	(415,184)	(800,202)	(1,338,132)	(8,200,804)
PROVISION FOR INCOME TAXES
NET LOSS	$ (279,981)	$ (415,184)	$ (800,202)	$ (1,338,132)	$ (8,200,804)
BASIC AND DILUTED LOSS PER SHARE	$ 0	$ 0	$ 0	$ 0
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	12,830,000	12,190,000	12,830,000	12,190,000

Note 2 - Going Concern (Details) (USD $)	3 Months Ended		9 Months Ended		77 Months Ended
Note 2 - Going Concern (Details) (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Dec. 31, 2011
Net loss	$ 279,981	$ 415,184	$ 800,202	$ 1,338,132	$ 8,200,804
Deficit accumulated during the development stage	$ 8,200,804		$ 8,200,804		$ 8,200,804	$ 7,400,602

Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Details) (USD $)	Sep. 30, 2012	Dec. 31, 2011
PropertyPlantAndEquipmentGross	$ 5,390	$ 5,390
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	(4,930)	(3,981)
EQUIPMENT, net	$ 460	$ 1,409

Statements of Cash Flows (USD $)	9 Months Ended		77 Months Ended
Statements of Cash Flows (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
OPERATING ACTIVITIES
Net loss	$ (800,202)	$ (1,338,132)	$ (8,200,804)
Common stock issued for services	6,375		1,272,875
Warrants and options issued for services	14,443	17,526	77,021
Common stock issued with bridge financing			1,139,001
Depreciation expense	949	948	4,930
Change in derivative liability, net of bifurcation	32,923	172,327	1,019,246
Change in accounts payable and accrued expenses	35,272	573,072	534,707
Net Cash Used in Operating Activities	(710,240)	(569,259)	(4,153,024)
INVESTING ACTIVITIES
Purchase of equipment			(5,390)
Net Cash Used in Investing Activities			(5,390)
FINANCING ACTIVITIES
Preferred stock issued for cash	931,000	1,018,499	4,326,500
Stock offering costs paid	(186,325)	(173,966)	(1,013,102)
Common stock issued for cash			10,000
Proceeds from notes payable	55,075		944,950
Repayments of notes payable	(35,000)		(35,000)
Net Cash Provided by Financing Activities	764,750	844,533	4,233,348
NET INCREASE (DECREASE) IN CASH	54,510	275,274	74,934
CASH AT BEGINNING OF PERIOD	20,424	48,993
CASH AT END OF PERIOD	74,934	324,267	74,934
CASH PAID FOR:
Interest
Income taxes
NON CASH FINANCING ACTIVITIES:
Preferred stock issued for bridge financing			889,875
Derivative liability non cash financing activity	$ 249,979	$ 1,531,796	$ 4,640,965